start,end,Title_of_study,Last_name_of_first_author,Publication_year,Covidence_number,Year_s_that_study_was_conducted,Year_s_that_study_was_conducted_,Year_s_that_study_was_conducted1,Year_s_that_study_was_conducted2,Year_s_that_study_was_conducted3,Year_s_that_study_was_conducted4,Year_s_that_study_was_conducted5,Year_s_that_study_was_conducted6,Year_s_that_study_was_conducted7,Year_s_that_study_was_conducted8,Year_s_that_study_was_conducted9,Year_s_that_study_was_conducte10,Year_s_that_study_was_conducte11,Year_s_that_study_was_conducte12,Year_s_that_study_was_conducte13,Year_s_that_study_was_conducte14,Year_s_that_study_was_conducte15,Year_s_that_study_was_conducte16,Year_s_that_study_was_conducte17,Year_s_that_study_was_conducte18,Year_s_that_study_was_conducte19,Year_s_that_study_was_conducte20,Year_s_that_study_was_conducte21,Year_s_that_study_was_conducte22,Year_s_that_study_was_conducte23,Year_s_that_study_was_conducte24,Year_s_that_study_was_conducte25,Year_s_that_study_was_conducte26,Year_s_that_study_was_conducte27,Year_s_that_study_was_conducte28,Year_s_that_study_was_conducte29,Year_s_that_study_was_conducte30,Year_s_that_study_was_conducte31,Year_s_that_study_was_conducte32,Year_s_that_study_was_conducte33,Year_s_that_study_was_conducte34,Year_s_that_study_was_conducte35,Year_s_that_study_was_conducte36,Year_s_that_study_was_conducte37,Year_s_that_study_was_conducte38,Year_s_that_study_was_conducte39,Year_s_that_study_was_conducte40,Year_s_that_study_was_conducte41,Year_s_that_study_was_conducte42,Year_s_of_original_sample_collec,Year_s_of_original_sample_colle1,Year_s_of_original_sample_colle2,Year_s_of_original_sample_colle3,Year_s_of_original_sample_colle4,Year_s_of_original_sample_colle5,Year_s_of_original_sample_colle6,Year_s_of_original_sample_colle7,Year_s_of_original_sample_colle8,Year_s_of_original_sample_colle9,Year_s_of_original_sample_coll10,Year_s_of_original_sample_coll11,Year_s_of_original_sample_coll12,Year_s_of_original_sample_coll13,Year_s_of_original_sample_coll14,Year_s_of_original_sample_coll15,Year_s_of_original_sample_coll16,Year_s_of_original_sample_coll17,Year_s_of_original_sample_coll18,Year_s_of_original_sample_coll19,Year_s_of_original_sample_coll20,Year_s_of_original_sample_coll21,Year_s_of_original_sample_coll22,Year_s_of_original_sample_coll23,Year_s_of_original_sample_coll24,Year_s_of_original_sample_coll25,Year_s_of_original_sample_coll26,Year_s_of_original_sample_coll27,Year_s_of_original_sample_coll28,Year_s_of_original_sample_coll29,Year_s_of_original_sample_coll30,Year_s_of_original_sample_coll31,Year_s_of_original_sample_coll32,Year_s_of_original_sample_coll33,Year_s_of_original_sample_coll34,Year_s_of_original_sample_coll35,Year_s_of_original_sample_coll36,Year_s_of_original_sample_coll37,Year_s_of_original_sample_coll38,Year_s_of_original_sample_coll39,Year_s_of_original_sample_coll40,Year_s_of_original_sample_coll41,Year_s_of_original_sample_coll42,Year_s_of_original_sample_coll43,Year_s_of_original_sample_coll44,Year_s_of_original_sample_coll45,Year_s_of_original_sample_coll46,Year_s_of_original_sample_coll47,Year_s_of_original_sample_coll48,Year_s_of_original_sample_coll49,Year_s_of_original_sample_coll50,Year_s_of_original_sample_coll51,Year_s_of_original_sample_coll52,Year_s_of_original_sample_coll53,Year_s_of_original_sample_coll54,Year_s_of_original_sample_coll55,Year_s_of_original_sample_coll56,Year_s_of_original_sample_coll57,Year_s_of_original_sample_coll58,Year_s_of_original_sample_coll59,Year_s_of_original_sample_coll60,Year_s_of_original_sample_coll61,Year_s_of_original_sample_coll62,Year_s_of_original_sample_coll63,Year_s_of_original_sample_coll64,Year_s_of_original_sample_coll65,Year_s_of_original_sample_coll66,Year_s_of_original_sample_coll67,Year_s_of_original_sample_coll68,Year_s_of_original_sample_coll69,Year_s_of_original_sample_coll70,Year_s_of_original_sample_coll71,Year_s_of_original_sample_coll72,Year_s_of_original_sample_coll73,Year_s_of_original_sample_coll74,Year_s_of_original_sample_coll75,Year_s_of_original_sample_coll76,Year_s_of_original_sample_coll77,Year_s_of_original_sample_coll78,Year_s_of_original_sample_coll79,Year_s_of_original_sample_coll80,Year_s_of_original_sample_coll81,Year_s_of_original_sample_coll82,Year_s_of_original_sample_coll83,Year_s_of_original_sample_coll84,Year_s_of_original_sample_coll85,Year_s_of_original_sample_coll86,Year_s_of_original_sample_coll87,Year_s_of_original_sample_coll88,Year_s_of_original_sample_coll89,Year_s_of_original_sample_coll90,Year_s_of_original_sample_coll91,Year_s_of_original_sample_coll92,Year_s_of_original_sample_coll93,Year_s_of_original_sample_coll94,Year_s_of_original_sample_coll95,Year_s_of_original_sample_coll96,Year_s_of_original_sample_coll97,Year_s_of_original_sample_coll98,Year_s_of_original_sample_coll99,Year_s_of_original_sample_col100,Year_s_of_original_sample_col101,Year_s_of_original_sample_col102,Year_s_of_original_sample_col103,Year_s_of_original_sample_col104,Year_s_of_original_sample_col105,Year_s_of_original_sample_col106,Year_s_of_original_sample_col107,Year_s_of_original_sample_col108,Year_s_of_original_sample_col109,Year_s_of_original_sample_col110,Year_s_of_original_sample_col111,Year_s_of_original_sample_col112,Year_s_of_original_sample_col113,Year_s_of_original_sample_col114,Year_s_of_original_sample_col115,Year_s_of_original_sample_col116,Year_s_of_original_sample_col117,Year_s_of_original_sample_col118,Year_s_of_original_sample_col119,Year_s_of_original_sample_col120,Year_s_of_original_sample_col121,Year_s_of_original_sample_col122,Year_s_of_original_sample_col123,Study_country_s_001,Study_country_s_001_AF,Study_country_s_001_AX,Study_country_s_001_AL,Study_country_s_001_DZ,Study_country_s_001_AS,Study_country_s_001_AD,Study_country_s_001_AO,Study_country_s_001_AI,Study_country_s_001_AQ,Study_country_s_001_AG,Study_country_s_001_AR,Study_country_s_001_AM,Study_country_s_001_AW,Study_country_s_001_AU,Study_country_s_001_AT,Study_country_s_001_AZ,Study_country_s_001_BS,Study_country_s_001_BH,Study_country_s_001_BD,Study_country_s_001_BB,Study_country_s_001_BY,Study_country_s_001_BE,Study_country_s_001_BZ,Study_country_s_001_BJ,Study_country_s_001_BM,Study_country_s_001_BT,Study_country_s_001_BO,Study_country_s_001_BQ,Study_country_s_001_BA,Study_country_s_001_BW,Study_country_s_001_BV,Study_country_s_001_BR,Study_country_s_001_IO,Study_country_s_001_BN,Study_country_s_001_BG,Study_country_s_001_BF,Study_country_s_001_BI,Study_country_s_001_KH,Study_country_s_001_CM,Study_country_s_001_CA,Study_country_s_001_CV,Study_country_s_001_KY,Study_country_s_001_CF,Study_country_s_001_TD,Study_country_s_001_CL,Study_country_s_001_CN,Study_country_s_001_CX,Study_country_s_001_CC,Study_country_s_001_CO,Study_country_s_001_KM,Study_country_s_001_CG,Study_country_s_001_CD,Study_country_s_001_CK,Study_country_s_001_CR,Study_country_s_001_CI,Study_country_s_001_HR,Study_country_s_001_CU,Study_country_s_001_CW,Study_country_s_001_CY,Study_country_s_001_CZ,Study_country_s_001_DK,Study_country_s_001_DJ,Study_country_s_001_DM,Study_country_s_001_DO,Study_country_s_001_EC,Study_country_s_001_EG,Study_country_s_001_SV,Study_country_s_001_GQ,Study_country_s_001_ER,Study_country_s_001_EE,Study_country_s_001_ET,Study_country_s_001_FK,Study_country_s_001_FO,Study_country_s_001_FJ,Study_country_s_001_FI,Study_country_s_001_FR,Study_country_s_001_GF,Study_country_s_001_PF,Study_country_s_001_TF,Study_country_s_001_GA,Study_country_s_001_GM,Study_country_s_001_GE,Study_country_s_001_DE,Study_country_s_001_GH,Study_country_s_001_GI,Study_country_s_001_GR,Study_country_s_001_GL,Study_country_s_001_GD,Study_country_s_001_GP,Study_country_s_001_GU,Study_country_s_001_GT,Study_country_s_001_GG,Study_country_s_001_GN,Study_country_s_001_GW,Study_country_s_001_GY,Study_country_s_001_HT,Study_country_s_001_HM,Study_country_s_001_VA,Study_country_s_001_HN,Study_country_s_001_HK,Study_country_s_001_HU,Study_country_s_001_IS,Study_country_s_001_IN,Study_country_s_001_ID,Study_country_s_001_IR,Study_country_s_001_IQ,Study_country_s_001_IE,Study_country_s_001_IM,Study_country_s_001_IL,Study_country_s_001_IT,Study_country_s_001_JM,Study_country_s_001_JP,Study_country_s_001_JE,Study_country_s_001_JO,Study_country_s_001_KZ,Study_country_s_001_KE,Study_country_s_001_KI,Study_country_s_001_KP,Study_country_s_001_KR,Study_country_s_001_KW,Study_country_s_001_KG,Study_country_s_001_LA,Study_country_s_001_LV,Study_country_s_001_LB,Study_country_s_001_LS,Study_country_s_001_LR,Study_country_s_001_LY,Study_country_s_001_LI,Study_country_s_001_LT,Study_country_s_001_LU,Study_country_s_001_MO,Study_country_s_001_MK,Study_country_s_001_MG,Study_country_s_001_MW,Study_country_s_001_MY,Study_country_s_001_MV,Study_country_s_001_ML,Study_country_s_001_MT,Study_country_s_001_MH,Study_country_s_001_MQ,Study_country_s_001_MR,Study_country_s_001_MU,Study_country_s_001_YT,Study_country_s_001_MX,Study_country_s_001_FM,Study_country_s_001_MD,Study_country_s_001_MC,Study_country_s_001_MN,Study_country_s_001_ME,Study_country_s_001_MS,Study_country_s_001_MA,Study_country_s_001_MZ,Study_country_s_001_MM,Study_country_s_001_NA,Study_country_s_001_NR,Study_country_s_001_NP,Study_country_s_001_NL,Study_country_s_001_NC,Study_country_s_001_NZ,Study_country_s_001_NI,Study_country_s_001_NE,Study_country_s_001_NG,Study_country_s_001_NU,Study_country_s_001_NF,Study_country_s_001_MP,Study_country_s_001_NO,Study_country_s_001_OM,Study_country_s_001_PK,Study_country_s_001_PW,Study_country_s_001_PS,Study_country_s_001_PA,Study_country_s_001_PG,Study_country_s_001_PY,Study_country_s_001_PE,Study_country_s_001_PH,Study_country_s_001_PN,Study_country_s_001_PL,Study_country_s_001_PT,Study_country_s_001_PR,Study_country_s_001_QA,Study_country_s_001_RE,Study_country_s_001_RO,Study_country_s_001_RU,Study_country_s_001_RW,Study_country_s_001_BL,Study_country_s_001_SH,Study_country_s_001_KN,Study_country_s_001_LC,Study_country_s_001_MF,Study_country_s_001_PM,Study_country_s_001_VC,Study_country_s_001_WS,Study_country_s_001_SM,Study_country_s_001_ST,Study_country_s_001_SA,Study_country_s_001_SN,Study_country_s_001_RS,Study_country_s_001_SC,Study_country_s_001_SL,Study_country_s_001_SG,Study_country_s_001_SX,Study_country_s_001_SK,Study_country_s_001_SI,Study_country_s_001_SB,Study_country_s_001_SO,Study_country_s_001_ZA,Study_country_s_001_GS,Study_country_s_001_SS,Study_country_s_001_ES,Study_country_s_001_LK,Study_country_s_001_SD,Study_country_s_001_SR,Study_country_s_001_SJ,Study_country_s_001_SZ,Study_country_s_001_SE,Study_country_s_001_CH,Study_country_s_001_SY,Study_country_s_001_TW,Study_country_s_001_TJ,Study_country_s_001_TZ,Study_country_s_001_TH,Study_country_s_001_TL,Study_country_s_001_TG,Study_country_s_001_TK,Study_country_s_001_TO,Study_country_s_001_TT,Study_country_s_001_TN,Study_country_s_001_TR,Study_country_s_001_TM,Study_country_s_001_TC,Study_country_s_001_TV,Study_country_s_001_UG,Study_country_s_001_UA,Study_country_s_001_AE,Study_country_s_001_GB,Study_country_s_001_US,Study_country_s_001_UM,Study_country_s_001_UY,Study_country_s_001_UZ,Study_country_s_001_VU,Study_country_s_001_VE,Study_country_s_001_VN,Study_country_s_001_VG,Study_country_s_001_VI,Study_country_s_001_WF,Study_country_s_001_EH,Study_country_s_001_YE,Study_country_s_001_ZM,Study_country_s_001_ZW,Study_country_s_001_yes,Is_a_VPD_the_main_ob_f_the_resea,The_residual_samples_surveillanc,If_Yes_select_one_of_the_foll,If_Other_specify_below,Did_the_residual_sample_come_f,If_Yes_select_below,If_Yes_select_below_unspecified_,If_Yes_select_below_unspecified1,If_Yes_select_below_nhanes__usa,If_Yes_select_below_pienter__net,If_Yes_select_below_esen__europe,If_Yes_select_below_kiggs__germa,If_Yes_select_below_ncirs__austr,If_Yes_select_below_hpa_serosurv,If_Yes_select_below_uk_biobank_c,If_Yes_select_below_vietnam_sero,If_Yes_select_below_cirn__canada,If_Yes_select_below_id_surveilla,If_Yes_select_below_israel_natio,If_Yes_select_below_blood_and_or,If_Yes_select_below_u_s__defense,If_Yes_select_below_hungarian_se,If_Yes_select_below_finnish_mate,If_Yes_select_below_singapore_na,If_Yes_select_below_iceland_mate,If_Yes_select_below_national_hea,If_Yes_select_below_german_healt,If_Yes_select_below_knhanes,If_Yes_select_below_national_ped,If_Yes_select_below_janus__norwa,If_Yes_select_below_gumcad_sti_s,If_Yes_select_below_german_natio,If_Yes_select_below_retrovirus_e,If_Yes_select_below_swiss_hiv_co,If_Yes_select_below_israel_defen,If_Yes_select_below_us_national_,If_Yes_select_below_diabetomobil,If_Yes_select_below_other,If_Other_specify_below_001,Population_that_the_residual_s,Population_that_the_residual_s_g,Population_that_the_residual_s_p,Population_that_the_residual_s_b,Population_that_the_residual_s_1,Population_that_the_residual_s_2,Population_that_the_residual_s_s,Population_that_the_residual_s_i,Population_that_the_residual_s_n,Population_that_the_residual_s_m,Population_that_the_residual_s_3,Population_that_the_residual_s_h,Population_that_the_residual_s_4,Population_that_the_residual_s_t,Population_that_the_residual_s_5,Population_that_the_residual_s_6,Population_that_the_residual_s_7,Population_that_the_residual_s_u,Population_that_the_residual_s_8,Population_that_the_residual_s_o,What_was_the_populat_of_residual,Provide_details_of_t_original_po,Original_use_for_samples,Original_use_for_samples_blood_d,Original_use_for_samples_plasma_,Original_use_for_samples_seropre,Original_use_for_samples_diagnos,Original_use_for_samples_other_n,Original_use_for_samples_other,What_was_the_origina_use_for_the,Did_the_residual_population_ha,What_were_the_inclusion_criteria,Did_the_residual_population_ha_0,What_were_the_exclusion_criteria,Collection_site_of_residual_spec,COLLECTION_HH,COLLECTION_SCHOOL,COLLECTION_HOSPITAL,COLLECTION_BLOOD,COLLECTION_PLASMA,COLLECTION_DIAGNOSTIC,COLLECTION_HOMELESS,COLLECTION_PRISON,COLLECTION_UNKNOWN,COLLECTION_OTHER,What_was_the_collect_e_residual_,Storage_site_of_residual_specime,STORAGE_UNSPECIFIED,STORAGE_RESEARCH,STORAGE_BLOOD,STORAGE_DIAGNOSTIC,Individual_meta_data_used_in_the,META_BASICDEMOG,META_EXTENDED,META_EPIDATA_VPD,META_EPIDATA_NONVPD,META_NONE,Did_the_authors_include_a_stat,ETHICS_CMTEAPPROVED,ETHICS_BROADCONSENT,ETHICS_RETROCONSENT,ETHICS_RECWAIVERONRECONSENT,ETHICS_DEIDENTIFIED,ETHICS_EXEMPTPH,ETHICS_OTHER,ETHICS_NR,What_were_the_ethica_iderations_,Total_sample_size_of_whole_analy,Sample_size_of_residual_specimen,Sample_size_of_the_o_al_sample_w,Specimen_type,Specimen_type_fingerprick,Specimen_type_venous,Serological_tests_performed,Serological_tests_performed_neut,Serological_tests_performed_hema,Serological_tests_performed_elis,Serological_tests_performed_chem,Serological_tests_performed_fluo,Serological_tests_performed_radi,Serological_tests_performed_mult,Serological_tests_performed_rapi,Serological_tests_performed_epit,Serological_tests_performed_isoe,Serological_tests_performed_immu,Serological_tests_performed_late,Serological_tests_performed_prot,Serological_tests_performed_flu1,Serological_tests_performed_toxi,Serological_tests_performed_othe,If_Other_specify_below_002,VPD_s_of_interest,VPD_s_of_interest_cholera,VPD_s_of_interest_dengue,VPD_s_of_interest_diptheria,VPD_s_of_interest_hepatitis_a,VPD_s_of_interest_hepatitis_b,VPD_s_of_interest_hepatitis_e,VPD_s_of_interest_hemophilus_inf,VPD_s_of_interest_human_papillom,VPD_s_of_interest_influenza,VPD_s_of_interest_japanese_encep,VPD_s_of_interest_measles,VPD_s_of_interest_mumps,VPD_s_of_interest_neisseria_meni,VPD_s_of_interest_pertussis,VPD_s_of_interest_pneumococcal,VPD_s_of_interest_poliomyelitis_,VPD_s_of_interest_rotavirus,VPD_s_of_interest_rubella,VPD_s_of_interest_sars_cov_2,VPD_s_of_interest_tetanus,VPD_s_of_interest_tick_borne_enc,VPD_s_of_interest_tuberculosis,VPD_s_of_interest_typhoid__salmo,VPD_s_of_interest_varicella_herp,VPD_s_of_interest_yellow_fever,Acknowledgement_of_b_rom_residua,Handling_bias_of_residual_sample,Handling_bias_of_residual_sampl1,Handling_bias_of_residual_sampl2,Handling_bias_of_residual_sampl3,Handling_bias_of_residual_sampl4,Handling_bias_of_residual_sampl5,Handling_bias_of_residual_sampl6,Handling_bias_of_residual_sampl7,Handling_bias_of_residual_sampl8,Handling_bias_of_residual_sampl9,Paper_objective,Paper_objective_to_describe_popu,Paper_objective_to_describe_sero,Paper_objective_to_evaluate_the_,Paper_objective_to_describe_anti,Paper_objective_to_describe_ant1,Paper_objective_to_estimate_infe,Paper_objective_to_compare_the_u,Paper_objective_to_identify_risk,Paper_objective_to_evaluate_outc,Paper_objective_to_evaluate_chan,Paper_objective_to_describe_cros,Paper_objective_to_describe_vira,Paper_objective_to_compare_popul,Paper_objective_other,What_is_the_other_objective,Anything_else_we_should_know,_id,_uuid,_submission_time,_validation_status,_notes,_status,_submitted_by,__version__,_tags,_index,WV,Covidence_Ref__,DOI,VPD_GROUP_AIRBORNE,VPD_GROUP_VECTOR,VPD_GROUP_FOODWATER,VPD_GROUP_HUMAN,VPD_GROUP_OTHER,POP_GENERAL,POP_BLOODPLASMA,POP_PATIENT,POP_PREGNANT,POP_OCCUPATION,POP_VULNERABLE,POP_STUDENTS,POP_DRUGUSERS,POP_NOTSPECIFIED,original_use_bloodplasma,BIAS_SUBSAMPLING,BIAS_INCEXC,BIAS_STRATANALY,BIAS_WEIGHTED,BIAS_COMPVALID,BIAS_COMPPUB,BIAS_RETEST,BIAS_SENS,BIAS_NONE,NOTBIASED,COLLECTION_BLOODPLASMA,FIRSTYEAR_COLLECTION,PUBYEAR,DIFF_COLLECTION_PUB,Covidence_number_N,NUMBERPATHOGENS,NUMBERCOUNTR,NUMBERPOPN
2022-05-08T10:21:59.055-04:00,2022-12-05T21:27:48.042-05:00,Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.,Achonu,2011-01-01,3408,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women patient_population,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,repository of residual serum specimens submitted to Public Health Ontario Laboratories (PHOL) for preventable disease and prenatal screening,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,4399,3375,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results testing_samples_multiple_times_for_the_s,0,0,1,0,0,0,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,1,0,1,0,0,0,0,,,155915393,1ac9e2f0-ae63-4ce0-83cf-bbfd3ec96d20,2022-05-08T14:33:00,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,66,1,3408,10.1371/journal.pone.0026427,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,2009,2011,2,3408,1,1,2
2022-12-12T16:35:38.173-03:00,2022-12-12T16:43:27.251-03:00,Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.,Adetifa,2021-01-01,14192,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,KE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,9922,9922,10258,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,207873278,ab7a42bd-cd58-478e-be6b-3d1fa3a623b4,2022-12-12T19:43:20,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,581,1,14192,10.1038/s41467-021-24062-3,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,1,0,0,0,1,2020,2021,1,1419,1,1,1
2022-03-02T11:26:22.052-05:00,2022-12-20T21:33:08.443-05:00,Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data.,Aebi,2001-01-01,3840,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,age-specific 0-16,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,970,970,,venous,0,1,elisa_eia__enzyme_immunoassay radio_immunoassay,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,,,,,,,,,,,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,144409356,4f19f492-3a49-43ac-b3c7-235c9ecbe925,2022-03-02T16:33:49,,,submitted_via_web,awinter,vpQrgGPTK7VgMoGYycNBPf,,18,1,3840,10.1016/s0264-410x(01)00035-4,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1997,2001,4,3840,1,1,1
2022-08-04T14:40:14.804-03:00,2023-01-08T09:53:45.343-08:00,"The seropervelance of infectious hepatitis viruses (HBV, HCV and HEV) among blood donors and their correlation to risk factors in Qena governorate, Upper Egypt.",Ahmed,2020-01-01,173,2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,EG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,671,671,11604,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood to_identify_risk_factors_of_se,0,0,1,0,0,0,0,1,0,0,0,0,0,0,,only HEV samples were considered residual,173959553,856a23d3-8ba3-4268-9d9b-6c29271ed951,2022-08-04T18:14:14,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,396,1,173,10.1007/s13337-020-00589-9,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2013,2020,7,173,1,1,1
2022-04-25T19:28:03.858-04:00,2023-01-09T11:02:52.957-07:00,"Immunological and molecular detection of hepatitis E virus in AL-Samawah city, Iraq",Al-Oebady,2019-01-01,9216,2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,IQ,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,63,63,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,153852703,519f2e60-a310-45da-9019-5254992e3fff,2022-04-26T15:29:24,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,40,1,9216,10.5958/0976-5506.2019.01379.2,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2017,2019,2,9216,1,1,1
2022-12-12T16:25:12.308-03:00,2022-12-12T16:35:37.935-03:00,The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E,AlAbsi,2021-01-01,16085,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017 2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,QA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,non hep A or C patients,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,259,259,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,207872307,0f249221-8045-431f-a0ca-4e21d8256c50,2022-12-12T19:35:27,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,580,1,16085,10.1186/s12876-021-01841-2,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2017,2021,4,1608,1,1,1
2022-05-17T20:55:58.859-04:00,2023-01-08T17:14:55.655-08:00,Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia.,Alandijany,2021-01-01,828,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,SA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,956,956,,,,,neutralization_test elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,157587569,b7d664d3-3def-42e4-a580-34dc9c6325b0,2022-05-18T01:24:07,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,94,1,828,10.3390/healthcare9010051,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2020,2021,1,828,1,1,1
2022-12-12T15:57:37.882-03:00,2022-12-12T16:25:12.101-03:00,"Seroprevalence of COVID-19 in Riyadh city during the early increase of COVID-19 infections in Saudi Arabia, June 2020.",Alenazi,2022-01-01,14683,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,SA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,782,782,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,207871016,94fced3f-b225-494f-a996-21a2ded82d6c,2022-12-12T19:25:04,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,579,1,14683,10.1016/j.sjbs.2022.103282,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1468,1,1,2
2022-04-24T21:13:20.315-04:00,2023-01-09T17:47:26.608-08:00,Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia,Alharbi,2021-01-01,1342,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,SA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,blood donors and residual samples from laboratories.,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,11703,11272,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,These sera were tested in pools of 10 samples,153726410,8cc6b7b8-cc2d-4a49-ad0b-9a5ba0d1d81c,2022-04-25T22:46:38,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,37,1,1342,10.1016/j.jiph.2021.04.006,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,1,0,1,0,0,1,1,0,0,0,1,2020,2021,1,1342,1,1,2
2022-06-29T09:45:20.692-03:00,2022-12-23T08:44:39.624-03:00,"Hemagglutination Inhibition Antibody Response Following Influenza A(H1N1)pdm09 Virus Natural Infection: A Cross-Sectional Study from Thirthahalli, Karnataka, India.",Alladi,2019-01-01,2670,2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza positive cases,diagnostic_sample,0,0,0,1,0,0,,yes,recent influenza diagnosis,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,50,50,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_antibody_kin_infect to_describe_cross_reactivity,0,0,0,0,1,0,0,0,0,0,1,0,0,0,,,166541699,5aa7ebdc-4818-44f9-8a8f-927cbb0ac9b8,2022-06-29T12:52:17,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,190,1,2670,10.1089/vim.2019.0010,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2017,2019,2,2670,1,1,1
2022-11-25T14:01:29.110-03:00,2023-01-11T11:31:30.848-07:00,"High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia",Alzabeedi,2022-01-01,14774,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,SA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,yes,"free of COVID-19 symptoms and have never been infected with SARS-CoV-2. A blood donor was ruled out if he/she had been diagnosed with a disease or showed outward signs of infections such as cough, sore throat, or fever",blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,4368,4368,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,203518419,685bc0c3-c52f-496c-91f6-a7b1d08bf3b2,2022-11-25T17:22:20,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,507,1,14774,10.3390/vaccines10081279,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,1,2020,2022,2,1477,1,1,1
2022-04-23T18:24:21.359-04:00,2023-01-11T12:58:00.283-08:00,"Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK",Amirthalingam,2021-01-01,1675,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,donors 17–69 years of age,blood_donation,1,0,0,0,0,0,,no,,yes,acute illness last 2 weeks,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,,,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,Total sample size of participants or samples unclear,153425600,2173afde-d4ca-470a-82f7-c6c35eb8eba2,2022-04-23T22:44:59,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,34,1,1675,10.3201/eid2707.203167,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,1,0,1,1,0,0,0,1,2018,2021,3,1675,1,1,1
2022-04-19T10:40:24.470-04:00,2023-01-15T13:49:16.542-08:00,"Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil.",Amorim Filho,2020-01-01,2195,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2857,2857,,venous,0,1,rapid_test_igg_lateral_flow,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,152692799,7db372fc-bc1b-43bc-b4c5-1970f12bfadf,2022-04-19T14:45:19,,,submitted_via_web,iesteban,veAwrTM59Sap9PspfNKuZC,,24,1,2195,10.11606/s1518-8787.2020054002643,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2020,0,2195,1,1,1
2022-04-23T18:07:12.887-04:00,2023-01-14T16:08:31.348-08:00,Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer.,Anderson,2017-01-01,1693,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,janus__norway__cancer_registry,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with confirmed squamous cell carcinoma of the oropharynx,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,552,92,92,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f,0,0,1,0,1,0,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,153424840,d7d9d39d-c4de-4d73-9388-289150b67a83,2022-04-23T22:24:32,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,33,1,1693,10.1016/j.oraloncology.2017.08.014,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,2017,,1693,1,1,1
2022-05-17T21:23:55.293-04:00,2023-01-15T10:40:21.945-08:00,Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.,Anderson,2021-01-01,2046,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2013 2014 2015 2016 2017 2018 2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,We tested serum samples collected from 263 children (ages 1–17) at the Children’s Hospital of Philadelphia which had been originally collected for lead testing and 168 adults (ages 18–90) who had been recruited into the Penn Medicine Biobank.,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,yes,"medical history of cancer or organ transplantation, pregnancy during the previous 9 months, or an infectious disease within the previous 28 days prior to blood draw",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,682,431,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,0,0,0,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_infect to_describe_viral_dynamics,1,0,0,0,1,0,0,0,0,0,0,1,0,0,,,157588214,3437c435-ecd0-4d72-90c1-199dfcab6625,2022-05-18T01:39:41,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,95,1,2046,10.1016/j.cell.2021.02.010,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,1,0,0,0,0,2013,2021,8,2046,1,1,1
2022-05-17T21:39:29.329-04:00,2023-01-10T21:51:11.251-08:00,Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.,Andersson,2013-01-01,1430,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,janus__norway__cancer_registry,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,the Janus Biobank in Norway and the Southern Sweden Microbiology Biobank (SSMB),other,0,0,0,0,0,1,uknown,yes,"diagnosis of basal cell carcinoma, or r squamous cell carcinoma of the skin (SCC) and with other non-melanoma-type skin cancer",unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,5552,2776,2776,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,year of sample collection unknown,157589522,8cb62167-ffd4-48c0-92ed-dd2b7b07fbe0,2022-05-18T02:02:13,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,96,1,1430,10.1002/ijc.28188,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,2013,,1430,1,2,1
2022-04-25T19:01:55.777-04:00,2023-01-05T10:28:48.155-07:00,Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer,Andersson,2012-01-01,7473,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,NO SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,janus__norway__cancer_registry,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors patient_population,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,2 Biobanks from multiple populations,blood_donation diagnostic_sample,1,0,0,1,0,0,,yes,Diagnostis of skin cancer. Cases had at least 1 serum sample taken at least 1 month before diagnosis.,no,,hospital_clinic blood_donation_site diagnostic_center_laboratory,0,0,1,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,9260,2623,1993000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_evaluate_outcomes_of_seropo,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,"Sample size from the abstract differs from the article, very confusing.",153728720,245016d0-2881-4655-9064-c4354b449f93,2022-04-25T23:28:14,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,39,1,7473,10.1093/aje/kwr373,0,0,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,1972,2012,40,7473,1,2,3
2022-05-17T22:02:01.452-04:00,2024-04-25T20:34:17.531-04:00,Towards elimination: measles susceptibility in Australia and 17 European countries.,Andrews,2008-01-01,4172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2000 2001 2002 2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU BE BG CY CZ HU IE IL LV LT LU MT RO SK SI ES SE GB,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,54527,54527,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,to evaluate age-specific susceptibility,157592672,a54cc8c4-a1e0-44fe-821e-ce7b34740f8b,2022-05-18T02:51:19,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,97,1,4172,10.2471/blt.07.041129,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1996,2008,12,4172,1,18,2
2022-06-29T10:36:01.378-03:00,2022-12-24T10:43:30.691-03:00,"Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008-2010.",Ang,2013-01-01,3071,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,national_pediatric_seroprevale,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,National Pediatric Seroprevalence Study,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 1 to 17,yes,"immunocompromised, diagnosis of measles, pertussis, poliomyelitis, HBV infection, Dengue, and Hand, Foot and Mouth disorder.",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__exempt_as_public_health_s,0,0,0,0,0,1,0,0,,1200,1200,,,,,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,166559655,39482edb-e91c-4091-a071-bd4787ede774,2022-06-29T13:50:43,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,194,1,3071,10.1016/j.vaccine.2013.10.057,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2008,2013,5,3071,1,1,1
2022-06-29T09:52:09.354-03:00,2022-12-11T22:16:21.158-05:00,Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review.,Ang,2013-01-01,3631,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1998 2004 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,singapore,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,yes,"Singapore residents, Aged 18 to 69, Ethnic chinese, malayan or indian",yes,"Aged 75 to 79, other ethnic groups",unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,12141,12144,13228,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,166547740,41709de5-4a91-4013-876b-de0e4bdf59c0,2022-06-29T13:10:06,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,191,1,3631,10.1002/jmv.23496,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,1998,2013,15,3631,1,1,1
2022-04-26T11:37:06.401-04:00,2022-12-16T15:12:19.624-05:00,Seroprevalence of past dengue virus infection among children and adolescents in Singapore.,Ang,2015-01-01,3702,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,national_pediatric_seroprevale,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"a national pediatric seroprevalence survey, Singapore residents aged 1–17 years seen in two hospitals",diagnostic_sample,0,0,0,1,0,0,,yes,"o Singapore residents of Chinese, Malay and Indian ethnicity aged 1–17 years attending inpatient services or day surgery at the two hospitals",yes,"Sera of patients known to be immunocompromised, on immunosupressive therapy, or who had been diagnosed with infectious diseases such as dengue were excluded.",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,1200,1200,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,153856142,3aa110dd-cf6f-4c85-9d20-5f744e2fb15f,2022-04-26T15:48:45,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,42,1,3702,10.1002/jmv.24287,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2008,2015,7,3702,1,1,1
2022-06-29T10:24:33.161-03:00,2022-12-20T21:35:36.218-05:00,Prevalence of diphtheria and tetanus antibodies among adults in Singapore: a national serological study to identify most susceptible population groups.,Ang,2016-01-01,3850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,singapore,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,yes,Aged 18 to 79,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,3293,3293,4337,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria tetanus,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,166555211,8769b33c-1e69-4509-b815-af32ae7a2129,2022-06-29T13:36:09,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,193,1,3850,10.1093/pubmed/fdv011,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2010,2016,6,3850,2,1,1
2022-06-13T13:43:17.239-07:00,2024-04-25T20:22:43.419-04:00,"Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.",Ang,2013-01-01,3867,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,MY,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,inpatient services or day surgery,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"Children known to be immunocompromised, on immunosupressive therapy, or who had been diagnosed with infectious diseases such as measles, mumps, rubella, chickenpox, diphtheria, pertussis, poliomyelitis, hepatitis B, dengue, or hand, foot and mouth disease",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__exempt_as_public_health_s,0,0,0,0,0,1,0,0,,1200,1200,,,,,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,measles mumps rubella,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d,0,1,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,163215787,a9dfaedb-81b0-4fb5-97d2-1d973bc3559c,2022-06-14T20:25:47,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,123,1,3867,10.1017/S0950268812002130,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,2008,2013,5,3867,3,1,1
2022-06-29T10:10:01.504-03:00,2024-04-25T20:29:19.610-04:00,Seroepidemiology of dengue virus infection in the adult population in tropical Singapore.,Ang,2015-01-01,4033,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,singapore,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,yes,Aged 18-79,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,3293,3293,4337,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,166551970,eb80e1ab-be9e-48f4-bcc6-4abbd273a626,2022-06-29T13:24:41,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,192,1,4033,10.1017/S0950268814002507,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2010,2015,5,4033,1,1,1
2022-12-12T15:36:30.662-03:00,2022-12-12T15:50:09.139-03:00,Prevalence of measles antibodies among migrant workers in Singapore: a serological study to identify susceptible population subgroups.,Ang,2022-01-01,14520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016 2017 2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,migrants,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,survey on latent tuberculosis,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,household hospital_clinic,1,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti yes__exempt_as_public_health_s,0,1,0,0,0,1,0,0,,2234,2234,3584,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_subsampling conducted_stratified_analysis__results,1,0,1,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,207866541,f85350a9-33cb-47c0-bf5d-22ccd3b45a29,2022-12-12T18:50:01,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,577,1,14520,10.1186/s12879-022-07066-2,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2016,2022,6,1452,1,1,1
2022-12-12T15:50:09.274-03:00,2022-12-12T15:57:37.728-03:00,"Seroprevalence of IgG antibodies against diphtheria antitoxin among migrant workers in Singapore, 2016-2019.",Ang,2022-01-01,14617,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016 2017 2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,migrants,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,survey on latent tuberculosis among migrant workers in Singapore,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,household hospital_clinic,1,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti yes__exempt_as_public_health_s,0,1,0,0,0,1,0,0,,2176,2176,2191,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,207867550,d116039b-0a01-44a1-8153-790f159ce3ff,2022-12-12T18:57:29,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,578,1,14617,10.1186/s12889-022-12528-y,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2016,2022,6,1461,1,1,1
2022-12-12T15:16:14.034-03:00,2022-12-12T15:36:30.560-03:00,High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.,Angsuwatcharakon,2021-01-01,14158,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"stored serum samples from previous rabies preexposure prophylaxis research,",diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"Participants with a history of chronic illness, those undergoing immunosuppressive therapy, have received blood products within 4 weeks, or received MMR vaccine after the period of the 7 years of age had been excluded",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,456,456,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,207864703,4bdc9afb-6038-48d5-913d-ef620afb21d5,2022-12-12T18:36:22,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,576,1,14158,10.1016/j.vaccine.2021.08.079,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2020,2021,1,1415,1,1,1
2022-11-20T20:39:37.592-03:00,2023-01-11T10:38:26.790-07:00,Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors.,Arabkhazaeli,2022-01-01,14399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1339,1339,,venous,0,1,rapid_test_igg_lateral_flow,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,201937440,90fffb4a-3412-4ff9-8d22-ef981ca8ff63,2022-11-21T00:58:34,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,484,1,14399,10.1016/j.tracli.2021.08.008,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2022,2,1439,1,1,1
2022-06-29T10:50:35.903-03:00,2022-12-23T10:46:33.108-03:00,Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.,Arnheim Dahlström,2011-01-01,2699,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI IS NO SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,finnish_maternity_cohort__fmc,,yes,iceland_maternity_cohort janus__norway__cancer_registry,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,pregnant_women patient_population,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"4 serum banks = Finish Maternity Cohort, + Janus Biobank + North Sweden Maternity Cohort (not national) + Iceland Maternity Cohort",diagnostic_sample,0,0,0,1,0,0,,yes,diagnosis of cervical cancer o squamous cell carcinoma and 1 blood sample before diagnosis,unknown,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3584,604,1000000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,,166568553,0f169dbb-478a-4ca1-995c-ce5b185048fd,2022-06-29T14:18:50,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,195,1,2699,10.1158/1055-9965.EPI-11-0761,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1975,2011,36,2699,1,4,2
2022-06-29T11:18:42.675-03:00,2023-01-04T12:21:13.381-07:00,Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation,Arslan,2000-01-01,6136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1990 1991 1992 1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,end stage liver disease with orthotopic liver transplant,diagnostic_sample,0,0,0,1,0,0,,yes,2 years of follow up,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,no,0,0,0,0,0,0,0,1,,296,296,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,166572644,d083b23a-eed1-4d20-8763-9afb85590257,2022-06-29T14:33:52,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,196,1,6136,10.1002/lt.500060216,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1990,2000,10,6136,1,1,1
2022-12-23T08:00:47.345-03:00,2022-12-23T08:06:58.433-03:00,Seroprevalence of anti-SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia: a facility-based surveillance.,Assefa,2021-01-01,14280,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,ET,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,1447,1447,3312,venous,0,1,rapid_test_igg_lateral_flow,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,210050946,7bac6ebf-ab2e-442a-b027-431250d4be2d,2022-12-23T11:06:50,,,submitted_via_web,iesteban,vJzTYFwzQYR9pFHSy55TD3,,613,1,14280,10.1136/bmjopen-2021-055834,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2021,1,1428,1,1,1
2022-06-21T11:55:55.313-03:00,2023-05-17T19:00:36.900-04:00,Serological and molecular characterization of hepatitis b virus in asymptomatic blood donors in Iran,Attaran,2018-01-01,9127,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012 2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,IR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Asymptomatic blood donors who were positive for hepatitis B surface antigen during 2012 to 2014 were selected,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,no,0,0,0,0,0,0,0,1,,166,166,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,164791188,20718d2a-bf02-474c-888d-afb05ff3daed,2022-06-21T19:31:33,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,156,1,9127,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2012,2018,6,9127,1,1,1
2022-04-26T11:29:14.405-04:00,2022-12-23T08:47:40.390-03:00,"Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013.",Aubry,2015-01-01,2683,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,PF,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,593,593,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue japanese_encephalitis,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,stratified for analysis in group donors according to travel history,153854236,bfc91d25-553e-4e66-94d7-e2036a20932d,2022-04-26T15:37:15,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,41,1,2683,10.1016/j.ijid.2015.10.005,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2011,2015,4,2683,2,1,1
2022-07-03T14:13:24.173-03:00,2022-12-21T13:33:13.534-05:00,Immunity against diphtheria and tetanus in German blood donors.,Aue,2003-01-01,3969,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994 1995 1996 1997 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,321,321,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria tetanus,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,167467316,0b505653-4b6f-4670-929b-7e737170dd9a,2022-07-03T17:22:16,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,205,1,3969,10.1007/s00430-002-0163-9,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,1994,2003,9,3969,2,1,1
2022-05-12T21:48:01.336-04:00,2022-12-24T10:59:22.478-03:00,Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment,Babu,2018-01-01,3134,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011 2012 2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,HK US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Patients + serosurvey,seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,yes,individuals  who were healthy or had stable medical conditions and were  from 6 months to 80 years of age,yes,immunosupressed,hospital_clinic unknown,0,0,1,0,0,0,0,0,1,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,445,445,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results,0,1,1,0,0,0,0,0,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,156737040,209e5911-96e4-460b-a534-6c286c9a1ad7,2022-05-13T02:02:42,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,81,1,3134,10.1093/infdis/jiy291,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,2010,2018,8,3134,1,2,2
2022-08-02T11:15:02.210-04:00,2022-12-26T16:53:44.918-03:00,"Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.",Backhouse,2007-01-01,3276,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,ncirs__australia,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,samples from 37 major daignostic labs around Australia from subjects aged 1-34 years,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"subjects known to be immunocompromised, to have received multiple transfusions in the past 3 months, or to be infected with HIV",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2409,2409,8000,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,neisseria_meningitis,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d,0,1,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,173922027,b1dcd494-1839-4d70-bd7e-5a18725361e0,2022-08-04T15:39:45,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,392,1,3276,10.1016/j.vaccine.2006.09.087,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2002,2007,5,3276,1,1,1
2022-07-03T14:22:04.200-03:00,2023-01-05T10:32:34.501-07:00,Prevalence and clinical significance of occult hepatitis B virus infection among renal transplant recipients in Korea,Bae,2012-01-01,7546,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006 2007 2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with end stage renal disease who received a renal transplant,diagnostic_sample,0,0,0,1,0,0,,yes,"HBsAg-negative and hepatitis B surface antibody (anti-HBs)-negative or anti-HBs-positive, but with a titer of less than 500 IU/l.",unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,217,217,377,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,167470073,510647ef-9792-4dd3-9221-5fd8aa908ab5,2022-07-03T17:40:08,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,206,1,7546,10.3109/00365548.2012.680488,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2005,2012,7,7546,1,1,1
2022-05-03T09:38:00.162-04:00,2022-12-20T09:28:21.669-07:00,Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020,Bajema,2021-01-01,4257,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,residual serum specimens provided by persons of all ages that were originally submitted for routine screening or clinical management from 2 private clinical commercial laboratories,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,177919,177919,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,155104874,1dd48cd6-0502-4549-80e0-f771f3b7287c,2022-05-03T13:51:56,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,50,1,4257,10.1001/jamainternmed.2020.7976,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2020,2021,1,4257,1,1,1
2022-12-05T18:14:49.310-03:00,2023-07-05T15:12:10.687-07:00,Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey.,Bajema,2021-01-01,14406,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2012,2012,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_population_seropos to_compare_the_use_of_residual,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,,206394251,f44a0707-0772-4a6e-8d89-460cdd634f2f,2022-12-05T21:31:38,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,563,1,14406,10.1093/cid/ciaa1804,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,2020,2021,1,1440,1,1,1
2022-05-03T09:51:48.034-04:00,2022-12-27T12:08:22.777-07:00,Minipool testing for SARS-CoV-2 RNA in United States blood donors,Bakkour,2021-01-01,5425,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"REDS Epidemiology, Surveillance and Preparedness of the Novel SARS-CoV-2 (RESPONSE) study",blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,extended_demographic_data__e_g__residenc,0,1,0,0,0,no,0,0,0,0,0,0,0,1,,11,11,17995,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,viral RNA in minipooled samples (17995) out of 257809 donors. But only those with a +RNa were tested for Abs (11).,155109449,baca7cad-aacd-4c46-b2c7-afc7b29d97c5,2022-05-03T14:24:26,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,51,1,5425,10.1111/trf.16511,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2020,2021,1,5425,1,1,1
2022-05-03T09:17:11.002-04:00,2023-01-10T10:50:46.641-07:00,Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020,Basavaraju,2020-01-01,9756,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"age range 16-95, but not as inclusion criteria",blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,7389,7389,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay epitope_blocking_assay_using_m,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,155103012,79c4d8fb-b794-4294-a0aa-c3c64d911299,2022-05-03T13:38:09,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,49,1,9756,10.1093/cid/ciaa1785,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2019,2020,1,9756,1,1,1
2022-07-03T14:39:57.111-03:00,2023-01-08T10:42:52.392-08:00,Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.,Bassal,2021-01-01,336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_national_serum_bank_by_,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,yes,immunocompromised,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3164,3164,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc,0,1,0,1,0,0,0,0,0,0,0,0,0,0,,,167471856,abfce766-7a03-4e71-8e08-b0a9badede12,2022-07-03T17:53:24,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,207,1,336,10.1080/21645515.2020.1824968,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,1,1,1,0,0,1,0,0,0,0,1,2015,2021,6,336,1,1,2
2022-05-04T15:56:56.030-04:00,2022-12-22T12:27:22.693-05:00,Seroprevalence of Hepatitis A Twelve Years After the Implementation of Toddlers' Vaccination: A Population-Based Study in Israel.,Bassal,2017-01-01,4018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_national_serum_bank_by_,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Serum bank including blood donors and patient population,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,yes,confirmed or suspected immunologic disorders,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2027,2027,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,1,1,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,"Prevaccination data had been already tested (1883), hence only the post vaccination samples are residual (2027)",155283162,fc6830ea-28dc-4936-819e-84cabc7ab228,2022-05-04T20:12:31,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,55,1,4018,10.1097/INF.0000000000001640,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,1,1,1,0,0,1,1,0,0,0,1,2011,2017,6,4018,1,1,2
2022-08-02T18:34:44.747-03:00,2023-01-18T11:59:00.543-08:00,Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.,Bassig,2018-01-01,213,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1986 1987 1988 1989 1993 1994 1995 1996 1997 1998 1999 2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CN SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,3 different surveys,other_non_serological_survey,0,0,0,0,1,0,,yes,Patients with non Hodgkin lymphoma as cases,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,428,214,156443,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se to_compare_population_seroposi,0,1,0,0,0,0,0,1,0,0,0,0,1,0,,,173742944,d6863fa0-fdf9-4b70-8df5-8b4598859f68,2022-08-03T19:24:35,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,388,1,213,10.1002/ijc.31385,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1986,2018,32,213,1,2,1
2022-06-08T11:10:49.575-07:00,2022-12-21T21:51:05.721-05:00,"Prevalence of herpes -, measles morbillivirus-, parvovirus B19 - and rubella viruses immunoglobulin G among women with chronic hepatitis B of reproductive age in Denmark: A cross-sectional study.",Bergløv,2020-01-01,4043,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,DK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Original sample is the Danish Database for Hepatitis B and C (DANHEP). DANHEP is a nationwide clinical database of patients with chronic hepatitis B and C, 15 years of age, admitted or referred to a hospital in Denmark.",diagnostic_sample,0,0,0,1,0,0,,no,,yes,Women born in Denmark; small sample size of birth region,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,177,177,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,measles rubella varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,specifically morbillivirus antibodies (measles?),161961204,5fd89323-f454-4778-8f7b-4ef4d8a6577f,2022-06-08T18:40:38,,,submitted_via_web,mpilews1,vi2DwcDjaJ6wcVBLuKqpCk,,115,1,4043,10.1016/j.ijid.2020.09.1477,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2005,2020,15,4043,3,1,1
2022-06-30T06:37:51.366-03:00,2022-12-20T21:44:40.565-05:00,Seroepidemiological study of hepatitis E virus in different population groups.,Bernal,1995-01-01,3865,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,MA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population pregnant_women blood_donors injection_drug_users,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,"blood donors, pregnant women, moroccan subjects, children and IDUs",blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,blood_donation_site unknown,0,0,0,1,0,0,0,0,1,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,1993,1993,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,Year of sample collection uknown,166742309,da07c74a-64bd-450e-8c42-27e0e974d3da,2022-06-30T09:48:34,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,197,1,3865,10.1007/BF01691376,0,0,1,0,0,1,1,0,1,0,0,0,1,0,1,0,0,1,0,0,1,0,0,0,0,1,,1995,,3865,1,1,4
2022-11-25T13:56:01.565-03:00,2023-01-11T11:35:10.795-07:00,Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022.,Bingham,2022-01-01,14835,2022,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2022,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3395,3395,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,weighted_final_results testing_samples_multiple_times_for_the_s,0,0,0,1,0,0,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,203512127,a3b42711-76cb-46e9-9bbf-5cf5d1ac5a5b,2022-11-25T17:01:24,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,506,1,14835,10.21203/rs.3.rs-1687679/v1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,2022,2022,0,1483,1,1,1
2022-04-26T11:48:36.165-04:00,2023-01-04T13:11:52.834-07:00,A serological re-evaluation of acute non-A non-B hepatitis from the early 1970s,Binotto,2000-01-01,6196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1971 1972 1973 1974,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Previously admitted patient for clinical hepatitis,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,114,57,72,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_b hepatitis_e,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,153899304,20aaf436-697a-43f5-a3d2-3b011a174681,2022-04-26T18:46:15,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,43,1,6196,,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1971,2000,29,6196,3,1,1
2022-05-04T16:12:20.934-04:00,2023-01-10T21:56:17.524-08:00,Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers.,Bjørge,1997-01-01,1479,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,finnish_maternity_cohort__fmc,,yes,janus__norway__cancer_registry,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,pregnant_women patient_population,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"The Finnish maternity cohort + Janus Project (people who participated in county health examinations, mostly for cardiovascular diseases, and from blood donors)",blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,epi_data_not_on_vpd_of_interest__e_g__hi,0,0,0,1,0,no,0,0,0,0,0,0,0,1,,321,81,1200000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_seroprevalence_amo to_identify_risk_factors_of_se to_evaluate_outcomes_of_seropo to_compare_population_seroposi,1,1,0,0,0,0,0,1,1,0,0,0,1,0,,,155284481,af2baf1a-3a15-45f2-bfed-afb9cb3e5832,2022-05-04T20:31:19,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,56,1,1479,10.1136/bmj.315.7109.646,0,0,0,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,1985,1997,12,1479,1,2,2
2022-08-02T18:04:43.671-03:00,2023-01-15T10:35:57.456-08:00,Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.,Bjørge,2002-01-01,2043,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,FI NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,finnish_maternity_cohort__fmc,,yes,other,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Janus Biobank,pregnant_women blood_donors patient_population,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,anal and perianal skin cancer cases,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,yes,"two of the previous perianal skin cancer cases were also excluded, one due to multiple malignancies, the other due to histology (Paget’s disease of perineum).",blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,1528,28,1060000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se to_evaluate_outcomes_of_seropo,0,1,0,0,0,0,0,1,1,0,0,0,0,0,,year of sample collection is unknown,173538590,7d451b91-fa5c-4d20-af8c-616ae059d4bd,2022-08-02T21:34:55,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,387,1,2043,10.1038/sj.bjc.6600350,0,0,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,,2002,,2043,1,2,3
2022-02-22T14:35:05.861-05:00,2022-12-26T16:57:48.138-03:00,"Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.",Boccalini,2013-01-01,3298,2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Sample 1, pediatric patients attending an ER. Sample 2, adults outpatients",diagnostic_sample,0,0,0,1,0,0,,no,,yes,immunosupression,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1071,1071,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,,143103453,146de047-5181-49a8-81b6-440ba5451ab7,2022-02-22T19:55:48,,,submitted_via_web,iesteban,vpQrgGPTK7VgMoGYycNBPf,,11,1,3298,10.4161/hv.23259,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2009,2013,4,3298,1,1,1
2022-08-04T15:36:23.668-03:00,2023-01-08T10:57:11.290-08:00,Childhood exposure to infection and risk of adult onset wheeze and atopy.,Bodner,2000-01-01,400,1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,asthma patients from a cohort study,diagnostic_sample,0,0,0,1,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,374,113,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,174068307,4ed16047-8df0-4b7f-8d96-6ac70d20aa46,2022-08-05T09:55:15,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,399,1,400,10.1136/thorax.55.5.383,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1995,2000,5,400,1,1,1
2022-11-27T11:59:32.624-03:00,2023-01-11T10:41:02.070-07:00,Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic.,Boehme,2022-01-01,14410,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"samples were excluded with the following International Classification of Diseases-10 (ICD-10) and Current Procedural Technology (CPT) codes: immunodeficiency (primary im mune deficiency, D80-D89), transplant recipient (codes beginning with Z94), and cancer (C00-D49). Samples from patients receiving chemotherapy (before 2 months), steroids (before 30 days), and/or intravenous immunoglobulin (before 6 months) were excluded",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2357,2357,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,1,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,203983802,8494b698-fc4a-4db0-9710-10a7bbef7bce,2022-11-27T15:09:20,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,524,1,14410,10.1093/jpids/piac010,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1,0,1,0,0,0,0,0,2020,2022,2,1441,1,1,1
2022-05-03T19:39:34.917-04:00,2023-01-18T11:43:22.604-08:00,"Repeated Leftover Serosurvey of SARS-CoV-2 IgG Antibodies in Greece, May to August 2020",Bogogiannidou,2021-01-01,2414,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,GR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,20110,20110,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results,0,0,1,1,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,155159042,132599eb-79d9-4ab3-8c86-2efeb5ad4f73,2022-05-03T23:44:53,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,53,1,2414,10.3390/vaccines9050504,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,2020,2021,1,2414,1,1,1
2022-02-09T15:25:51.563-07:00,2024-04-25T20:18:06.657-04:00,"Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020",Bogogiannidou,2020-01-01,3319,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,GR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"a nationwide laboratory network, including both private and public hospital laboratories (27 laboratories in total), samples were collected from individuals who visited the laboratories for a check-up, chronic disease follow-up or other reasons",diagnostic_sample,0,0,0,1,0,0,,no,,yes,The samples were collected from individuals who visited the laboratories for reasons unrelated to COVID-19.,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,6586,6586,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_it_to_alternative_data_source_f,1,0,1,0,1,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,140812999,6a3face7-06a1-45ab-8b26-0f4d9796b17b,2022-02-09T22:34:12,,,submitted_via_web,mpilews1,vpQrgGPTK7VgMoGYycNBPf,,1,,3319,10.2807/1560-7917.ES.2020.25.31.2001369,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,2020,2020,0,3319,1,1,1
2022-02-18T13:13:18.316-07:00,2022-12-05T21:31:52.442-05:00,"Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.",Bolotin,2019-01-01,3411,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,cirn__canada,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Sera were collected between November 2013 and May 2014 from a large private diagnostic laboratory, which conducts much of the physician-requested outpatient testing in the province, as well as testing of hospitalized patients.",diagnostic_sample,0,0,0,1,0,0,,yes,used sera from individuals aged 1–39 years,yes,patients born before 1970,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1199,1199,,venous,0,1,neutralization_test multiplex,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,142687320,636e7867-7682-4e14-983c-f399f2d18e32,2022-02-20T19:37:20,,,submitted_via_web,mpilews1,vpQrgGPTK7VgMoGYycNBPf,,9,,3411,10.1080/21645515.2019.1619402,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,2013,2019,6,3411,1,1,1
2022-06-13T13:28:48.164-07:00,2022-12-22T12:39:15.633-05:00,SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.,Bolotin,2021-01-01,4011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,residual specimens submitted to the Public Health Ontario Laboratory,diagnostic_sample,0,0,0,1,0,0,,yes,"Both sexes, all age groups, and all geographic regions in Ontario",no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,21676,21676,,,,,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,0,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,162976919,aa95b281-284f-4a3a-a479-d9eb1a414abb,2022-06-13T20:43:27,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,122,1,4011,10.1093/infdis/jiaa796,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,2020,2021,1,4011,1,1,1
2022-11-27T11:50:40.390-03:00,2023-01-10T13:38:22.806-07:00,"Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020.",Bolotin,2021-01-01,14221,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,8902,8902,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d conducted_sensitivity_analysis,1,0,1,1,0,1,0,0,1,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,203981441,59e9b8e5-a14b-4d2d-80f4-df6bceee03fa,2022-11-27T14:59:26,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,523,1,14221,10.2807/1560-7917.ES.2021.26.50.2001559,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,1,0,0,0,2020,2021,1,1422,1,1,1
2022-04-21T18:48:27.000-04:00,2022-12-16T15:14:54.238-05:00,"Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France.",Bone,2012-01-01,3704,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,20-70 years,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,1708,1708,1936,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,national serological study in mainland France,153136845,b9b5a1b5-3d82-447e-93c2-63dc09044e30,2022-04-21T23:11:53,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,29,1,3704,10.1371/journal.pone.0033056,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,1,0,0,0,1,2009,2012,3,3704,1,1,1
2022-05-10T09:26:27.481-04:00,2022-12-11T21:57:52.471-05:00,Population-level antibody estimates to novel influenza A/H7N9,Boni,2013-01-01,3575,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2010 2011 2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,VN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,routine laboratory analyses,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1723,1723,,venous,0,1,hemagglutination_inhibition_as protein_microarray__pa,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results testing_samples_multiple_times_for_the_s,0,0,1,0,0,0,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,156241732,05bd5085-702d-4533-a13d-17a7186d0987,2022-05-10T14:02:19,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,74,1,3575,10.1093/infdis/jit224,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,2010,2013,3,3575,1,1,1
2022-07-04T06:33:22.179-03:00,2022-12-23T10:59:16.299-03:00,Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians.,Booy,2011-01-01,2840,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006 2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,3 different research studies that collected samples,seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,yes,Aged > 60 years,unknown,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,259,259,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,167556845,4a31438f-155d-4597-ad69-8ffc47d33d31,2022-07-04T09:40:21,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,208,1,2840,10.5694/j.1326-5377.2011.tb04139.x,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2006,2011,5,2840,1,1,1
2022-03-01T11:01:57.336-05:00,2023-01-10T21:48:52.099-08:00,Application of a fast and cost-effective 'three-in-one' MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience.,Borocz,2020-01-01,1363,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HU,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Random samples from serum bank of residual routine laboratory samples,diagnostic_sample,0,0,0,1,0,0,,no,,yes,seriously immunocompromised patients,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,6995,6995,,venous,0,1,elisa_eia__enzyme_immunoassay radio_immunoassay,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,measles mumps rubella,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_it_to_alternative_data_source_f testing_samples_multiple_times_for_the_s,1,0,0,0,1,0,0,1,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_identify_risk_factors_of_se,1,0,0,1,0,0,0,1,0,0,0,0,0,0,,Dates of vaccination used to define age group boundaries,144422507,40945125-bb8d-4ad2-931e-6db5010efc52,2022-03-02T17:56:22,,,submitted_via_web,abernas,vpQrgGPTK7VgMoGYycNBPf,,20,1,1363,10.1017/S0950268819002280,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,,2020,,1363,3,1,1
2022-11-24T16:47:39.413-03:00,2023-01-11T11:48:33.871-07:00,Cross-reactive antibodies to sars-cov-2 and mers-cov in pre-covid-19 blood samples from sierra leoneans,Borrega,2021-01-01,16171,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016 2017 2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,SL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Sierra Leonean Lassa fever and Ebola survivors and their contacts,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,226,120,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_identify_risk_factors_of_se to_describe_cross_reactivity to_compare_population_seroposi,0,0,0,0,0,0,0,1,0,0,1,0,1,0,,,203237502,b095c55c-2830-46fa-8da1-0e9b69138f14,2022-11-24T19:59:01,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,502,1,16171,10.3390/v13112325,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2016,2021,5,1617,1,1,1
2022-05-05T09:12:07.495-04:00,2022-12-14T21:33:08.576-07:00,Prevalence of anti-hepatitis E virus antibodies in French blood donors.,Boutrouille,2007-01-01,4187,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,1998,1998,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,year of sample collection unknown,155373765,35c71e5f-8573-4524-b4af-985ebd891185,2022-05-05T13:23:41,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,59,1,4187,10.1128/JCM.00235-07,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,,2007,,4187,1,1,1
2022-08-17T15:16:26.069-03:00,2022-12-20T21:48:25.434-05:00,Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands.,Bouwknegt,2008-01-01,3870,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AT NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,other,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,veterinarians,,seroprevalence_study,0,0,1,0,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,846,49,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,year of sample collection is not present in the article,176628725,0a55daed-26fd-4c0e-8a62-adff0ee99c9b,2022-08-17T18:43:25,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,454,1,3870,10.1017/S0950268807008941,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,,2008,,3870,1,2,1
2022-06-30T06:48:25.986-03:00,2022-12-27T10:48:06.136-07:00,Low levels of detectable pertussis antibody among a large cohort of pregnant women in Canada,Brooks,2018-01-01,4761,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Samples taken during second trimester were used, from a study called Maternal-Infant Research on Environmental chemicals",diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1752,1752,1928,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,166745627,d7520fe5-c1d3-4dc1-b21e-9d66ce96712b,2022-06-30T10:00:32,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,198,1,4761,10.1016/j.vaccine.2018.08.066,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2008,2018,10,4761,1,1,1
2022-07-04T06:40:11.735-03:00,2022-12-26T16:59:57.754-03:00,"Prevalence of markers for HIV, hepatitis B and hepatitis C infection in UK military recruits.",Brown,2011-01-01,3300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007 2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,14663,14663,14759,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,to evaluate the need for blood screening during military recruitment,167558389,ccb92d22-3188-4533-bc8e-dcd33d7d9106,2022-07-04T09:46:57,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,209,1,3300,10.1017/S0950268810002712,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2007,2011,4,3300,1,1,1
2022-12-12T16:43:27.498-03:00,2022-12-12T16:50:47.966-03:00,"Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.",Busch,2022-01-01,14749,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,"Inclusion criteria were: (1) blood donation between 1 January and 31 December 2021; (2) residence in study regions; (3) satisfaction of US Food and Drug Administration regulations and each blood collection organization’s donation requirements (eg, age 16 years, weight >110 lb, and healthy status, including being afebrile); (4) measurement of SARS-CoV-2 antibodies; and (5) self-reported COVID-19 vaccination history",yes,Excluded were (1) persons making COVID-19 convalescent plasma donations and (2) those with records missing demographic data.,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1123855,1123855,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,207873991,62fa989f-ceba-44ae-87c1-ed80954a8779,2022-12-12T19:50:39,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,582,1,14749,10.1093/cid/ciac470,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,1,2021,2022,1,1474,1,1,1
2022-06-22T09:35:14.361-03:00,2022-12-23T08:39:37.453-03:00,Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.,Buss,2021-01-01,2620,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,,17526,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,"Total sample size is unclear, after reading supplementary material",164989930,6a31d1e8-8301-4337-a2de-b0929ef265a3,2022-06-22T13:19:31,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,164,1,2620,10.1126/science.abe9728,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,2020,2021,1,2620,1,1,1
2022-11-20T18:20:46.193-03:00,2023-01-12T10:43:59.061-07:00,Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors,Buss,2022-01-01,15715,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,,,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_describe_antibody_kin_infect to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,1,1,1,0,0,0,1,0,0,0,0,,Total sample size unclear,201933997,3074acd5-19c5-4b06-a8a1-f98d02cb00cf,2022-11-20T23:39:32,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,483,1,15715,10.1101/2022.06.16.22276483,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1571,1,1,1
2022-11-24T17:29:42.743-03:00,2023-01-11T11:01:11.754-07:00,Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection.,Butler,2022-01-01,14454,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,8509,8509,,venous,0,1,elisa_eia__enzyme_immunoassay rapid_test_igg_lateral_flow,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,203510228,f99f362e-612e-4046-984c-3f9e24bea434,2022-11-25T16:56:00,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,505,1,14454,10.1016/j.jcv.2021.105045,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,1,0,0,0,1,2020,2022,2,1445,1,1,1
2022-06-24T09:51:04.335-03:00,2022-12-22T12:36:23.313-05:00,The seroepidemiology of pertussis in Australia during an epidemic period.,Cagney,2006-01-01,3817,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"The sera used in this study were collected as part of the Australian National Serosurvey, which is a nationally representative sample of sera collected between 1997 to 1998 from people undergoing pathology tests",diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1054,1054,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_estimate_infection_rates_or,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,165516236,377c4c8d-0b84-4db8-a473-b26acf4cc783,2022-06-24T13:16:04,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,165,1,3817,10.1017/S095026880600625X,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1997,2006,9,3817,1,1,1
2022-06-30T07:02:27.279-03:00,2023-01-10T10:52:45.924-07:00,Rubella seroprevalence among women aged 15-39 years in Morocco,Caidi,2009-01-01,13997,2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,MA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Women aged 15 to 39, participants from a national survey on anemia",other_non_serological_survey,0,0,0,0,1,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,967,967,1524,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,166748082,59841da5-ba36-44e5-82a3-11eb844995c9,2022-06-30T10:09:04,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,199,1,13997,10.26719/2009.15.3.526,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2000,2009,9,1399,1,1,1
2022-06-27T06:21:50.417-03:00,2022-12-14T21:48:03.293-07:00,Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.,Campbell,2012-01-01,4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,ncirs__australia,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"immunocompromised, multiple or recent transfusion, HIV diagnosis",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,3224,3224,7200,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,166007356,bde892b8-5d88-47fe-bd9a-71f7876989ee,2022-06-27T09:40:29,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,176,1,4196,10.1371/journal.pone.0035874,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2007,2012,5,4196,1,1,1
2022-04-19T21:02:44.957-07:00,2023-02-09T10:30:15.616-05:00,"Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020.",Capai,2020-01-01,1340,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with a blood analysis conducted in one of the two private participating laboratories,diagnostic_sample,0,0,0,1,0,0,,no,,yes,one or more samples from the same person (only one sample was included in the study) and/or sample with missing information on age and/or sex and/or invalid serology result (insufficient serum volume or invalid result),diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,2312,1973,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,compared_it_to_alternative_data_source_f,0,0,0,0,1,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,152770774,ae4680a0-b561-40d4-9d1e-6e7e2695a043,2022-04-20T04:13:51,,,submitted_via_web,mpilews1,veAwrTM59Sap9PspfNKuZC,,26,1,1340,10.3390/jcm9113569,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2020,2020,0,1340,1,1,1
2022-06-21T11:44:46.370-03:00,2022-12-06T13:50:02.388-07:00,"Seroprevalence of hepatitis E virus among blood donors on Corsica, France, 2017.",Capai,2020-01-01,4121,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2705,2705,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,164722664,6c9b701c-4ef4-4b2b-89cd-d88f998cb8fc,2022-06-21T14:56:04,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,153,1,4121,10.2807/1560-7917.ES.2020.25.5.1900336,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2017,2020,3,4121,1,1,1
2022-11-24T17:14:55.865-03:00,2023-01-10T13:44:29.723-07:00,Impact of the Second Epidemic Wave of SARS-CoV-2: Increased Exposure of Young People.,Capai,2021-01-01,14297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,4505,4505,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,203243058,c08e624b-8512-4f34-abdb-2deab4fe6fe6,2022-11-24T20:29:38,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,504,1,14297,10.3389/fpubh.2021.715192,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2021,1,1429,1,1,1
2022-11-24T16:59:05.794-03:00,2023-01-11T11:04:56.561-07:00,Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space,Carcelen,2022-01-01,14512,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,ZM,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV survey,seroprevalence_study,0,0,1,0,0,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,9854,9854,25383,fingerprick venous,1,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles rubella,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,203240556,195a54e5-8fbe-48c2-9737-4e16f6454fad,2022-11-24T20:14:51,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,503,1,14512,10.1038/s41598-022-14493-3,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2016,2022,6,1451,2,1,1
2022-11-25T17:31:47.261-03:00,2023-01-10T13:39:33.591-07:00,Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.,Carlton,2021-01-01,14223,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,NZ,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,9806,9806,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,203565872,80ab34e7-b350-4403-bc70-6b978c630312,2022-11-25T20:53:58,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,512,1,14223,10.1017/S0950268821001643,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,2020,2021,1,1422,1,1,1
2022-04-21T19:11:43.259-04:00,2022-12-20T21:31:47.885-05:00,Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area.,Cassaniti,2021-01-01,3825,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1922,1922,2500,venous,0,1,neutralization_test chemiluminescence_immunoassay,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_infect,1,0,0,0,1,0,0,0,0,0,0,0,0,0,,,153137708,02842a57-5c9e-4dcc-bcc1-08ed42111498,2022-04-21T23:26:10,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,30,1,3825,10.1016/j.cmi.2021.01.030,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,2020,2021,1,3825,1,1,1
2022-06-30T10:53:44.912-03:00,2023-01-10T21:58:41.881-08:00,"Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden.",Castro Dopico,2021-01-01,1518,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,yes,Aged >18 years.,yes,Asymptomatic,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,none,0,0,0,0,1,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,5695,5100,85550,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,weighted_final_results testing_samples_multiple_times_for_the_s,0,0,0,1,0,0,0,1,0,to_describe_population_seropos to_describe_seroprevalence_amo to_estimate_infection_rates_or,1,1,0,0,0,1,0,0,0,0,0,0,0,0,,,166820209,afddf1c3-39f7-4ab9-aced-a0b5cb3150e9,2022-06-30T14:07:43,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,200,1,1518,10.1111/joim.13304,1,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,2020,2021,1,1518,1,1,2
2022-04-19T20:46:49.683-07:00,2022-12-20T22:14:13.081-05:00,"Serological surveillance of measles in blood donors in Rio de Janeiro, Brazil.",Castro-Silva,2003-01-01,3937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,plasma_donors,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,plasma donations obtained at HEMORIO which is located in the city of Rio de Janeiro and is the largest blood bank in the state of Rio de Janeiro,plasma_donation,0,1,0,0,0,0,,no,,no,,plasma_donation_site,0,0,0,0,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1101,1101,100000,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,152770194,00a81989-e0a1-4f1b-9500-93dad4644589,2022-04-20T04:01:43,,,submitted_via_web,mpilews1,veAwrTM59Sap9PspfNKuZC,,25,1,3937,10.1590/s1020-49892003001000008,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,2000,2003,3,3937,1,1,1
2022-12-21T16:30:19.833-03:00,2022-12-21T17:05:50.760-03:00,Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.,Chanchlani,2022-01-01,14172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,11422,11422,14106,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,209767597,5ca8784a-20e9-452d-8bcd-94f6c99244cf,2022-12-21T20:05:41,,,submitted_via_web,iesteban,vK5JR7f6tri3BCsuYQDPWy,,606,1,14172,10.1093/ecco-jcc/jjab153,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020,2022,2,1417,1,1,1
2022-06-22T09:23:01.534-03:00,2022-12-23T10:58:29.456-03:00,The prevalence of antibodies to SARS-CoV-2 among blood donors in China.,Chang,2021-01-01,2810,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,"(1) all donors should meet the basic requirements of blood donation in China. The legal age for blood donation in China is from 18 years old to 55 years old. If regular donors pass the physical examination, they could donate until 60 years old, or even 65 years old in Shenzhen, (2) have neither a fever (body temperature 37.3 °C) nor any respiratory symptoms for at least 28 days, (3) have neither close contact to those confirmed or suspected COVID-19 cases or clustering occurrence of cases for at least 28 days, (4) body temperature is normal before donation (37.3 °C), and (5) in Shenzhen and Shijiazhuang, donors who have a history of residence in or travel from Hubei province or have close contact to people from Hubei are suggested to defer blood donation for at least 28 days.",unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,38144,38144,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,1,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,164971650,c98a312a-e173-4a9f-8d15-eb70030ecb31,2022-06-22T12:35:22,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,163,1,2810,10.1038/s41467-021-21503-x,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,1,0,1,0,0,0,0,1,2020,2021,1,2810,1,1,1
2022-11-24T15:54:36.118-03:00,2023-01-10T13:41:39.922-07:00,"Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic",Charlton,2021-01-01,14250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,93993,93993,104723,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,203235241,c4374d57-052e-439b-9fac-187a61349d2f,2022-11-24T19:47:34,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,501,1,14250,10.1128/Spectrum.00291-21,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2021,1,1425,1,1,1
2022-11-24T15:49:41.490-03:00,2023-01-11T11:49:26.036-07:00,Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam,Chau,2021-01-01,16228,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016 2017 2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,VN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,350,348,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,203222968,4d813116-ab89-4c50-a0f7-d93c07f50671,2022-11-24T18:54:30,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,500,1,16228,10.1016/j.ijid.2021.07.072,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2015,2021,6,1622,1,1,1
2022-11-20T18:14:23.750-03:00,2023-01-11T10:45:40.934-07:00,"SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.",Chaves,2022-01-01,14420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,7837,7837,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,201924106,ec9048be-5ea2-4ada-860a-17e83641a2b0,2022-11-20T21:20:41,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,482,1,14420,10.3201/eid2804.211961,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1442,1,1,1
2022-12-05T18:00:21.790-03:00,2022-12-05T18:14:49.085-03:00,Pro-inflammatory immune profile mediated by TNF and IFN- and regulated by IL-10 is associated to IgG anti-SARS-CoV-2 in asymptomatic blood donors,Chaves,2022-01-01,15729,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,7837,7837,,,,,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,206391671,4a2ca3b0-9615-4505-a0ea-05e7b82f4099,2022-12-05T21:14:40,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,562,1,15729,10.1016/j.cyto.2022.155874,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2020,2022,2,1572,1,1,1
2022-06-30T11:48:17.687-03:00,2024-04-25T20:02:56.336-04:00,Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan.,Chen,2015-01-01,2168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Samples were initially collected in a national Taiwan Survey on Prevalence of Hyperglycemia, Hyperlipidemia and Hypertension (conducted twice in 2002 and 2007)",other_non_serological_survey,0,0,0,0,1,0,,yes,Aged >15 years,yes,aboriginal,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,10690,10690,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_describe_antibody_kin_infect to_evaluate_changes_in_seropos to_describe_viral_dynamics,1,0,0,1,1,0,0,0,0,1,0,1,0,0,,,166843120,f8d15099-83cd-47c2-81c5-ba2b1c14824c,2022-06-30T15:23:42,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,203,1,2168,10.1016/j.jhep.2015.03.013,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2002,2015,13,2168,1,1,1
2022-08-21T19:28:31.356-04:00,2022-12-05T17:18:28.421-05:00,"Identification of hepatitis E virus subtype 4f in blood donors in Shanghai, China.",Chen,2019-01-01,3339,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011 2014 2015 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,1,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,4044,4044,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,1,0,0,0,0,1,0,1,0,0,0,0,,,177509162,7cf9532d-6794-4efa-9298-59adf13f7fb9,2022-08-21T23:35:44,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,461,1,3339,10.1016/j.virusres.2019.03.001,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2010,2019,9,3339,1,1,1
2022-06-30T11:31:01.547-03:00,2022-12-11T22:22:00.901-05:00,Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.,Chen,2007-01-01,3656,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Enterovirus serosurvey study in Taiwan.,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1702,1702,4618,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,166832621,8bf01a46-2830-4e2f-9eee-981eed2ba50f,2022-06-30T14:48:28,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,202,1,3656,10.1016/j.jcv.2006.12.004,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,1999,2007,8,3656,1,1,1
2022-07-04T06:46:48.052-03:00,2022-12-22T12:32:13.160-05:00,Measles antibody: reevaluation of protective titers,Chen,1990-01-01,3793,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1985,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,an American Red Cross Blood drive,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,epi_data_on_vpd_of_interest__e_g__vaccin,0,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,80,80,139,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,other,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Correlation of protection,,167560558,8ce5a0ab-ae97-4bbb-9ca6-aa19547c42e1,2022-07-04T09:55:11,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,210,1,3793,10.1093/infdis/162.5.1036,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,1985,1990,5,3793,1,1,1
2022-06-30T11:07:32.969-03:00,2022-12-21T21:56:46.986-05:00,Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan,Chen,2011-01-01,4057,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Samples were from a previous serosurvey, a Taiwan CDC funded study",seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,3102,1544,3554,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,Only prepandemic samples were considered as residual,166828057,00734ab4-d9fc-4fca-9798-249c9866efb5,2022-06-30T14:31:12,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,201,1,4057,10.1371/journal.pone.0024440,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,2007,2011,4,4057,1,1,1
2022-11-27T11:43:25.590-03:00,2023-02-09T10:24:54.522-05:00,Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic Risk.,Cheung,2022-01-01,14411,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,HK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,353,353,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,203979347,8de9f900-c66b-488a-aa84-ad2b45799053,2022-11-27T14:50:34,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,522,1,14411,10.3201/eid2805.211965,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2013,2022,9,1441,1,1,1
2022-05-15T20:23:50.532-04:00,2022-12-11T17:43:00.980-05:00,Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population.,Chi,2010-01-01,3371,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,These human sera were collected from donors who visited or were admitted to the National Cheng Kung University Hospital,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,229,229,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,157154012,f23d23e8-134e-4fa2-a37c-0afc2086a5e2,2022-05-16T00:35:33,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,90,1,3371,10.1128/CVI.00212-10,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2008,2010,2,3371,1,1,1
2022-05-18T16:06:03.069-04:00,2022-12-19T08:42:26.430-05:00,Current seroepidemiology of hepatitis A in Hong Kong.,Chin,1991-01-01,3781,1990,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1987 1988 1989,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Participants were screened for hepatitis B virus (HBV) serological markers for a vaccination programm,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,702,702,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,157812420,3364cb3a-61b2-42ac-a60e-c9e1d4c26ef1,2022-05-18T20:17:38,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,102,1,3781,10.1002/jmv.1890340312,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1987,1991,4,3781,1,1,1
2022-02-18T12:00:40.296-07:00,2023-01-09T17:37:44.544-08:00,Sero-prevalence of arthropod-borne viral infections among Lukanga swamp residents in Zambia.,Chisenga,2020-01-01,1247,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,ZM,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,other,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,"Fishmongers. In the trial, participants were considered eligible if they were aged 18 years and above, resided in Lukanga swamps for over a year, involved with fish mongering, willing to be followed up for 2 years, willing to be vaccinated, healthy by medical history and clinical examination, and willing and able to provide written informed consent. Pregnant women were excluded as well as those with fever, any acute disease, any systemic disorder as determined by medical history or physical examination that would compromise the participant’s health.",,other,0,0,0,0,0,1,cholera mass vaccination campaign,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__other,0,0,0,0,0,0,1,0,"a waver on re-consenting was granted by the University of Zambia Biomedical Research Authority, Lusaka, Zambia",214,214,10000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_identify_risk_factors_of_se,1,0,0,1,0,0,0,1,0,0,0,0,0,0,,,142432800,674a7db2-53f4-45cf-b09a-715b077316ee,2022-02-18T20:13:24,,,submitted_via_web,mpilews1,vpQrgGPTK7VgMoGYycNBPf,,5,,1247,10.1371/journal.pone.0235322,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2016,2020,4,1247,1,1,1
2022-02-25T20:35:35.451-05:00,2024-04-19T11:56:45.826-04:00,Sero-Prevalence Surveillance to Predict Vaccine-Preventable Disease Outbreaks; A Lesson from the 2014 Measles Epidemic in Northern Vietnam.,Choisy,2019-01-01,791,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,VN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,yes,yes,vietnam,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Periodic age-stratified residual serum collections from 4 hospitals in Vietnam (one in Hanoi, one in Hue, one in Buon Ma Thuot, and one in Ho Chi Minh City)",diagnostic_sample,0,0,0,1,0,0,,yes,children and women of childbearing age,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,3662,3662,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d,1,0,0,0,1,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,144223751,116cce93-f628-4432-beee-c5af4485db6b,2022-03-01T15:27:10,,,submitted_via_web,abernas,vpQrgGPTK7VgMoGYycNBPf,,13,1,791,10.1093/ofid/ofz030,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,2012,2019,7,791,1,1,1
2022-04-19T09:59:59.280-04:00,2022-12-16T14:33:07.750-05:00,Time Trend of the Prevalence of Hepatitis E Antibodies among Farmers and Blood Donors: A Potential Zoonosis in Denmark,Christensen,2008-01-01,3658,2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1983,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors other,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Farmers,,seroprevalence_study,0,0,1,0,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1458,916,991,venous,0,1,elisa_eia__enzyme_immunoassay epitope_blocking_assay_using_m,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,"Informed consent only in blood donors (control group, not residual)",152688910,29005f18-4501-4859-a5c1-d4d41db83684,2022-04-19T14:25:13,,,submitted_via_web,iesteban,veAwrTM59Sap9PspfNKuZC,,23,1,3658,10.1086/591970,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,1983,2008,25,3658,1,1,2
2022-02-22T14:55:37.642-05:00,2023-01-09T17:41:28.213-08:00,Plasma Donors in the Southwestern United States Positively Contribute to the Diverse Therapeutic Antibody Profile of Immune Globulin Products,Ciencewicki,2020-01-01,1292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,plasma_donors,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation other,1,0,0,0,0,1,Plasma donation,yes,1) The primary selection criterion for donation centers was proximity to regions of high HAV incidence and seroprevalence.2) centers that perform testing at the facility to allow for quick access to samples; (3) centers that have sufficient unique donors over a short time-span to produce an adequate sample size,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,171,171,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a measles,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results testing_samples_multiple_times_for_the_s,0,0,1,0,0,0,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,They used pooled plasma samples. There were 171 total pooled samples. Each pooled plasma samples included samples from 16 patients.,143119075,a3be512a-127b-46d1-abbc-2cb5c241a632,2022-02-22T22:21:19,,,submitted_via_web,iesteban,vpQrgGPTK7VgMoGYycNBPf,,12,1,1292,10.1038/s41598-020-63794-y,1,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,,2020,,1292,2,1,1
2022-11-27T11:36:50.357-03:00,2023-01-11T10:53:45.690-07:00,Contrasting SARS-CoV-2 epidemics in Singapore: cohort studies in migrant workers and the general population.,Clapham,2022-01-01,14491,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,singapore,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,unknown,,unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1415,937,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,203977462,3904bcf4-f05b-4844-9e9e-038107a76642,2022-11-27T14:43:19,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,521,1,14491,10.1016/j.ijid.2021.11.043,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2019,2022,3,1449,1,1,1
2022-05-01T22:57:13.700-04:00,2023-01-11T12:47:37.132-08:00,Hepatitis E virus in Scottish blood donors,Cleland,2013-01-01,1583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005 2006 2007 2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Samples were obtained from the Research Anonymous Archive,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1559,1559,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood to_estimate_infection_rates_or,0,0,1,0,0,1,0,0,0,0,0,0,0,0,,,155099203,0ec665c2-84b1-4769-b80e-6441610e063e,2022-05-03T13:05:31,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,48,1,1583,10.1111/vox.12056,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2004,2013,9,1583,1,1,1
2022-11-24T13:48:54.617-03:00,2023-01-11T11:24:16.984-07:00,Prospective investigation of herpesvirus infection and risk of glioma.,Coghill,2022-01-01,14646,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1998 1999 2000 2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NO US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,janus__norway__cancer_registry,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with glioma,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,757,361,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_estimate_infection_rates_or to_evaluate_outcomes_of_seropo,0,0,0,0,0,1,0,0,1,0,0,0,0,0,,,203196729,a5b907fc-9719-4cd9-a1f9-a39ce150305a,2022-11-24T17:25:31,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,498,1,14646,10.1002/ijc.33987,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1998,2022,24,1464,1,2,1
2022-08-14T07:37:16.925-03:00,2022-12-16T15:44:16.628-05:00,Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.,Cohen,2006-01-01,3764,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_national_serum_bank_by_,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,3326,3326,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,175849753,78a02356-6041-4c7a-ad20-60ffb141c1ef,2022-08-14T10:47:18,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,439,1,3764,10.1016/j.vaccine.2006.04.024,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,1997,2006,9,3764,1,1,2
2022-08-08T11:54:46.963-04:00,2023-01-15T13:51:36.345-08:00,Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.,Collenberg,2006-01-01,2209,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BF,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors patient_population,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Pregnant women attending a prevention of mother to child transmission of HIV at Nouna District Hospital;,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,683,683,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue hepatitis_b,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,174699680,50ef08db-e4cb-4cd2-837a-dddee2a5fda0,2022-08-08T20:51:20,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,418,1,2209,10.1002/jmv.20593,0,1,0,1,0,0,1,1,1,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,1,2003,2006,3,2209,2,1,3
2022-07-04T06:55:01.667-03:00,2022-12-11T21:45:01.971-05:00,Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales.,Collins,2018-01-01,3539,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,National Health Survey with the Seroepidemiology Unit,diagnostic_sample,0,0,0,1,0,0,,yes,Up to 8 years,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1000,1000,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hemophilus_influenza__hib,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,"fluorescent bead assay is the test they used, I believe ELISA is the best fit as option for selection",167565696,90a4cfe6-126f-44c2-b69c-16d953dcb4b3,2022-07-04T10:13:34,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,211,1,3539,10.1016/j.jinf.2017.12.010,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2013,2018,5,3539,1,1,1
2022-06-30T12:18:46.524-03:00,2023-01-04T13:28:03.916-07:00,"Low prevalence of diphtheria immunity in the population of Florence, Italy",Comodo,1996-01-01,6408,1995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,641,641,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,166846088,d9b58a56-e302-4c7a-9e31-c920536d141b,2022-06-30T15:33:28,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,204,1,6408,10.1007/BF00145414,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1994,1996,2,6408,1,1,1
2022-11-27T09:00:15.773-03:00,2023-01-11T11:25:04.766-07:00,"Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020-May 2021.",Couture,2022-01-01,14691,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,41583,41583,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results,0,0,1,1,0,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,203975874,7a1b0b8a-c504-4886-9daa-0e9a4aa1fe5c,2022-11-27T14:36:44,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,520,1,14691,10.1093/ofid/ofac044,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,2020,2022,2,1469,1,1,1
2022-08-08T15:35:00.025-03:00,2022-12-21T22:06:53.936-05:00,Hepatitis E virus seroprevalence in blood donors in a university hospital in Chile,Covarrubias,2018-01-01,4071,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,CL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,186,186,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,174679482,5e00fa8e-5029-4f68-8553-3fca8159ad92,2022-08-08T18:47:27,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,414,1,4071,10.4067/s0716-10182018000400455,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2014,2018,4,4071,1,1,1
2022-07-10T22:00:18.750-03:00,2023-01-05T10:20:21.110-07:00,"Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005.",Cowie,2010-01-01,7092,2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1995 2000 2005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Samples were used after collection in the Victorian HBV serosurvey,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"Any samples from a patient ever referred for serologic testing for HBV, hepatitis C virus (HCV) or human immunodeficiency virus (HIV) at VIDRL were excluded",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3212,3212,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,1,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,168933588,3d38d8ac-137e-4db2-85f5-f88e59cde377,2022-07-11T12:09:50,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,261,1,7092,10.1111/j.1753-6405.2010.00477.x,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1,0,1,1,0,0,0,0,1995,2010,15,7092,1,1,1
2022-06-12T11:16:19.464-07:00,2022-12-05T17:35:55.944-05:00,"Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009.",Cox,2011-01-01,3365,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,leftover serum specimens initially drawn for other lab testing; blood bank testing; children's medical center and outpatient pediatric clinic,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,yes,Infants <6 months (potential for maternal antibody transmission),hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified yes__exempt_as_public_health_s,0,0,0,0,1,1,0,0,,876,876,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,1,1,1,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,162974516,75ce683b-e54a-488d-a9e1-ac28c6beac06,2022-06-13T20:28:58,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,121,1,3365,10.1371/journal.pone.0029301,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,1,1,1,1,0,1,1,0,0,0,1,2009,2011,2,3365,1,1,2
2022-06-12T10:52:40.621-07:00,2023-01-08T17:08:12.997-08:00,"SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals.",Coyle,2021-01-01,746,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,QA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Routine clinical care: home care visits, outpatient visits, inpatient visits, and emergency department visits",diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,112941,112941,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,1,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,162730998,5d17cf7d-e8e0-49d0-9f4d-5f6a07d8b15e,2022-06-12T18:16:29,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,120,1,746,10.1016/j.isci.2021.102646,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1,0,1,0,0,0,0,0,2020,2021,1,746,1,1,1
2022-06-14T15:01:30.742-07:00,2022-12-14T16:28:14.441-07:00,Seroprevalence and durability of rubella virus antibodies in a highly immunized population.,Crooke,2019-01-01,4132,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Mayo Clinic Biobank,diagnostic_sample,0,0,0,1,0,0,,yes,18-45 years old and had at least 0.5 mL of serum available,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__consent_given_in_retrospe,1,0,1,0,0,0,0,0,,1393,1393,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_subsampling compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,163710957,990d4f65-7562-4000-aa5a-0ebf2248f5e5,2022-06-16T22:28:17,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,128,1,4132,10.1016/j.vaccine.2019.05.049,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,2019,,4132,1,1,1
2022-04-25T18:45:29.761-04:00,2023-01-18T11:28:46.114-08:00,Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.,Crum-Cianflone,2011-01-01,2325,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV infected patients from the United States Military HIV Natural History Study (NHS),diagnostic_sample,0,0,0,1,0,0,,yes,"age R18 years; negative HAV immunoglobulin G (IgG) prior to vaccination; documented receipt of 2 HAV vaccinations administered 6–18 months apart after HIV diagnosis; and available blood specimens at 12 (6 6) months and R3 years after receipt of the second HAV vaccine to evaluate the initial and long-term antibody responses, respectively",yes,"participants who received ,2 or .2 HAV vaccine doses",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,246,246,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc to_evaluate_changes_in_seropos,0,1,0,1,0,0,0,0,0,1,0,0,0,0,,"130 patients, positive initial samples were retested.",153727382,091ffebd-29b7-4569-a350-854a44a37ab9,2022-04-25T23:02:06,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,38,1,2325,10.1093/infdis/jir180,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,,2011,,2325,1,1,1
2022-07-05T10:24:43.115-03:00,2022-12-11T21:59:27.471-05:00,Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls.,Cubie,1998-01-01,3583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994 1995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,school_children,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,Samples taken as part of rubella vaccination program,seroprevalence_study,0,0,1,0,0,0,,yes,Aged 11-13,unknown,,school,0,1,0,0,0,0,0,0,0,1,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1192,1192,,fingerprick,1,0,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,167873957,69dc35e6-f578-4ec2-a3fc-33732b2314a9,2022-07-05T13:33:18,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,216,1,3583,,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1994,1998,4,3583,1,1,1
2022-02-22T14:06:51.776-05:00,2022-12-21T20:53:59.485-05:00,Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A.,Dalton,2008-01-01,3978,2005-2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,5841,500,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_e,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,143101014,6e25df4c-b7f0-4e9a-b625-4ddfa9af91e6,2022-02-22T19:35:16,,,submitted_via_web,iesteban,vpQrgGPTK7VgMoGYycNBPf,,10,1,3978,10.1007/s10096-008-0480-z,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2005,2008,3,3978,2,1,1
2022-05-19T20:40:54.875-04:00,2022-12-20T08:59:22.921-07:00,Hepatitis E in new zealand.,Dalton,2007-01-01,4208,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NZ,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"A group of 265 anonymous NZ blood donors were tested for HEV IgG. In addition, 77 patients with unexplained hepatitis were tested",blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,342,342,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,year of sample collection is unknown,158057811,8761228d-1ce7-476d-beac-bb8b2e4d7721,2022-05-20T00:51:21,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,104,1,4208,10.1111/j.1440-1746.2007.04894.x,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,,2007,,4208,1,1,2
2022-06-07T13:44:10.447-04:00,2022-12-20T09:05:52.125-07:00,"Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease",Dalton,2008-01-01,4211,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"blood donors; medical and surgical day cases and inpatients, and medical outpatients;",blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,yes,jaundice or had abnormal serum alanine aminotransferase,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,962,962,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,161712027,693b03d3-64b9-4bb0-9fe0-c8961d233dd8,2022-06-07T18:05:55,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,114,1,4211,10.1097/MEG.0b013e3282f5195a,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,1,2006,2008,2,4211,1,1,2
2022-11-24T12:45:23.927-03:00,2024-04-25T20:38:51.141-04:00,"Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.",Damjanovic,2022-01-01,14614,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,newborns dried blood spots,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"repeats from the same infant, collected more than 30 days after birth, from infants whose parents opted out of public health research, from infants who had received transfusions, or from infants of mothers residing outside New York State",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,415293,415293,416278,fingerprick,1,0,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,203183865,7a95ec72-42b1-4da2-a0aa-1a383a629a88,2022-11-24T16:48:49,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,497,1,14614,10.1001/jamanetworkopen.2022.27995,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2019,2022,3,1461,1,1,1
2022-05-19T20:51:11.279-04:00,2022-12-14T20:10:26.401-07:00,Solomon Islands dengue seroprevalence study--previous circulation of dengue confirmed.,Darcy,2001-01-01,4153,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994 1995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,SB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"The samples analyzed in this study were 515 stored sera taken from blood bank donors presenting to the National Referral Hospital, Honiara during 1994 and 1995.",blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,515,515,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,158058164,0a1c32cb-863e-4f48-b5f0-8c60195cc9e7,2022-05-20T01:00:39,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,105,1,4153,,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,1994,2001,7,4153,1,1,1
2023-01-26T09:59:22.454-05:00,2023-02-24T11:57:11.265-05:00,Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study,Dassah,2015-01-01,1822,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,GH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population school_children,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,healthy children ages 1-10 years within the community during a malaria outreach program,seroprevalence_study,0,0,1,0,0,0,,yes,completed the EPI,no,,unknown,0,0,0,0,0,0,0,0,1,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__consent_given_in_retrospe,1,0,1,0,0,0,0,0,,104,104,200,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,,221322047,189f599b-b8bf-4482-9437-2116ddd1f750,2023-02-24T16:57:56,,,submitted_via_web,abernas,vJzTYFwzQYR9pFHSy55TD3,,616,1,1822,10.1371/journal.pone.0145209,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,2009,2015,6,1822,1,1,2
2022-06-10T10:23:38.360-07:00,2022-12-16T14:41:21.736-05:00,Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population,Davidovici,2007-01-01,3668,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000 2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Serum bank collected by Israel CDC from diagnostic labs for 0-18yo and routine screening tests of healthy blood donors for 18+,blood_donation seroprevalence_study diagnostic_sample,1,0,1,1,0,0,,unknown,,unknown,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1555,1555,1642,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,162413777,2813ee2b-16ea-4ebf-8699-0999bfa9f2cf,2022-06-10T17:37:06,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,118,1,3668,10.1007/s10654-007-9169-3,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,1,2000,2007,7,3668,1,1,2
2022-11-27T08:35:12.275-03:00,2023-02-05T15:10:04.024-07:00,Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.,Davis,2021-01-01,14204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,yes,"Donors who felt unhealthy including, but not limited to, elevated temperature, low blood hematocrit or signs of respiratory infection were excluded. Samples without complete biogeographical information were subsequently excluded",blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti yes__received_waiver_on_re_con yes__samples_de_identified,0,1,0,1,1,0,0,0,,9550,9550,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,203926955,10443d14-94b0-42dd-9a06-20ede74e7a19,2022-11-27T12:00:11,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,519,1,14204,10.1371/journal.pone.0254667,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2020,2021,1,1420,1,1,1
2022-11-24T12:23:09.419-03:00,2023-01-11T11:29:05.915-07:00,Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts.,Delaugerre,2022-01-01,14737,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV study,diagnostic_sample,0,0,0,1,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,844,844,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s conducted_sensitivity_analysis,0,0,1,0,0,1,0,1,1,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,203160420,9c31c1e8-47aa-465f-8606-4471fa9158fe,2022-11-24T15:45:18,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,496,1,14737,10.1093/ofid/ofac188,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,1,0,0,0,2020,2022,2,1473,1,1,1
2022-07-05T11:11:50.328-03:00,2022-12-24T10:49:02.124-03:00,Prevalence of human papillomavirus antibodies in males and females in England.,Desai,2011-01-01,3100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002 2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 10-45,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,4647,4647,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,167898655,c69e651a-2e79-44fd-858d-7911dde80333,2022-07-05T14:51:39,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,219,1,3100,10.1097/OLQ.0b013e31820bc880,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2002,2011,9,3100,1,1,1
2022-07-27T14:42:55.909-03:00,2023-01-18T11:26:39.358-08:00,Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic /California/07/2009(H1N1) influenza in healthy volunteers.,Desheva,2015-01-01,2324,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,RU,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 2-83 years,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__other,0,0,0,0,0,0,1,0,samples were leftover,219,219,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_describe_antibody_kin_infect to_describe_cross_reactivity,1,0,0,1,1,0,0,0,0,0,1,0,0,0,,,172302288,6f507f03-7439-4f81-b969-f82321680a48,2022-07-27T18:05:02,,,submitted_via_web,iesteban,vLT9WLEGcKDiqsV6vaVroi,,359,1,2324,10.1186/s13104-015-1086-z,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2005,2015,10,2324,1,1,1
2022-11-24T12:17:27.938-03:00,2023-01-11T10:44:41.480-07:00,"SARS-CoV-2 seroprevalence in children and their family members, July-October 2020, Brussels",Dethioux,2022-01-01,14413,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,6 months to 16 years old,diagnostic_sample,0,0,0,1,0,0,,no,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,172,112,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,,203151995,3ecf0e3a-8fe4-4f7f-b624-06d291a4d6e8,2022-11-24T15:23:04,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,495,1,14413,10.1007/s00431-021-04284-9,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2022,2,1441,1,1,1
2022-07-27T15:04:51.281-03:00,2023-05-21T10:32:14.080-04:00,"Seroprevalence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in children undergoing endoscopy in our pediatric gastroenterology clinic",Deveci,2020-01-01,9356,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,TR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patient who underwent endoscopy,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,377,377,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,172310986,7d0304e0-d236-4a45-a25a-3eecfdee97f5,2022-07-27T18:52:43,,,submitted_via_web,iesteban,vLT9WLEGcKDiqsV6vaVroi,,360,1,9356,10.5578/ced.202002,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2017,2020,3,9356,1,1,1
2022-07-05T17:30:04.269-03:00,2023-01-11T12:49:45.432-08:00,Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy.,Di Stefano,2021-01-01,1594,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,yes,Criteria for exclusion of donors were (1) age <18 years or >65 years; (2)body weight <50 kg; (3) hemoglobin value <12.5 g/dL for females and 13.5 g/dL for males; (4) history of jaundice; (5) sickle cell disease; (6) hypertension; (7) current fever; or (8) reported previously diagnosed SARS-CoV-2 infection.,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1797,1797,,venous,0,1,chemiluminescence_immunoassay epitope_blocking_assay_using_m,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,0,1,0,1,0,to_evaluate_the_need_for_blood,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,167981051,ed621cf6-b62b-4426-8c44-c393ed2573e7,2022-07-05T20:40:25,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,220,1,1594,10.1159/000515258,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,0,2020,2021,1,1594,1,1,1
2022-05-12T22:42:54.502-04:00,2022-12-21T21:54:38.510-05:00,Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.,Dickson,2021-01-01,4056,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,residual blood samples were obtained from regional biochemistry laboratories in six participating regional health authority areas covering approximately 75% of the Scottish population,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,4751,4751,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,156740324,1cc0386b-c462-4a32-80a5-adf6a041b109,2022-05-13T02:53:22,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,84,1,4056,10.1016/j.puhe.2020.11.014,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2020,2021,1,4056,1,1,1
2022-07-05T18:08:25.030-03:00,2022-12-24T10:56:58.254-03:00,Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units.,Diedrich,2002-01-01,3129,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,German Health Survey and patient samples,seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,no,,unknown,,household diagnostic_center_laboratory,1,0,0,0,0,1,0,0,0,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,3445,3445,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,poliomyelitis__polio,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,167994965,522e8e30-d58f-4828-aeb2-41b7bb23c9a8,2022-07-05T22:25:47,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,223,1,3129,10.1186/1471-2334-2-2,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,1996,2002,6,3129,1,1,2
2022-11-27T08:15:15.379-03:00,2023-01-11T11:27:01.415-07:00,SARS-CoV-2 seroprevalence rates of children seeking medical care in Louisiana during the state stay at home order.,Dietrich,2021-01-01,14728,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,812,812,1690,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,203920074,b62e6db0-fb13-4a1f-9fc5-5be976333c5b,2022-11-27T11:35:06,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,518,1,14728,10.1016/j.jcvp.2021.100047,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2021,1,1472,1,1,1
2022-06-21T09:14:49.517-03:00,2023-01-18T11:37:13.878-08:00,Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer.,Dillner,1998-01-01,2373,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1968 1969 1970 1971 1972,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,The Mobile Clinic of the Social Insurance Institution of Finland carried out a health screening examination,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,epi_data_not_on_vpd_of_interest__e_g__hi,0,0,0,1,0,no,0,0,0,0,0,0,0,1,,455,165,20243,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_outcomes_of_seropo to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,1,1,0,0,0,0,,,164666007,42afa493-75a3-4796-a009-d1f5d2b96a9c,2022-06-21T12:33:51,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,148,1,2373,10.1002/(sici)1097-0215(19980209)75:4<564::aid-ijc12>3.0.co;2-9,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1968,1998,30,2373,1,1,1
2022-05-11T16:32:32.726-04:00,2022-12-20T09:27:13.085-07:00,Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak.,Dingens,2020-01-01,4254,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"These samples were collected from 1076 unique children who visited the hospital and received blood draws for any reason, including respiratory illnesses, surgery, or ongoing medical care.",diagnostic_sample,0,0,0,1,0,0,,no,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1775,1775,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,156496164,c6136b6d-7d13-43e7-8b2a-f8c8f6f6162d,2022-05-11T20:50:55,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,76,1,4254,10.1038/s41467-020-18178-1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2020,2020,0,4254,1,1,1
2022-08-03T18:37:42.044-03:00,2022-12-22T11:47:32.521-03:00,"Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study)",Diop-Ndiaye,2008-01-01,2513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1998 1999 2000 2001 2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,SN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV infected patients that participated in a clinical trial,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,no,0,0,0,0,0,0,0,1,,363,363,401,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,173952221,cf161d13-cceb-40e5-ab80-84330a1e4a82,2022-08-04T17:40:26,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,395,1,2513,10.1002/jmv.21236,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1998,2008,10,2513,1,1,1
2022-11-24T12:12:34.445-03:00,2023-01-11T10:30:50.898-07:00,Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines.,Dodd,2021-01-01,14316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1531221,1531221,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_describe_viral_dynamics,1,0,0,0,0,0,0,0,0,0,0,1,0,0,,,203149574,82db55bf-640a-4fbd-82eb-2891521fda5e,2022-11-24T15:17:40,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,494,1,14316,10.1016/j.tmrv.2021.07.001,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2021,1,1431,1,1,1
2022-07-05T19:25:36.386-03:00,2022-12-14T21:15:06.266-07:00,Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study.,Dowse,2011-01-01,4174,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women patient_population,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"Aged 1-19, 21-45 years",yes,samples tested for respiratory infections,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1384,1384,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,167997261,032977ef-24bb-4f2b-bc0e-44b5f93cc721,2022-07-05T22:48:35,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,224,1,4174,10.5694/j.1326-5377.2011.tb04170.x,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2009,2011,2,4174,1,1,2
2022-11-25T14:22:25.363-03:00,2023-01-11T10:57:50.385-07:00,Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020,Drews,2022-01-01,14494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3000,3000,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_cross_reactivity,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,203525087,db611823-dfa3-4710-abbe-b7100dda0c0a,2022-11-25T17:46:28,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,508,1,14494,10.1111/trf.16713,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2020,2022,2,1449,1,1,1
2022-11-20T18:07:19.331-03:00,2023-01-11T11:15:12.186-07:00,SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.,Drews,2022-01-01,14584,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,4500,4500,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_evaluate_changes_in_seropos,1,0,0,1,0,0,0,0,0,1,0,0,0,0,,,201923601,210f5311-f74f-4309-a39a-d111009374a8,2022-11-20T21:14:19,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,481,1,14584,10.1128/spectrum.02262-21,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2021,2022,1,1458,1,1,1
2022-07-05T19:48:23.031-03:00,2024-04-25T20:42:59.954-04:00,Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period.,Dudareva,2011-01-01,2417,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,option_22,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,yes,adults,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1602,1602,7500,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos to_describe_cross_reactivity,1,0,0,0,0,1,0,0,0,1,1,0,0,0,,,168003784,6f8dd2dc-b344-41b3-ba11-a4c7170b7e21,2022-07-06T00:46:00,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,225,1,2417,10.1371/journal.pone.0021340,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,2008,2011,3,2417,1,1,1
2022-06-27T11:13:49.840-03:00,2022-12-21T22:03:40.916-05:00,Australian rubella serosurvey 2012-2013: On track for elimination?,Edirisuriya,2018-01-01,4065,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,aged 1 - 49 years,yes,"immunocompromised, HIV infection, blood products tranfusion in past 3 months",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2729,2729,12411,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d,1,1,1,1,1,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,166089967,3491f54e-b332-4349-91d4-b11981d3788f,2022-06-27T14:46:37,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,182,1,4065,10.1016/j.vaccine.2018.03.086,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1,1,1,0,0,0,0,0,2012,2018,6,4065,1,1,1
2022-08-15T11:07:20.222-04:00,2022-12-20T21:59:14.572-05:00,The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.,Edmunds,2000-01-01,3763,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1995 1996 1997 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI FR DE IT NL SE GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population school_children,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,"ESEN; many countries used residuals from labs or health centres, some used vaccine trials",seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,unknown,,yes,"in all cases, sera likely no to be representatitve of the population were excluded (i.e. sera from patients known to be immunocompromised, or with known recent blood transfusion)",household hospital_clinic diagnostic_center_laboratory unknown,1,0,1,0,0,1,0,0,1,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,,,,,,,neutralization_test elisa_eia__enzyme_immunoassay fluorescent_immunoassay toxin_binding_inhibition_assay,1,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results,0,0,1,1,0,0,0,0,0,to_describe_population_seropos to_compare_population_seroposi,1,0,0,0,0,0,0,0,0,0,0,0,1,0,,,176064768,0f86887b-f94f-4113-9194-0739877e64c7,2022-08-15T15:26:36,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,449,1,3763,10.1017/s0950268899004161,1,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1995,2000,5,3763,1,7,3
2022-06-17T14:51:51.003-07:00,2022-12-14T16:32:17.976-07:00,An outbreak of measles among unvaccinated young adults and measles seroprevalence study: implications for measles outbreak control in adult populations.,Ehresmann,2004-01-01,4140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Red Cross Regional Blood Services retained serum samples,blood_donation,1,0,0,0,0,0,,yes,age (20-29 or 30-39) and residence (Minneapolis-St. Paul metropolitan area),no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,508,508,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d,0,1,0,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,,164762790,4c9dc523-7bf1-4afc-b82f-7ee6da09525c,2022-06-21T17:14:58,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,154,1,4140,10.1086/377714,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,1,1996,2004,8,4140,1,1,1
2022-07-05T21:45:49.184-03:00,2023-01-18T12:00:09.068-08:00,Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012.,Ehteram,2013-01-01,281,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,IR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,530,530,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood to_identify_risk_factors_of_se,0,0,1,0,0,0,0,1,0,0,0,0,0,0,,,168004007,0f90267d-39a5-4a49-9733-bfef40abddbe,2022-07-06T00:53:48,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,226,1,281,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2012,2013,1,281,1,1,1
2022-11-23T18:27:13.772-03:00,2023-01-11T11:32:30.115-07:00,"A Retrospective Study of the Seroprevalence of Dengue Virus and Chikungunya Virus Exposures in Nigeria, 2010-2018.",Ekong,2022-01-01,14777,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,NG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,701,401,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,202904219,25f5e2d5-96f8-4ffc-8a70-8d6ecde5978d,2022-11-23T21:37:22,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,492,1,14777,10.3390/pathogens11070762,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2010,2022,12,1477,1,1,1
2022-07-19T15:43:21.609-07:00,2024-04-25T20:15:51.646-04:00,Seroprevalence of pandemic influenza A (H1N1)pdm09 in two regions in Morocco following the 2010-2011 influenza season,El Rhaffouli,2013-01-01,3035,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,MA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors military,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,"samples taken from military hospital in Rabat at two time points, samples also collected from military hospital in Meknes during the later time point",blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,650,650,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,Article in French,171337344,834cfe9a-f442-482e-b0c0-2214c6c32f69,2022-07-23T00:05:50,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,328,1,3035,10.1016/j.patbio.2012.05.004,1,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,2007,2013,6,3035,1,1,2
2022-12-22T17:14:42.398-03:00,2022-12-22T17:24:41.609-03:00,SARS-CoV-2 antibody seroprevalence rates among Egyptian blood donors around the third wave: Cross-sectional study.,Eldesoukey,2022-01-01,14738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,EG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,3058,3058,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,209963545,fc9e6091-e0b2-4aff-b81d-ff4e379d169a,2022-12-22T20:24:33,,,submitted_via_web,iesteban,vJzTYFwzQYR9pFHSy55TD3,,609,1,14738,10.1002/hsr2.634,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2021,2022,1,1473,1,1,1
2022-08-09T11:17:07.172-04:00,2023-01-05T10:52:25.099-07:00,Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors,Engle,2014-01-01,7853,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1965 1966 1967 1968,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Consecutive patients between Jan 1965 and June 1968 scheduled for open heart surgery who met the following criteria: at least 21 years of age, undergoing cardia surgery associated with transfusion of large quantities of blood, agreement to period blood collection at home after surgery, residence within reasonable driving distance from NIH",diagnostic_sample,0,0,0,1,0,0,,no,,no,,household hospital_clinic,1,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,66,66,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_b hepatitis_e,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_seroprevalence_amo to_evaluate_the_need_for_blood to_evaluate_changes_in_seropos,0,1,1,0,0,0,0,0,0,1,0,0,0,0,,,174906245,41f7d367-1025-4d43-b6cc-f5209f10d775,2022-08-09T19:20:45,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,429,1,7853,10.1111/trf.12682,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1965,2014,49,7853,3,1,1
2022-08-09T15:38:51.088-04:00,2024-04-25T20:33:34.479-04:00,Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?,Eriksen,2013-01-01,4161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BE BG CY CZ FI HU IE IL LV LT LU MT RO SK SI ES SE GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"varied by country, half were residual, the rest used population sampling",seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,household hospital_clinic,1,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,53964,53964,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,mumps,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_compare_population_seroposi,1,0,0,0,0,0,0,0,0,0,0,0,1,0,,,174913011,072e6ae3-5ccb-49e1-9328-079951571074,2022-08-09T20:01:04,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,431,1,4161,10.1017/S0950268812001136,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1996,2013,17,4161,1,18,2
2022-11-23T18:19:16.828-03:00,2023-01-11T11:30:12.864-07:00,Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study.,Erikstrup,2022-01-01,14765,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021 2022,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__exempt_as_public_health_s,0,0,0,0,0,1,0,0,,43088,43088,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_infect to_estimate_infection_rates_or,1,0,0,0,1,1,0,0,0,0,0,0,0,0,,,202902543,14c8d0df-fa76-4631-b828-b8849e10bef1,2022-11-23T21:27:08,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,491,1,14765,10.1016/j.lanepe.2022.100479,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2021,2022,1,1476,1,1,1
2022-12-16T11:39:58.450-03:00,2022-12-16T11:53:24.614-03:00,Prevalence of antibodies against SARS-CoV-2 among pregnant women in Norway during the period December 2019 through December 2020.,Eskild,2022-01-01,14529,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,stored after compulsory testing for syphilis antibodies in antenatal care,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,6520,6520,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,208770385,42c9084c-bb73-4880-9172-b9e648ac5fb2,2022-12-16T14:53:16,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,588,1,14529,10.1017/S0950268822000073,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,2019,2022,3,1452,1,1,1
2022-07-17T20:23:49.877-03:00,2022-12-23T08:28:46.375-03:00,"Implications of dengue outbreaks for blood supply, Australia.",Faddy,2013-01-01,2571,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,20052,20052,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,170202357,f540f33e-35ba-45ac-9273-81b4bf1dbadf,2022-07-18T08:49:48,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,299,1,2571,10.3201/eid1905.121664,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2008,2013,5,2571,1,1,1
2022-08-14T08:02:35.507-03:00,2022-12-21T13:35:43.731-05:00,"Pertussis seroprevalence in adults, post-partum women and umbilical cord blood.",Fallo,2014-01-01,3972,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,AR,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,other populations from the study are not considered residual,blood_donation,1,0,0,0,0,0,,,,yes,recent immunoglobulin infusion or blood transfusion recipient.,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,304,103,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,175854119,4849ff31-07ba-4dc7-8eb5-eee021fcb178,2022-08-14T11:22:01,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,441,1,3972,10.5546/aap.2014.315,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,1,2009,2014,5,3972,1,1,1
2022-11-23T17:45:27.359-03:00,2023-01-11T11:54:04.977-07:00,Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: Is there a need for a vaccine booster dose for adolescents and young adults?,Farahat,2021-01-01,16502,2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,SA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors military healthcare_workers,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,,"three groups of adult (18 years old) individuals: (1) blood donors who attended the main blood bank in KAMC-Jeddah; (2) newly recruited HCWs undergoing pre-employment assessment at the employee health clinic in the main hospital, representing Saudi and non-Saudi expatriate workers; and (3) newly recruited military personnel undergoing pre-employment examination at the military pre-employment clinic",blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,yes,immunocompromised persons and those with recent history of cough or other illnesses,hospital_clinic blood_donation_site diagnostic_center_laboratory,0,0,1,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,1200,1200,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,202900926,bfb09e11-2c28-4976-92a7-3af0287b917a,2022-11-23T21:19:11,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,490,1,16502,10.1136/bmjopen-2020-042711,1,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,1,2018,2021,3,1650,1,1,2
2022-06-24T11:04:38.140-03:00,2022-12-21T20:57:36.228-05:00,"Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore.",Fatha,2014-01-01,3985,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"2 surveys, a pediatric survey and adult one from a cross sectional national health survey",diagnostic_sample,0,0,0,1,0,0,,yes,aged 1 - 74,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__exempt_as_public_health_s,1,0,0,0,0,1,0,0,,4493,4493,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d,0,0,1,0,1,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,165538930,45f3a981-6dad-4445-9976-81a7f3a905eb,2022-06-24T14:38:35,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,168,1,3985,10.1016/j.ijid.2013.10.003,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,2008,2014,6,3985,1,1,1
2022-05-10T08:34:30.727-04:00,2023-01-08T10:19:52.190-08:00,Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study.,Faust,2016-01-01,277,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Cancer registry follow-up of large Nordic biobanks,diagnostic_sample,0,0,0,1,0,0,,yes,patient with diagnosis of basal cell carcinoma  and Squamous Cell Carcinoma of the Skin,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,none,0,0,0,0,1,no,0,0,0,0,0,0,0,1,,18520,9260,,venous,0,1,radio_immunoassay,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,year of samples collection unknown,156226007,6d08fd6e-c301-4efc-bdcc-f2cd4d1079f1,2022-05-10T12:49:10,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,72,1,277,10.1158/1055-9965.EPI-15-1290,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,2016,,277,1,1,1
2022-07-18T05:49:38.735-03:00,2022-12-23T08:30:40.305-03:00,Measles immunity and immunization status in under-5-year-old children in New South Wales: a population-based study.,Ferson,1998-01-01,2577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,National Lead Survey,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,347,347,689,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,170203926,e183c00c-2292-48fd-a487-36f8470d081d,2022-07-18T08:58:24,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,300,1,2577,10.1046/j.1440-1754.1998.00259.x,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,1995,1998,3,2577,1,1,1
2022-07-04T11:34:36.489-03:00,2022-12-23T11:11:58.471-03:00,"SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.",Fischer,2020-01-01,2904,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,extended_demographic_data__e_g__residenc,0,1,0,0,0,yes__exempt_as_public_health_s,0,0,0,0,0,1,0,0,,3186,3186,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,167646776,a0504e4e-17ae-4aa3-9920-b74323310c40,2022-07-04T14:40:59,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,212,1,2904,10.2807/1560-7917.ES.2020.25.28.2001285,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2020,2020,0,2904,1,1,1
2022-11-20T09:07:55.404-03:00,2023-01-11T11:41:41.507-07:00,"SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, July 2020 to June 2021 – a follow-up",Fischer,2022-01-01,15900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,16217,16217,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results testing_samples_multiple_times_for_the_s,0,0,1,0,0,0,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,201838313,7674c968-0d53-4750-bf0d-8c0cec569f31,2022-11-20T12:31:18,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,480,1,15900,10.1101/2022.02.11.22270833,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,2020,2022,2,1590,1,1,1
2022-07-06T14:42:56.361-03:00,2023-01-09T16:05:17.186-08:00,Hepatitis C virus seroprevalence in clients of sexually transmitted disease clinics in North Carolina.,Fiscus,1994-01-01,1054,1990,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1988,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population injection_drug_users msm,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,,Patients from a STD clinic,diagnostic_sample,0,0,0,1,0,0,,yes,"IDU, HIV +, homosexual/bisexual, syphilis seroreactive",yes,samples senti for HIV testing,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,576,378,3052,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,168202544,90524396-c9a5-439b-ab2b-a83f3f045e92,2022-07-06T17:54:39,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,230,1,1054,10.1097/00007435-199405000-00005,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1988,1994,6,1054,1,1,3
2022-07-04T11:41:42.965-03:00,2022-12-19T08:41:42.133-05:00,Prevalence of antibodies to hepatitis E in two rural Egyptian communities.,Fix,2000-01-01,3778,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,EG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,An Hepatitis C Research Study,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,10026,10026,14737,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,167650376,66d0e367-7686-4a33-83ba-13d49c118a3f,2022-07-04T14:53:14,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,213,1,3778,10.4269/ajtmh.2000.62.519,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,1997,2000,3,3778,1,1,1
2022-11-20T08:58:28.729-03:00,2023-01-11T11:21:12.162-07:00,Epidemiology of Dengue in Argentina: Antibodies seroprevalence in blood donors and circulating serotypes.,Flichman,2022-01-01,14618,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,AR,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1530,1530,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,201832337,2e34eb3a-7a44-418d-966b-88eac0f8f3e3,2022-11-20T12:07:51,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,479,1,14618,10.1016/j.jcv.2022.105078,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1461,1,1,1
2022-11-25T17:13:13.284-03:00,2023-01-11T11:57:29.989-07:00,Role of Hepatitis E Virus Infection in North American Patients With Severe Acute Liver Injury,Fontana,2020-01-01,16635,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,CA US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with acute liver injury,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,594,594,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_seroprevalence_amo to_evaluate_outcomes_of_seropo to_evaluate_changes_in_seropos,0,1,0,0,0,0,0,0,1,1,0,0,0,0,,,203561592,f5a136e5-261c-4392-8100-2ceb4ea40ec8,2022-11-25T20:31:42,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,511,1,16635,10.14309/ctg.0000000000000273,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2008,2020,12,1663,1,2,1
2022-07-04T11:53:05.142-03:00,2022-12-26T16:35:10.932-03:00,Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center.,Freeman,2021-01-01,3220,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,pediatric immunocompromised patients,diagnostic_sample,0,0,0,1,0,0,,yes,aged <19 years,yes,"below the age of 6  months (due to maternal antibody confounding), had a prolonged hospitalization of greater than 30 days at the time of blood collection (due to lack of community exposure), and if they were receiving treatments that would specifically interfere with antibody production or profile (i.e., intravenous or subcutaneous immunoglobulin, rituximab, or bortezomib) in the 6 months prior to sample collection",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,485,485,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,0,0,1,0,1,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,167654971,85e8d43b-a08b-4cba-bd92-975be331fa59,2022-07-04T15:10:30,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,214,1,3220,10.1093/jpids/piaa123,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,0,2020,2021,1,3220,1,1,1
2022-11-21T12:26:14.348-03:00,2023-01-10T13:31:53.671-07:00,Hepatitis E virus as a trigger for Guillain-Barré syndrome,Fritz-Weltin,2021-01-01,14164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,diagnosed with Guillian Barre Syndrome,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,426,163,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,1,1,0,0,0,0,0,,,202123702,1172b524-930c-4766-b8bc-16be2425f05c,2022-11-21T15:38:21,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,488,1,14164,10.1186/s12883-021-02334-1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2008,2021,13,1416,1,1,1
2022-11-21T12:17:22.457-03:00,2023-01-10T13:33:03.218-07:00,"Hepatitis E virus prevalence among blood donors in Dali, China",Fu,2021-01-01,14169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1864,1864,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,202119430,58ba4378-31bf-427e-883e-f2e4260944e7,2022-11-21T15:26:10,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,487,1,14169,10.1186/s12985-021-01607-y,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2018,2021,3,1416,1,1,1
2022-05-11T16:09:05.720-04:00,2023-01-10T21:54:20.931-08:00,"Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan.",Furukawa,2021-01-01,1462,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients who visited or were admitted to the five hospitals and a foundation in Hyogo Prefecture,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,10377,10377,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay rapid_test_igg_lateral_flow,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_infect to_identify_risk_factors_of_se,1,0,0,0,1,0,0,1,0,0,0,0,0,0,,,156494330,e89baab2-a73c-472c-8c46-004de6435a2e,2022-05-11T20:32:43,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,75,1,1462,10.31662/jmaj.2020-0094,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2021,1,1462,1,1,1
2022-06-24T14:25:17.722-03:00,2022-12-20T21:38:43.195-05:00,The epidemiology of Varicella Zoster Virus infection in Italy.,Gabutti,2008-01-01,3852,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"immunocompromised, blood transfusion in past 6 months, acute infectious disease",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified yes__other,0,1,0,0,1,0,1,0,conducted in compliance with the Helsinki Declaration,3094,3094,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,165586143,73d464d0-45fb-413c-8005-2f800b535b4b,2022-06-24T17:52:06,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,169,1,3852,10.1186/1471-2458-8-372,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2003,2008,5,3852,1,1,1
2022-11-21T12:01:41.027-03:00,2023-01-11T10:36:55.698-07:00,Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2.,Galipeau,2021-01-01,14370,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"pediatrics and adolescents, individuals 21 to 70 years of age, older than 70 years of age, and individuals living with HCV or HIV",diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,580,580,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_evaluate_outcomes_of_seropo to_describe_cross_reactivity,0,0,0,0,0,0,0,0,1,0,1,0,0,0,,,202116314,6970fe4e-2278-419a-96fa-8b88d29fec0b,2022-11-21T15:17:18,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,486,1,14370,10.1016/j.ebiom.2021.103700,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2021,1,1437,1,1,1
2022-07-04T12:10:21.456-03:00,2022-12-24T10:35:37.028-03:00,Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors.,Gallian,2020-01-01,2997,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,1462,998,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,167660734,6128a29d-0d07-4a4b-965c-3099ecfc89e6,2022-07-04T15:30:25,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,215,1,2997,10.1016/j.antiviral.2020.104880,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2020,0,2997,1,1,1
2022-06-28T10:40:01.209-03:00,2022-12-23T08:29:49.150-03:00,"Dengue virus infections among blood donors in Guangxi of China, 2013-2014.",Gao,2018-01-01,2575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,no,0,0,0,0,0,0,0,1,,1685,1685,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,166320489,4d658a41-cc64-4834-a4cf-c49d2a6e0d4c,2022-06-28T13:54:03,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,187,1,2575,10.1111/tme.12448,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2013,2018,5,2575,1,1,1
2022-11-21T11:54:53.578-03:00,2023-01-10T13:37:38.703-07:00,"Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020.",George,2021-01-01,14217,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,yes,samples with no sex or age data,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,6477,6477,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,202111398,2e5f0265-b16f-43e0-bd27-f003cc2637e5,2022-11-21T15:02:13,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,485,1,14217,10.7196/SAMJ.2021.v111i11.15669,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2021,1,1421,1,1,1
2022-05-04T16:31:08.556-04:00,2023-01-14T16:14:29.089-08:00,Retrospective study of COVID-19 seroprevalence among tissue donors at the onset of the outbreak before implementation of strict lockdown measures in France.,Germain,2021-01-01,1783,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,the Lille Tissue Bank on the entire group of tissue donors,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,235,235,242,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,155286859,14376994-7a21-454f-9223-af55a7c81ec4,2022-05-04T21:05:31,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,57,1,1783,10.1007/s10561-021-09901-3,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2019,2021,2,1783,1,1,1
2022-07-06T14:54:28.882-03:00,2022-12-26T16:39:26.764-03:00,"Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy.",Giammanco,2018-01-01,3264,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,328,328,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,poliomyelitis__polio,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos other,1,0,0,0,0,0,0,0,0,0,0,0,0,1,to assess serological protective titers,,168206812,ea65472e-9552-404d-9c29-f0dfd36ab9aa,2022-07-06T18:09:54,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,231,1,3264,10.1080/21645515.2018.1475812,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2009,2018,9,3264,1,1,1
2022-06-24T14:41:18.806-03:00,2022-12-24T11:17:33.991-03:00,Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020.,Gidding,2021-01-01,3196,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women plasma_donors patient_population,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,plasma_donation diagnostic_sample,0,1,0,1,0,0,,unknown,,yes,"inpatient, tested for SARS-CoV-2, or COVID-19 convalescent plasma donors",hospital_clinic plasma_donation_site,0,0,1,0,1,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,5339,5339,,venous,0,1,neutralization_test radio_immunoassay,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,1,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,165588657,85c681ab-6273-4cce-9795-ad091035bacd,2022-06-24T18:05:30,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,170,1,3196,10.5694/mja2.50940,1,0,0,0,0,0,1,1,1,0,0,0,0,0,1,1,1,1,1,0,1,0,0,0,0,1,2020,2021,1,3196,1,1,3
2022-06-21T10:23:30.905-07:00,2024-04-25T20:26:15.472-04:00,Declining measles antibodies in the era of elimination: Australia's experience.,Gidding,2018-01-01,4002,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2002 2007 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,1,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,ncirs__australia,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"Immunocompromised, had received multiple transfusions in the past three months, or were known to be infected with HIV",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2729,2729,12411,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,164817970,2d339d96-8008-470d-b851-9eafc7b7a4a3,2022-06-21T22:21:18,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,159,1,4002,10.1016/j.vaccine.2017.12.002,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,1996,2018,22,4002,1,1,1
2022-05-11T16:50:44.615-04:00,2022-12-21T21:10:04.146-05:00,"Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008-2011.",Gilbert,2017-01-01,4009,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Biobanked plasma samples were obtained from the Maternal-Infant Research on Environmental Chemicals (MIREC) study, in which pregnant women were recruited.",diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1752,1752,1928,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,"Rubella seems to be now a routine test during pregnancy, but it did not seem to be a routine test when the samples were originally collected.",156500647,637b122d-82c6-4848-8a94-88f7c21138e7,2022-05-11T21:27:34,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,77,1,4009,10.1016/j.vaccine.2017.04.057,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2008,2017,9,4009,1,1,1
2022-05-10T08:49:01.567-04:00,2023-01-15T10:41:44.998-08:00,Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage.,Gilson,1998-01-01,2059,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1990,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Genitourinary medicine (GUM) clinic attenders tested for syphilis,diagnostic_sample,0,0,0,1,0,0,,yes,Genitourinary medicine (GUM) clinic attenders tested for syphilis,yes,"Hepatitis B carriers, defined as patients with detectable HBV surface antigen (HBsAg) in serum for more than 6 months",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1801,1789,,venous,0,1,radio_immunoassay,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d,0,0,1,0,1,1,0,0,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc to_identify_risk_factors_of_se,0,1,0,1,0,0,0,1,0,0,0,0,0,0,,,156233716,6856b024-b79b-47cd-875e-47dfaf1292a7,2022-05-10T13:26:36,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,73,1,2059,10.1136/sti.74.2.110,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1990,1998,8,2059,1,1,1
2022-07-06T15:09:43.955-03:00,2022-12-20T21:45:53.998-05:00,Loss of hepatitis A virus antibodies after bone marrow transplantation.,Godoi,2006-01-01,3866,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994 1995 1996 1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Patients pre bone marrow transplant,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,no,0,0,0,0,0,0,0,1,,320,320,,venous,0,1,rapid_test_igg_lateral_flow,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,168209383,b7b894b0-2467-4493-9d89-043975137c20,2022-07-06T18:22:01,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,232,1,3866,10.1038/sj.bmt.1705391,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1994,2006,12,3866,1,1,1
2022-07-06T15:21:51.493-03:00,2022-12-11T17:47:06.278-05:00,"Hepatitis E virus immunoglobulin G antibodies in different populations in Campinas, Brazil.",Gonçales,2000-01-01,3387,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Blood donors, women attending an HIV and healthcare works (interpreted as not residual)",blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,0,1,0,1,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,589,419,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,Year of sample collection is unknown.,168213094,92626aef-3dea-4e46-bc29-92ad55fc987f,2022-07-06T18:39:39,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,233,1,3387,10.1128/CDLI.7.5.813-816.2000,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,,2000,,3387,1,1,2
2022-07-18T06:09:05.072-03:00,2022-12-16T14:27:14.982-05:00,Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland.,Grabarczyk,2018-01-01,3447,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,PL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,3079,3079,12664,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,170208426,dcf03b42-85a1-4b1d-a1b8-bccd346fe464,2022-07-18T09:19:05,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,302,1,3447,10.1111/trf.14531,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,1,2014,2018,4,3447,1,1,1
2022-05-08T10:56:57.090-04:00,2022-12-11T21:17:38.948-05:00,"SARS-CoV-2 was already circulating in Italy, in early December 2019",Gragnani,2021-01-01,3443,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Patientes with liver disease,diagnostic_sample,0,0,0,1,0,0,,yes,liver disease,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,290,234,,venous,0,1,chemiluminescence_immunoassay rapid_test_igg_lateral_flow,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,155920402,384e7306-55e2-4918-b9e8-dc26b1965a9e,2022-05-08T15:12:46,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,69,1,3443,10.26355/eurrev_202104_25746,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2019,2021,2,3443,1,1,1
2022-05-05T09:23:30.244-04:00,2022-12-20T21:53:47.950-05:00,"Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.",Guiomar,2017-01-01,3878,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,PT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,11 hospital laboratories from the Portuguese Laboratory Network for the Diagnosis of Influenza Infection,diagnostic_sample,0,0,0,1,0,0,,no,,yes,suspected Influenza infection,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,626,626,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_describe_cross_reactivity,1,0,0,0,0,0,0,1,0,0,1,0,0,0,,,155376056,ede701d5-432c-45da-bc6b-f9776f86ce03,2022-05-05T13:37:42,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,60,1,3878,10.1016/j.vaccine.2017.02.019,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,0,2014,2017,3,3878,1,1,1
2022-07-12T11:54:04.910-07:00,2022-12-11T22:16:50.227-05:00,Prevalence of hepatitis E virus in Chinese blood donors.,Guo,2010-01-01,3637,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002 2003 2004 2005 2006 2007 2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors plasma_donors,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Plasma samples from urban blood centers in China (Huzhou, Wuhan, Xiamen, Shaoxing, Quzhou, Wenzhou)",blood_donation plasma_donation,1,1,0,0,0,0,,no,,no,,blood_donation_site plasma_donation_site,0,0,0,1,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,44816,44816,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,169196150,ce510200-6834-40f4-9dee-7e0a70403197,2022-07-12T19:02:35,,,submitted_via_web,abernas,vQteqvkE44GFbPjGfNx2An,,281,1,3637,10.1128/JCM.01466-09,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,2002,2010,8,3637,1,1,1
2022-05-01T22:18:36.158-04:00,2023-01-14T16:12:09.298-08:00,Diphtheria antitoxin levels in US blood and plasma donors,Gupta,1996-01-01,1751,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors plasma_donors,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"500 plasma donors, 62 blood donors.",blood_donation plasma_donation,1,1,0,0,0,0,,unknown,,unknown,,blood_donation_site plasma_donation_site,0,0,0,1,1,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,no,0,0,0,0,0,0,0,1,,562,562,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_vacc,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,,154969173,f7556c59-dfda-4d44-bec0-80d0b3f6196d,2022-05-02T02:34:08,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,45,1,1751,10.1093/infdis/173.6.1493,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,1985,1996,11,1751,1,1,1
2022-11-23T17:32:56.953-03:00,2023-01-11T11:33:59.131-07:00,Hepatitis E infection in adults with primary immunodeficiency with or without immunoglobulin replacement therapy.,Gérard,2022-01-01,14809,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,other,DEFI study,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,primary immunodeficiency,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,533,533,831,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_evaluate_outcomes_of_seropo,0,1,0,0,0,0,0,0,1,0,0,0,0,0,,,202892690,40b45af3-03b6-45e1-bebb-9eb1775b5d43,2022-11-23T20:45:40,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,489,1,14809,10.2450/2022.0258-21,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2004,2022,18,1480,1,1,1
2022-06-22T07:16:58.164-03:00,2022-12-23T08:49:52.794-03:00,Low seroprevalence of hepatitis E on Reunion island.,Gérardin,2019-01-01,2687,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,RE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,The study population was a subset of the CoPanFlu-RUN cohort dedicated to the 2009 pandemic flu,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,466,466,500,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,164967146,8d5cc685-b17e-4d85-af43-3c98301a183c,2022-06-22T12:23:09,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,162,1,2687,10.1016/j.onehlt.2019.100110,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2009,2019,10,2687,1,1,1
2022-07-18T05:58:14.905-03:00,2023-01-09T17:33:03.227-08:00,"Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.",Görander,2008-01-01,1227,2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,PL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Blood donors. STI patients were not considered residual,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,309,199,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_infect,1,0,0,0,1,0,0,0,0,0,0,0,0,0,,,170206846,d09eda85-96b4-4ef8-a4bc-1304311cb691,2022-07-18T09:09:14,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,301,1,1227,10.1128/CVI.00260-07,0,0,0,1,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2005,2008,3,1227,1,1,2
2022-07-18T06:18:55.521-03:00,2023-01-04T13:52:32.815-07:00,Prevalence of hepatitis E virus infection in liver transplant recipients,Haagsma,2009-01-01,6931,2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Liver transplant recipients,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,285,285,331,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,170210207,43dc4ff3-8168-4286-a837-57073987e07c,2022-07-18T09:27:36,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,303,1,6931,10.1002/lt.21819,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2006,2009,3,6931,1,1,1
2022-02-19T15:59:05.103-05:00,2022-12-23T11:08:42.892-03:00,Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.,Hackenberg,2013-01-01,2876,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,1399,1399,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,1,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,142575510,6b6e5134-65e4-4558-b74c-b4c38f96b82a,2022-02-19T21:11:52,,,submitted_via_web,abernas,vpQrgGPTK7VgMoGYycNBPf,,8,,2876,10.1007/s00430-012-0251-4,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,1,1,1,0,0,0,1,2010,2013,3,2876,1,1,1
2022-05-19T21:11:02.438-04:00,2023-05-21T10:25:04.545-04:00,Seroprevalence of human papillomavirus type 16 in pregnant women.,Hagensee,1999-01-01,3125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1985 1986 1987 1988 1989 1984,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Part of previous study,seroprevalence_study,0,0,1,0,0,0,,yes,"Aged 18-40, 23-26 weeks gestation",yes,"severe medical conditions, conditions related to premature labor, recent use of antibiotics, steroids or tocolytics.",unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2597,2597,3341,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,1,1,0,0,0,0,0,,,158059705,96700f4c-b892-4db6-8f68-84eec9e1ff5e,2022-05-20T01:33:21,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,107,1,3125,10.1016/s0029-7844(99)00454-8,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1985,1999,14,3125,1,1,1
2022-07-18T06:27:26.531-03:00,2022-12-14T16:26:36.862-07:00,Measles and rubella seroimmunity in newly arrived adult immigrants in Sweden.,Hagstam,2019-01-01,4116,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women migrants,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,newly arrived adult immigrants,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1973,1973,6544,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles rubella,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,170212632,9bb63673-6206-423a-b3c5-7e6a8c4f36c8,2022-07-18T09:41:44,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,304,1,4116,10.1080/23744235.2018.1524583,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2013,2019,6,4116,2,1,2
2022-07-18T06:41:36.044-03:00,2024-04-25T20:12:53.168-04:00,Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic.,Hamsikova,2013-01-01,2887,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CZ,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population blood_donors,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"National immunization survey, no acute febrile disease and no signs of immunodeficiency on the sampling day",blood_donation seroprevalence_study,1,0,1,0,0,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,3150,3150,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,170215269,cf0c4e51-d970-4afe-9f1e-d411c834a23e,2022-07-18T09:54:58,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,305,1,2887,10.1136/sextrans-2012-050486,0,0,0,1,0,1,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,0,1996,2013,17,2887,1,1,2
2022-07-18T06:54:48.972-03:00,2022-12-21T13:48:59.036-05:00,Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.,Han,2015-01-01,3976,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,3 hospitals,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,1190,1190,,venous,0,1,elisa_eia__enzyme_immunoassay fluorescent_antibody_to_membra,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,170343162,0310b7b0-8142-4e24-ab8c-f046902f6b4f,2022-07-18T17:56:18,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,306,1,3976,10.1017/S0950268814002441,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2012,2015,3,3976,1,1,1
2022-05-05T09:37:31.409-04:00,2023-01-15T10:56:38.617-08:00,Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.,Hancock,2009-01-01,2116,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2002 2003 2004 2005 2006 2007 2008 2009 1971 1976,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population blood_donors,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Blood donors + participants in vaccine clinical trials,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,679,679,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_describe_cross_reactivity,1,0,0,0,0,0,0,1,0,0,1,0,0,0,,,155378511,5a5e1599-5362-4731-8e59-3e3dd9e5b8f3,2022-05-05T13:53:40,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,61,1,2116,10.1056/NEJMoa0906453,1,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2002,2009,7,2116,1,1,2
2022-03-01T10:27:03.469-05:00,2024-04-25T20:20:01.768-04:00,Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.,Hardelid,2010-01-01,3799,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HPA Seroepidemiology Unit archive is an opportunistic collection of residual serum samples from routine microbiological testing,diagnostic_sample,0,0,0,1,0,0,,no,,yes,Patients who were known to be immunosuppressed,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,6297,6297,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,1,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_describe_cross_reactivity,1,0,0,0,0,1,0,0,0,0,1,0,0,0,,,144229857,b50d4d10-2e20-4ba3-8e71-58c4da44456b,2022-03-01T16:02:07,,,submitted_via_web,abernas,vpQrgGPTK7VgMoGYycNBPf,,14,1,3799,10.3310/hta14550-03,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,1,1,0,0,0,0,2008,2010,2,3799,1,1,1
2022-08-15T11:26:11.725-04:00,2022-12-24T11:12:20.280-03:00,Risk factors and seroprevalence of hepatitis E evaluated in frozen-serum samples (2002-2003) of pregnant women compared with female blood donors in a Southern region of Brazil.,Hardtke,2018-01-01,3183,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2002 2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"pregnant women attending Clinics Hospital, Federal Unversity of Parana, Brazil",blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,408,408,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,176668166,0c673d26-7bc1-4b65-898a-849f372cfea8,2022-08-17T23:50:51,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,458,1,3183,10.1002/jmv.25274,0,0,1,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,1,2002,2018,16,3183,1,1,2
2022-07-18T14:56:09.038-03:00,2022-12-20T22:07:32.845-05:00,Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients.,Harritshøj,2020-01-01,3906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,DK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Immunocompromised patients participants of the PERSIMUNE cohort. Blood donors were not considered residual samples,diagnostic_sample,0,0,0,1,0,0,,no,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,5249,4023,4062,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,170347091,597a779a-0ddb-4e3c-8dbf-15d3d3b25255,2022-07-18T18:14:04,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,307,1,3906,10.1016/j.ijid.2019.11.014,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2015,2020,5,3906,1,1,1
2022-07-18T15:13:54.548-03:00,2023-01-09T17:49:40.267-08:00,"Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.",Havers,2020-01-01,1351,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__received_waiver_on_re_con yes__exempt_as_public_health_s,0,0,0,1,0,1,0,0,,16025,16025,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,170359484,47c62469-d8d5-471c-a241-e18edbb91585,2022-07-18T19:12:37,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,308,1,1351,10.1001/jamainternmed.2020.4130,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2020,2020,0,1351,1,1,1
2022-11-20T08:23:49.172-03:00,2023-01-10T13:42:39.489-07:00,An age-stratified serosurvey against purified Salmonella enterica serovar Typhi antigens in the Lao People´s Democratic Republic.,Hefele,2021-01-01,14291,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2015 2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,1,0,0,0,0,LA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population blood_donors patient_population,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation seroprevalence_study diagnostic_sample,1,0,1,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,hospital_clinic blood_bank diagnostic_center_laboratory,0,1,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,937,937,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,typhoid__salmonella_typhi_or_typhoid_fev,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,201825650,720ce922-9619-4519-93fc-048dc6d2a6da,2022-11-20T11:32:26,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,477,1,14291,10.1371/journal.pntd.0010017,0,0,1,0,0,1,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2013,2021,8,1429,1,1,3
2022-08-14T07:47:08.106-03:00,2022-12-20T08:49:50.422-07:00,"Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.",Heijstek,2012-01-01,4204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997 1998 1999 2000 2001 2002 2003 2004 2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Pediatric patients with Juvenial Idiopathic Arthritis,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 1-19 years,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2576,400,416,venous,0,1,elisa_eia__enzyme_immunoassay multiplex toxin_binding_inhibition_assay,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,,diptheria measles mumps rubella tetanus,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,175851259,943351bf-9fa6-4419-8acd-881733bb0ec9,2022-08-14T11:02:45,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,440,1,4204,10.1136/annrheumdis-2011-200637,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1997,2012,15,4204,5,1,1
2022-07-11T09:09:39.288-03:00,2022-12-11T22:02:15.214-05:00,Hepatitis E prevalence in a sexual high-risk population compared to the general population.,Heil,2018-01-01,3592,2011 2012 2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,2011 2012 2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,sexual high-risk study population,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,2969,1482,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168936061,1c7fe91b-73a3-4486-b6b4-f28d852f88d2,2022-07-11T12:22:44,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,262,1,3592,10.1371/journal.pone.0191798,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2011,2018,7,3592,1,1,1
2022-08-17T20:08:17.259-04:00,2023-01-04T13:26:33.783-07:00,Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma,Heino,1995-01-01,6348,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,routine clinical samples from cancer patients; blood donors as controls,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,hospital_clinic blood_bank,0,1,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,143,143,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_evaluate_outcomes_of_seropo,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,177508956,df73b986-9a3d-48fe-ba0d-7795cc36c0e3,2022-08-21T23:29:25,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,460,1,6348,,0,0,0,1,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,,1995,,6348,1,1,2
2022-07-11T09:22:33.849-03:00,2022-12-24T10:54:16.140-03:00,Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.,Hendry,2020-01-01,3126,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,32 laboratories,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"HIV diagnosis, immunocompromised, recent transfusion and aged <1 year.",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1673,1673,12411,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,poliomyelitis__polio,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168939076,1957f282-eb99-4459-9e5c-2e805e2e50a8,2022-07-11T12:39:33,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,263,1,3126,10.1016/j.vaccine.2020.01.080,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2012,2020,8,3126,1,1,1
2022-07-31T11:04:09.669-04:00,2024-04-25T20:06:10.071-04:00,Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.,Hennessey,2009-01-01,2250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999 2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,inmates_incarcerated_individua,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,inmates; samples collected for HIV testing,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,prison,0,0,0,0,0,0,0,1,0,1,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,11170,11170,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling weighted_final_results compared_to_other_published_estimates__d,1,0,0,1,0,1,0,0,0,to_describe_seroprevalence_amo to_estimate_infection_rates_or to_identify_risk_factors_of_se,0,1,0,0,0,1,0,1,0,0,0,0,0,0,,,173454511,41355197-bc5e-4d98-a866-58fe12e339e8,2022-08-02T14:35:56,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,381,1,2250,10.1007/s11524-008-9305-8,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,1,0,0,0,0,0,1999,2009,10,2250,1,1,1
2022-06-17T14:41:43.338-07:00,2022-12-20T22:06:05.656-05:00,Hepatitis A seroprevalence and risk factors among homeless adults in San Francisco: should homelessness be included in the risk-based strategy for vaccination?,Hennessey,2009-01-01,3905,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999 2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,homeless_population,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,no,,no,,homeless_shelter,0,0,0,0,0,0,1,0,0,1,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1138,1138,1426,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d,0,0,1,0,1,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,163930863,4ebcba35-c87d-4ab5-a6b0-9747c40a7392,2022-06-17T21:52:01,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,139,1,3905,10.1177/003335490912400608,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,1999,2009,10,3905,1,1,1
2022-08-23T14:19:51.719-03:00,2022-12-16T14:30:43.824-05:00,Swine-like hepatitis E viruses are a cause of unexplained hepatitis in the Netherlands,Herremans,2007-01-01,3627,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002 2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with hepatitis,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,none,0,0,0,0,1,no,0,0,0,0,0,0,0,1,,1077,1077,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_it_to_alternative_data_source_f,0,0,0,0,1,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,178014562,98db8433-eb38-43e5-843c-35f61a8a4810,2022-08-23T17:33:26,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,463,1,3627,10.1111/j.1365-2893.2006.00786.x,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,2002,2007,5,3627,1,1,2
2022-11-20T08:09:03.715-03:00,2023-01-10T10:57:18.655-07:00,"Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020",Herzog,2022-01-01,14119,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,ambulatory patients,diagnostic_sample,0,0,0,1,0,0,,no,,yes,hospital or triage samples,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,22545,22545,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,1,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,201824164,77f541c4-09cc-48cf-8ba4-dd783ed1c8c2,2022-11-20T11:23:44,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,476,1,14119,10.2807/1560-7917.ES.2022.27.9.2100419,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1,0,1,0,0,0,0,0,2020,2022,2,1411,1,1,1
2022-12-23T08:19:05.231-03:00,2022-12-26T16:23:58.334-03:00,Dengue Virus Exposures Among Deployed U.S. Military Personnel.,Hesse,2017-01-01,3190,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,u_s__defense_medical_surveilla,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"Inclusion criteria were completion of a PDHA (required for all personnel deployed for greater than 30 days); a deployment of 6 months or greater to any country in South America, Central America, southeast Asia, or Africa; no previous deployments; a pre-deployment serum sample within 1 year of the start date of deployment; and a post-deployment serum sample within 1 year of the deployment end date",no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,1000,1000,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,210461177,cea5f3c5-8094-4849-81a4-ccb9f326f5b8,2022-12-26T19:25:35,,,submitted_via_web,iesteban,vJzTYFwzQYR9pFHSy55TD3,,614,1,3190,10.4269/ajtmh.16-0663,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1998,2017,19,3190,1,1,1
2022-07-11T09:48:03.915-03:00,2022-12-24T10:34:39.299-03:00,Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.,Hewitt,2014-01-01,2954,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,225000,225000,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,225000 samples were minipooled for testing,168953924,ede0a615-987d-4774-abff-1c6750b36a97,2022-07-11T14:07:17,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,265,1,2954,10.1016/S0140-6736(14)61034-5,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,2012,2014,2,2954,1,1,1
2022-07-11T09:39:25.433-03:00,2022-12-21T22:11:54.787-05:00,Prevalence of hepatitis E virus antibodies and infection in New Zealand blood donors.,Hewitt,2018-01-01,4082,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,NZ,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,1013,1013,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,Between eight and 12 plasma aliquots from individual donations were pooled,168940781,6dbce381-7d7a-4ace-87f8-e556857e03d9,2022-07-11T12:48:14,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,264,1,4082,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,1,0,0,0,1,2014,2018,4,4082,1,1,1
2022-06-28T09:31:41.649-03:00,2022-12-20T21:52:06.749-05:00,"Changes in seroprevalence to hepatitis A in Victoria, Australia: a comparison of three time points.",Heywood,2012-01-01,3875,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1988 1989 2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,HIV infection,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1544,1544,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,1,1,1,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,166299511,6725b259-ce02-4b10-8b7f-7146438c2c03,2022-06-28T12:46:24,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,183,1,3875,10.1016/j.vaccine.2012.07.058,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,1,0,1,0,0,0,0,0,1988,2012,24,3875,1,1,1
2022-05-18T15:26:05.251-04:00,2023-01-09T17:36:37.317-08:00,A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children.,Hippich,2021-01-01,1244,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"children aged 1 to 18 years living in Bavaria, Germany, and participating in a public health type 1 diabetes screening program",diagnostic_sample,0,0,0,1,0,0,,yes,children aged 1 to 18 years,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,15771,15771,,fingerprick,1,0,elisa_eia__enzyme_immunoassay epitope_blocking_assay_using_m,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_identify_risk_factors_of_se,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,"main technique is immunoprecipitation, I selected Epitope-blocking assay using monoclonal antibodies",157808817,39f84ed9-ab83-4152-a76b-92516c716d85,2022-05-18T19:53:46,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,100,1,1244,10.1016/j.medj.2020.10.003,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2019,2021,2,1244,1,1,1
2022-07-06T15:39:28.918-03:00,2024-04-25T19:57:57.159-04:00,Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.,Ho,2020-01-01,314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"National serum bank, collected twice, in 2006 and 2014.",blood_donation diagnostic_sample,1,0,0,1,0,0,,yes,Samples with >50ul,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3666,3666,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,1,0,1,0,0,0,0,,,168216364,6ff7af97-47e2-4528-9437-97e5eafb30d8,2022-07-06T18:54:40,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,234,1,314,10.1111/jvh.13347,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,0,2006,2020,14,314,1,1,2
2022-07-11T11:07:06.800-03:00,2022-12-27T11:25:34.594-07:00,"Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients",Ho,2020-01-01,5009,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,Aged< 20 years,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__received_waiver_on_re_con yes__samples_de_identified,1,1,0,1,1,0,0,0,,14765,14765,,venous,0,1,elisa_eia__enzyme_immunoassay rapid_test_igg_lateral_flow,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168956227,75c8fd34-5ec1-49af-8220-3b48e41e2122,2022-07-11T14:20:16,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,266,1,5009,10.1016/j.lanwpc.2020.100041,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,2020,2020,0,5009,1,,1
2022-11-27T07:48:57.840-03:00,2023-01-11T11:17:31.352-07:00,"Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020-February 2021.",Hobbs,2022-01-01,14598,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,112,112,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_outcomes_of_seropo,1,0,0,0,0,1,0,0,1,0,0,0,0,0,,,203913939,51f48280-6ffe-4b6b-be0b-abb74e82345c,2022-11-27T11:15:09,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,517,1,14598,10.1097/INF.0000000000003593,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2022,2,1459,1,1,1
2022-06-24T16:25:21.747-03:00,2022-12-24T10:56:14.104-03:00,Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases.,Hoffmann,2020-01-01,3128,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"consent, visited the inflammatory bowel disease clinic, and diagnosis of chron disease or ulcerative colitis",yes,"younger than 18 years, and denial to take part",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,481,481,642,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,165603706,7e43a46f-1d67-4523-91bd-f1d8a8db515d,2022-06-24T19:39:54,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,172,1,3128,10.1371/journal.pone.0239825,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2015,2020,5,3128,1,1,1
2022-05-11T17:48:06.685-04:00,2022-12-11T21:32:00.082-05:00,Past and present of hepatitis E in the Netherlands.,Hogema,2014-01-01,3489,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,plasma from blood donations,blood_donation,1,0,0,0,0,0,,yes,Aged 18-69,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,1160,1160,1500000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,156505769,41bfe26c-a0b1-4187-b683-e6e6bd8d515d,2022-05-11T22:21:17,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,79,1,3489,10.1111/trf.12733,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,1,1988,2014,26,3489,1,1,1
2022-11-27T07:36:33.099-03:00,2023-01-10T13:35:28.653-07:00,Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules.,Hong,2021-01-01,14188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017 2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,< 5 years of age that were initially received for diagnosis that is part of the routine primary management of suspected invasive bacterial infections,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__received_waiver_on_re_con yes__samples_de_identified,0,0,0,1,1,0,0,0,,232,232,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hemophilus_influenza__hib,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_antibody_kin_vacc,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,203906682,80b10089-5cea-4efc-97b6-8f822d49fee6,2022-11-27T10:48:55,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,516,1,14188,10.1186/s12879-021-06440-w,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2017,2021,4,1418,1,1,1
2022-05-11T17:27:23.375-04:00,2022-12-20T22:09:22.764-05:00,"Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011.",Hoschler,2012-01-01,3926,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"general microbilogy testing, aged 0-99 years",diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,4241,4241,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,156503185,0c177e46-1865-474d-b00e-f46775185026,2022-05-11T21:48:18,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,78,1,3926,10.3201/eid1811.120720,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,2010,2012,2,3926,1,1,1
2022-11-20T07:55:41.846-03:00,2023-01-11T11:40:48.662-07:00,"A Tale of 3 Pandemics: Severe Acute Respiratory Syndrome Coronavirus 2, Hepatitis C Virus, and Human Immunodeficiency Virus in an Urban Emergency Department in Baltimore, Maryland",Hsieh,2022-01-01,15778,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,7450,7450,7461,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,201820983,509f8bc8-9b2f-4c91-9e26-953ffe48c7ee,2022-11-20T11:09:15,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,475,1,15778,10.1093/ofid/ofac130,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2020,2022,2,1577,1,1,1
2022-05-08T11:27:47.045-04:00,2024-04-25T20:28:50.574-04:00,The incidence of Japanese encephalitis in Taiwan--a population-based study.,Hsu,2014-01-01,4024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"samples were obtained from the Taiwanese Survey on the Prevalence of Hyperglycemia, Hyperlipidemia, and Hypertension (TwSHHH), funded by the Health Promotion Administration, Ministry of Health and Welfare, Taiwan in 2002",other_non_serological_survey,0,0,0,0,1,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,6594,6594,6602,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,japanese_encephalitis,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,156216183,bdf3bef6-d8f0-4a36-96aa-e722cdab61b6,2022-05-10T12:04:30,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,70,1,4024,10.1371/journal.pntd.0003030,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2002,2014,12,4024,1,1,1
2022-05-26T11:00:56.164-04:00,2023-01-06T10:59:17.721-07:00,Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia,Hudu,2016-01-01,8682,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,MY,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,hepatitis B surface antigen-negative (HBsAg negative),no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1000,1000,1000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,160259099,3177ebc9-5f69-48a9-8bfd-c63b094de80d,2022-05-31T14:20:22,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,110,1,8682,10.4314/ahs.v16i3.6,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,,2016,,8682,1,1,1
2022-08-11T15:44:15.220-03:00,2022-12-20T13:04:00.404-05:00,Declining population immunity to mumps among Israeli military recruits.,Huerta,2006-01-01,3794,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_defense_force_health_su,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,Aged 18-19 years,diagnostic_sample,0,0,0,1,0,0,,no,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,353,353,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,mumps,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,175401822,9f7b7265-a9b2-4377-8ae1-f489f8a4f0d6,2022-08-11T20:33:25,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,436,1,3794,10.1016/j.vaccine.2006.05.072,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1999,2006,7,3794,1,1,1
2022-07-07T15:29:35.166-03:00,2022-12-14T20:19:46.569-07:00,Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison.,Huerta,2004-01-01,4154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,Ongoing prospective study in Israel,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,289,289,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,1,1,0,0,0,0,,,168460374,04c56692-7634-4ab9-85d2-d7790976b817,2022-07-07T18:39:31,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,247,1,4154,10.1016/j.ypmed.2004.04.036,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1999,2004,5,4154,1,1,1
2022-11-20T08:32:30.355-03:00,2023-01-11T11:55:56.699-07:00,Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting,Hughes,2021-01-01,16513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,other,NHS Greater Glasgow and Clyde (NHSGGC),no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,7480,7480,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,201830392,0bf3f85c-b530-42e9-a469-345bc06aa6a7,2022-11-20T11:58:24,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,478,1,16513,10.1093/infdis/jiaa788,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,2020,2021,1,1651,1,1,1
2022-07-11T11:20:06.254-03:00,2022-12-21T13:45:53.778-05:00,"Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi.",Hull,2017-01-01,3974,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997 1998 1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,MW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Children <  5 years admitted for acute gastroenteritis,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,75,75,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rotavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_infect to_identify_risk_factors_of_se,1,0,0,0,1,0,0,1,0,0,0,0,0,0,,,168959809,79a46575-06bd-443e-a72f-df70e19f9861,2022-07-11T14:41:16,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,267,1,3974,10.4314/mmj.v29i1.5,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,1997,2017,20,3974,1,1,1
2022-06-17T08:50:27.310-03:00,2022-12-05T17:42:07.935-05:00,Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar.,Humphrey,2019-01-01,3383,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2013 2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,QA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,male Qataris and expatriates (MENA and non-MENA nationals) who were > 18 years of age and residing in Qatar,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,1992,1992,5973,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,163810505,60173f14-75d0-4747-859b-cdf92c0b6a60,2022-06-17T12:05:42,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,132,1,3383,10.1371/journal.pone.0211574,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2013,2019,6,3383,1,1,1
2022-07-07T15:39:20.025-03:00,2022-12-26T16:50:28.747-03:00,Seroprevalence of pandemic (H1N1) 2009 in pregnant women in China: an observational study.,Huo,2011-01-01,3271,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1040,1040,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,168462779,7c3fcc2d-b725-4705-8592-8f183aa49c75,2022-07-07T18:52:43,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,248,1,3271,10.1371/journal.pone.0017995,1,0,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,1,2009,2011,2,3271,1,1,2
2022-05-12T22:19:58.751-04:00,2022-12-11T22:03:12.565-05:00,"Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012.",Huygen,2014-01-01,3613,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Samples from a study part of Eupert Labnetwork (not serial seroprevalence system),diagnostic_sample,0,0,0,1,0,0,,yes,Aged 20-39,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1500,1500,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results,1,0,1,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,156739446,e7eb3dee-8d94-4e10-a36f-dfd7ad2ec6a7,2022-05-13T02:43:05,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,83,1,3613,10.1017/S0950268813002458,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,2012,2014,2,3613,1,1,1
2022-12-05T17:51:18.671-03:00,2022-12-05T18:00:21.587-03:00,Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection.,Hønge,2022-01-01,14402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,DK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,105646,105646,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_antibody_kin_infect to_evaluate_outcomes_of_seropo,0,0,0,0,1,0,0,0,1,0,0,0,0,0,,,206389977,18f0e82f-b7ef-4d38-bc5b-ff821bc18d4f,2022-12-05T21:00:14,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,561,1,14402,10.1016/j.ijid.2022.01.041,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1440,1,1,1
2022-07-11T11:41:06.035-03:00,2022-12-26T16:49:33.236-03:00,Indigenous hepatitis E virus infection in England: more common than it seems.,Ijaz,2009-01-01,3269,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1991 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 1-85 years,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2731,2731,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,168961799,70fcfb6d-2863-4553-aaef-35b25a175e16,2022-07-11T14:52:19,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,268,1,3269,10.1016/j.jcv.2009.01.005,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1991,2009,18,3269,1,1,1
2022-07-18T16:25:20.675-03:00,2023-01-06T09:37:29.741-07:00,"Hepatitis E IgG seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France",Izopet,2015-01-01,8251,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005 2010 2011 2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,1,1,1,0,0,0,0,0,0,0,BD FR NP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2538,2538,2556,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_compare_population_seroposi,1,0,0,0,0,0,0,0,0,0,0,0,1,0,,,170368867,849a6056-eb8d-42c3-9e77-0735e2c9eb1d,2022-07-18T19:59:31,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,310,1,8251,10.1111/jvh.171-12425,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2004,2015,11,8251,1,3,2
2022-08-05T06:55:02.083-03:00,2022-12-20T21:49:31.910-05:00,"Seroprevalence of varicella-zoster virus in children with cancer in six hospitals in Santiago, Chile",Izquierdo,2012-01-01,3871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,children with cancer who have undergone chemotherapy or have undergone a hematopoietic stem cell transplant,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,179,179,200,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,174070809,ed6c8236-b59c-413b-aa36-d44e89e38c3c,2022-08-05T10:06:20,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,400,1,3871,10.4067/S0716-10182012000700002,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2004,2012,8,3871,1,1,1
2022-07-10T17:44:48.661-03:00,2022-12-21T22:27:55.617-05:00,Seroprevalence of dengue in blood donors in an outbreak: experience of a blood bank in north India,Jain,2019-01-01,4103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,369,369,,venous,0,1,rapid_test_igg_lateral_flow,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168866370,f6d4a639-ec84-43dc-90fe-748c78624294,2022-07-10T20:57:04,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,253,1,4103,10.1177/0049475519848947,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2016,2019,3,4103,1,1,1
2022-12-18T07:58:40.301-03:00,2022-12-21T16:08:18.044-03:00,Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study.,Jaiswal,2022-01-01,14466,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,yes,Eligible participants for this study were those with no current COVID-19 symptoms and no confirmed previous SARS-CoV-2 infection or in close contact of COVID-19 confirmed cases. Blood donors were excluded if they were diagnosed with COVID-19 disease or presented with physically identifiable symptoms of any previous infection mimicking flu like infection,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,586,586,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,209758752,1b4bc062-aebf-4f0f-8048-1466d991b6fb,2022-12-21T19:08:08,,,submitted_via_web,iesteban,vK5JR7f6tri3BCsuYQDPWy,,602,1,14466,10.1016/j.transci.2021.103338,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,1,2020,2022,2,1446,1,1,1
2022-07-10T17:56:54.732-03:00,2022-12-14T19:55:31.547-07:00,The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population.,Janaszek,2000-01-01,4143,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,PL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,6 hospitals + 1 laboratory,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 1-30 years,unknown,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,3000,3000,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168867045,ee2bbd3a-3938-46b4-be87-6f95d881f337,2022-07-10T21:10:35,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,254,1,4143,10.1017/s0950268899004616,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,1997,2000,3,4143,1,1,1
2022-07-10T18:10:24.939-03:00,2022-12-23T11:07:05.751-03:00,Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea.,Jeong,2021-01-01,2863,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,2 hospitals,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,7249,7249,,venous,0,1,neutralization_test radio_immunoassay,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168867828,e2dcc56d-b57f-4af2-831b-0e185e617ee7,2022-07-10T21:24:28,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,255,1,2863,10.1007/s12275-021-1095-7,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,2020,2021,1,2863,1,1,1
2022-02-19T12:19:46.049-05:00,2023-01-14T16:32:05.574-08:00,Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).,Jiang,2020-01-01,1968,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"nonseverely ill patients hospitalised in a field hospital in Wuhan, China",diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__other,1,0,0,0,0,0,1,0,Written informed consent was waived,214,214,,venous,0,1,neutralization_test chemiluminescence_immunoassay,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_identify_risk_factors_of_se to_evaluate_outcomes_of_seropo to_describe_viral_dynamics,0,0,0,0,0,0,0,1,1,0,0,1,0,0,,,142574413,9cc175af-8a65-4101-8865-764b5a618fb3,2022-02-19T20:59:14,,,submitted_via_web,abernas,vpQrgGPTK7VgMoGYycNBPf,,7,,1968,10.1002/cti2.1182,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,2020,2020,0,1968,1,1,1
2022-08-23T13:37:58.991-04:00,2024-04-25T20:09:38.775-04:00,Prevalence of markers of hepatitis B in the adult German population.,Jilg,2001-01-01,2561,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1993 1994 1995 1996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,other,Diabetomobile Study (Germany),no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"adults aged 18-70, excluding pregnant women",other_non_serological_survey,0,0,0,0,1,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,5305,5305,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,178632286,11e490f4-2ed3-4ecf-bfb9-d6656636d509,2022-08-25T16:54:59,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,473,1,2561,,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,1993,2001,8,2561,1,1,1
2022-08-03T17:42:20.148-03:00,2023-01-08T17:10:16.422-08:00,West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.,Johnson,2005-01-01,787,2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,healthcare_workers,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,113,113,144,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue japanese_encephalitis yellow_fever,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_cross_reactivity,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,173758784,cdda8e10-97c0-4f4e-8374-eef042a9bfbe,2022-08-03T20:56:02,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,390,1,787,10.1089/vbz.2005.5.137,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2003,2005,2,787,3,1,1
2022-07-06T18:10:34.094-03:00,2022-12-23T08:32:00.077-03:00,"Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010.",Jonas,2016-01-01,2579,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,National HIV Survey in 2010,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 15-44,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2044,2044,7983,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168239403,c17fb8c0-8e65-49df-9233-a23dabd82072,2022-07-06T21:24:04,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,235,1,2579,10.1016/j.ijid.2016.05.009,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2010,2016,6,2579,1,1,1
2022-11-27T07:27:36.350-03:00,2023-01-12T10:44:19.044-07:00,"Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021",Jones,2021-01-01,14151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1443519,1443519,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_describe_antibody_kin_infect to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,1,1,1,0,0,0,1,0,0,0,0,,,203903486,190b7ee5-d1cc-4523-a3bf-42c7fbdb589a,2022-11-27T10:36:28,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,515,1,14151,10.1001/jama.2021.15161,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,1,2020,2021,1,1415,1,1,1
2022-12-12T15:02:44.330-03:00,2022-12-12T15:16:13.950-03:00,Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis.,Jons,2021-01-01,14810,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2003 2004 2005 2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,multiple sclerosis,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"Three individuals were excluded based on the presence of other autoimmune diseases (systemic lupus erythematosus: n = 1 and rheumatoid arthritis n = 1) or human immunodeficiency virus (n = 1), because they were considered likely to have an altered immune response.",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,57,42,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,207860260,e83b7fa6-c982-43ab-a9a5-12c8ed7300d1,2022-12-12T18:16:05,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,575,1,14810,10.1016/j.msard.2021.103288,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2003,2021,18,1481,1,1,1
2022-07-06T18:23:53.929-03:00,2022-12-21T13:41:26.409-05:00,Seroprevalence and incidence of hepatitis E virus infection in German blood donors.,Juhl,2014-01-01,3973,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,1019,1019,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,Year of sample collection is unknown,168240796,8a912345-5c54-4ab3-838b-3909ef3ea72f,2022-07-06T21:34:04,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,236,1,3973,10.1111/trf.12121,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,,2014,,3973,1,1,1
2022-06-06T21:39:58.495-04:00,2022-12-21T22:26:44.263-05:00,A Nationwide Survey of the Seroprevalence of Hepatitis E Virus Infections Among Blood Donors in Thailand,Jupattanasin,2019-01-01,4096,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Substudy of serosurveillance of immunity to diphtheria, pertussis, and tetanus (which used blood donors)",blood_donation seroprevalence_study,1,0,1,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,630,630,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling testing_samples_multiple_times_for_the_s,1,0,0,0,0,0,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,161707081,c44e0997-f4f1-4d02-a524-f5edfdb7e926,2022-06-07T17:44:20,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,113,1,4096,10.1089/vim.2018.0146,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,2013,2019,6,4096,1,1,1
2022-07-10T18:24:17.108-03:00,2022-12-21T13:32:26.470-05:00,Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia.,Jõgi,2014-01-01,3965,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,EE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged <18 years,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1053,1053,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,168869105,6db6e059-4d95-41e5-9da9-d6bc69259269,2022-07-10T21:47:05,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,256,1,3965,10.1016/j.vaccine.2014.07.066,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2012,2014,2,3965,1,1,1
2022-07-10T18:46:54.023-03:00,2022-12-21T20:59:23.663-05:00,Estimated and reported incidence of pertussis in Estonian adults: A seroepidemiological study.,Jõgi,2015-01-01,3998,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,EE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,adults aged 20-99,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,3327,3327,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,168871384,26a98d16-45a3-40ce-8a6d-0e987cf42710,2022-07-10T23:03:43,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,257,1,3998,10.1016/j.vaccine.2015.08.007,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2013,2015,2,3998,1,1,1
2022-12-16T16:00:08.893-03:00,2022-12-16T16:05:02.443-03:00,SARS-Coronavirus-2 seroprevalence in asymptomatic healthy blood donors: Indicator of community spread.,Kale,2022-01-01,14409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,1066,1066,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,208816858,54035871-210d-40fa-a0af-0623c6fcbca0,2022-12-16T19:04:52,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,593,1,14409,10.1016/j.transci.2021.103293,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1440,1,1,1
2022-07-28T12:54:12.969-03:00,2023-05-22T10:59:11.428-04:00,Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.,Kang,2014-01-01,858,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV and HBV infected patients,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,150,150,4630,venous,0,1,other,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,unknown,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se to_describe_viral_dynamics,0,1,0,0,0,0,0,1,0,0,0,1,0,0,,Year of sample collection and serological test performed unknown,172514314,410f61e6-ef8c-449c-8685-feb4123685fe,2022-07-28T16:07:33,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,362,1,858,10.1097/QAI.0000000000000149,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,,2014,,858,1,1,1
2022-11-27T07:17:04.465-03:00,2023-01-11T11:22:55.818-07:00,"Seropositivity to SARS-CoV-2 in Alberta, Canada in a post-vaccination period (March 2021-July 2021).",Kanji,2022-01-01,14629,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,60632,60632,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,203901250,ac3a8bbb-ac45-4534-9658-5faee0f0384f,2022-11-27T10:27:30,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,514,1,14629,10.1080/23744235.2022.2080250,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2021,2022,1,1462,1,1,1
2022-08-08T19:09:03.363-03:00,2023-01-08T10:24:40.747-08:00,Sustained Cross-reactive Antibody Responses After Human Papillomavirus Vaccinations: Up to 12 Years Follow-up in the Finnish Maternity Cohort.,Kann,2021-01-01,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,FI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,finnish_maternity_cohort__fmc,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,pregnant women who had previously participated in 2 different HPV vaccine clinical trials,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1067,1067,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_describe_cross_reactivity,1,0,0,1,0,0,0,0,0,0,1,0,0,0,,year of sample collection is unclear,175370363,096422e3-f5bd-4937-b333-63be39932f2e,2022-08-11T17:46:03,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,432,1,300,10.1093/infdis/jiaa617,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,,2021,,300,1,1,1
2022-07-06T18:33:54.997-03:00,2022-12-20T09:22:31.673-07:00,Hepatitis E virus infection prevalence among selected populations in Iowa.,Karetnyi,1999-01-01,4249,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"patients with hepatitis and field workers, 2 blood donor groups used as controls",seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,none,0,0,0,0,1,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,734,271,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168243088,b8862287-5800-4f80-b64a-cfddecc3d425,2022-07-06T21:49:18,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,237,1,4249,10.1016/s1386-6532(99)00037-2,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1997,1999,2,4249,1,1,2
2022-11-29T17:39:38.904-03:00,2023-01-11T11:08:50.677-07:00,Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark.,Kaspersen,2022-01-01,14525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,DK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__exempt_as_public_health_s,1,1,0,0,0,1,0,0,,84944,84944,,venous,0,1,elisa_eia__enzyme_immunoassay rapid_test_igg_lateral_flow,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,204719218,ea98737c-9b70-45ea-8bcb-3faa5d329945,2022-11-29T20:46:57,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,528,1,14525,10.1093/infdis/jiab566,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2022,2,1452,1,1,1
2022-07-06T18:49:08.855-03:00,2022-12-11T17:22:32.175-05:00,Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India.,Katiyar,2018-01-01,3315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,633,633,1799,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,minipools of 3 samples were used,168246219,04b304ce-a7c4-40cf-b0ef-e1a26b900e44,2022-07-06T22:13:10,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,238,1,3315,10.1007/s12664-018-0880-7,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2016,2018,2,3315,1,1,1
2022-07-10T20:03:32.426-03:00,2023-01-06T11:01:19.285-07:00,Intra-familial transmission of chronic hepatitis B infection: A large population-based cohort study in northern Iran,Katoonizadeh,2018-01-01,8894,2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2004 2005 2006 2007 2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,GI cancer study,diagnostic_sample,0,0,0,1,0,0,,yes,> 40 years,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,7978,7978,50045,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,168874433,c5f78aee-4e84-44d9-984f-438d0d51e40d,2022-07-11T00:26:57,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,258,1,8894,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2004,2018,14,8894,1,1,1
2022-07-06T19:12:58.607-03:00,2023-01-18T11:30:27.252-08:00,Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.,Kaufmann,2011-01-01,2366,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,CH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,550,550,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168247114,b37f688b-3725-4e3f-9b1f-7887b8a79426,2022-07-06T22:20:55,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,239,1,2366,10.1371/journal.pone.0021150,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2009,2011,2,2366,1,1,1
2022-07-07T06:10:51.244-03:00,2022-12-24T10:50:29.899-03:00,Measles immunity among young adults in Victoria.,Kelly,2001-01-01,3113,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,blood donors + diagnostic samples for non rash diseases,blood_donation diagnostic_sample,1,0,0,1,0,0,,yes,Aged 18-30,unknown,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,612,612,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168316476,5ea9b170-ef3b-4ae1-bb7d-5838b0323de6,2022-07-07T09:20:35,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,241,1,3113,,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,1999,2001,2,3113,1,1,2
2022-07-06T19:20:45.231-03:00,2022-12-19T08:39:03.021-05:00,Interruption of rubella virus transmission in Australia may require vaccination of adult males: evidence from a Victorian sero-survey.,Kelly,2004-01-01,3776,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,samples sent for diagnostic testing,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"samples from patients with rash, or tested for measles or rubella",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,934,934,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168248577,4a64ec12-7e25-4e30-90e8-4b99514bdcfb,2022-07-06T22:35:30,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,240,1,3776,,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2002,2004,2,3776,1,1,1
2022-02-18T11:38:35.917-07:00,2024-04-25T20:21:32.468-04:00,"A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia.",Kelly,2002-01-01,3820,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,ncirs__australia,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients who had samples submitted for diagnostic testing to 45 public and private laboratories throughout Australia,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"exclude sera from subjects who were known to be immunocompromised, multiply transfused, infected with HIV or thought to have been recently infected with measles",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1503,385,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b measles mumps rubella varicella_herpes_zoster,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_compare_the_use_of_residual,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,unclear total sample size of residual samples (I added up rubella n from table 2),142423360,a854ddb6-3d8b-4158-95bc-5726d9267e26,2022-02-18T18:59:52,,,submitted_via_web,mpilews1,vpQrgGPTK7VgMoGYycNBPf,,4,,3820,10.1016/s0264-410x(02)00255-4,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1999,2002,3,3820,5,1,1
2022-06-20T10:09:47.193-03:00,2022-12-20T21:54:50.885-05:00,Does rubella immunity predict measles immunity? A serosurvey of pregnant women.,Kennedy,2006-01-01,3879,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,women seeking antenatal care in Iowa and submitted for routine testing (hepatitis B),diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,900,900,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles rubella,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,164527415,91f412e6-fe9d-48f5-b944-d4f0fd5a6059,2022-06-20T21:29:00,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,145,1,3879,10.1155/IDOG/2006/13890,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2004,2006,2,3879,2,1,1
2022-11-27T07:10:41.195-03:00,2023-01-11T11:28:19.381-07:00,Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas,Kennedy,2022-01-01,14735,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"age 18 years,  Arkansas residency, and a specimen collected at one of the study  sites",yes,"immunodeficiency (primary immunodeficiency, transplant recipient, and cancer)",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,5804,5804,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,1,0,1,0,0,0,0,,,203899500,333af6b5-5d0a-405b-b61e-59c0bb55d028,2022-11-27T10:16:59,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,513,1,14735,10.1093/ofid/ofac154,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,0,2020,2022,2,1473,1,1,1
2022-07-07T06:20:24.753-03:00,2022-12-16T15:19:17.223-05:00,Pertussis surveillance by small serosurveys of blood donors.,Kennerknecht,2018-01-01,3707,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,307,307,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,168322775,b07b6908-e31b-4560-a8a4-7f5131b9d648,2022-07-07T09:47:22,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,242,1,3707,10.1017/S0950268818001851,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2014,2018,4,3707,1,1,1
2022-07-07T06:47:11.903-03:00,2023-01-06T11:09:15.005-07:00,"Serologic characteristics of hepatitis B virus among hill-tribe children in Omkoi district, Chiangmai province, Thailand",Khamduang,2019-01-01,8990,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,school_children,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,Aged 7-14. Participants on a anemia survey,other_non_serological_survey,0,0,0,0,1,0,,unknown,,unknown,,school,0,1,0,0,0,0,0,0,0,1,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,210,210,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168325727,d9cd75a8-5125-4526-bc28-ac166aea4e9a,2022-07-07T09:58:04,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,243,1,8990,10.3855/jidc.10661,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2014,2019,5,8990,1,1,1
2022-05-15T21:06:03.153-04:00,2023-01-04T13:50:01.452-07:00,"Co-circulations of two genotypes of dengue virus in 2006 out-break of dengue hemorrhagic fever in Karachi, Pakistan",Khan,2008-01-01,6905,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,PK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,no,0,0,0,0,0,0,0,1,,250,250,1283,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,157155291,a901c80d-a66f-4c14-abb8-3ad5d3249a3a,2022-05-16T01:18:13,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,93,1,6905,10.1016/j.jcv.2008.06.003,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2006,2008,2,6905,1,1,1
2022-07-10T21:26:46.584-03:00,2022-12-16T14:40:03.509-05:00,Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.,Khetsuriani,2015-01-01,3666,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,TJ,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,National serosurvey,seroprevalence_study,0,0,1,0,0,0,,yes,Aged 1-40 years,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__exempt_as_public_health_s,1,1,0,0,0,1,0,0,,2188,2188,2459,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168874684,950adcf2-4955-4e9e-b2f3-7cb4d652bcc7,2022-07-11T00:37:13,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,259,1,3666,10.1016/j.vaccine.2015.05.092,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,2010,2015,5,3666,1,1,1
2022-07-07T06:57:54.345-03:00,2022-12-06T10:18:04.408-07:00,Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts.,Khetsuriani,2019-01-01,4115,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,GE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HBV Serosurvey,seroprevalence_study,0,0,1,0,0,0,,yes,"Aged 18-50 years, provided consent, and had significant amount of blood sample",unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti yes__exempt_as_public_health_s,0,1,0,0,0,1,0,0,,3125,3125,6011,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles rubella,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168328451,f342a03c-ead9-4add-8cd5-bf0153c1d873,2022-07-07T10:09:08,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,244,1,4115,10.1017/S0950268819002048,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2015,2019,4,4115,2,1,1
2022-06-27T06:49:50.914-03:00,2023-01-08T16:59:21.584-08:00,Comparative seroepidemiology of genital human papillomavirus infections in the general population in Singapore.,Khoo,2017-01-01,407,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other,0,0,0,0,0,1,"not clear, samples from another study",yes,Aged 21-75 years,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,750,750,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_describe_seroprevalence_amo to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,1,0,0,0,1,0,0,0,1,0,0,0,0,,,166012067,759312d0-30e8-4d0f-83ab-9e6145f23d58,2022-06-27T10:01:43,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,178,1,407,10.1016/j.puhe.2016.10.004,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2010,2017,7,407,1,1,1
2022-04-19T10:45:09.497-04:00,2022-12-23T10:51:21.009-03:00,"Absence of neutralizing antibodies against influenza A/H5N1 virus among children in Kamphaeng Phet, Thailand.",Khuntirat,2015-01-01,2789,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,children,seroprevalence_study,0,0,1,0,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,753,753,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,251 patients with 753 blood samples.,152870076,9ef7a208-df36-45e4-bdc2-9a424ae82f66,2022-04-20T13:55:33,,,submitted_via_web,iesteban,veAwrTM59Sap9PspfNKuZC,,27,1,2789,10.1016/j.jcv.2015.05.025,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,2004,2015,11,2789,1,1,1
2022-06-20T09:41:35.546-03:00,2023-01-04T13:15:49.637-07:00,Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area,Khuroo,2004-01-01,6261,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,multiple transfused patients,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,445,145,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo to_estimate_infection_rates_or to_evaluate_outcomes_of_seropo,0,1,0,0,0,1,0,0,1,0,0,0,0,0,,,164394880,3b71e91f-c3f2-433a-ba4e-34c3771f1590,2022-06-20T12:52:30,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,144,1,6261,10.1111/j.1440-1746.2004.03437.x,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1993,2004,11,6261,1,1,1
2022-06-24T10:38:14.742-03:00,2023-01-04T13:41:01.277-07:00,Prevalence of hepatitis E virus antibodies among different groups in the Amazonian basin,Kiesslich,2002-01-01,6753,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors patient_population,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"blood donors, hemodyalisis patients and pregnant women",blood_donation diagnostic_sample,1,0,0,1,0,0,,yes,aged 14 to 87,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,none,0,0,0,0,1,no,0,0,0,0,0,0,0,1,,519,519,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,Year of sample collection unknown,165530059,ed9f9ae0-084e-42b7-9dad-c012540931f1,2022-06-24T14:04:48,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,167,1,6753,10.1016/S0035-9203(02)90311-1,0,0,1,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,,2002,,6753,1,1,3
2022-07-10T21:37:02.345-03:00,2022-12-14T21:19:43.914-07:00,"Seroprevalence of measles among children affected by national measles elimination program in Korea, 2010.",Kim,2012-01-01,4178,2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"samples tested for measles, rubella, HIV and mumps",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1400,1400,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos other,1,0,0,0,0,0,0,0,0,0,0,0,0,1,to evaluate age-specific susceptibility,,168875311,73bddb92-6e98-4355-b68b-07e82108b44f,2022-07-11T01:00:30,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,260,1,4178,10.1016/j.vaccine.2012.03.073,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2010,2012,2,4178,1,1,1
2022-07-20T18:40:08.621-03:00,2022-12-11T21:19:11.049-05:00,Pertussis in Lao PDR: Seroprevalence and disease.,Kleine,2020-01-01,3446,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011 2012 2013 2014 2015 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,1,0,0,0,0,0,LA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population pregnant_women blood_donors school_children healthcare_workers,1,1,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,"A total 3072 serum samples were obtained from different cohorts: children with documented vaccination, pre-schoolers, schoolchildren, blood donors, healthcare workers (HCWs), and pregnant women and paired cord blood.",blood_donation seroprevalence_study diagnostic_sample,1,0,1,1,0,0,,unknown,,unknown,,household school blood_donation_site diagnostic_center_laboratory,1,1,0,1,0,1,0,0,0,1,,hospital_clinic blood_bank diagnostic_center_laboratory,0,1,1,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,3072,3072,3547,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,170879852,bdd745ed-9ca8-45da-abe3-630378e2fbfa,2022-07-20T21:56:57,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,323,1,3446,10.1016/j.ijid.2020.03.074,1,0,0,0,0,1,1,0,1,1,0,1,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2011,2020,9,3446,1,1,5
2022-07-20T18:56:55.560-03:00,2023-01-06T09:38:52.126-07:00,Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis,Kohlmann,2015-01-01,8399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006 2007 2008 2009 2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"natalizumab-treated MS patients, healthy blood donors and human immunodeficiency virus (HIV) infected patients.",blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1404,1404,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_evaluate_outcomes_of_seropo,0,1,0,0,0,0,0,0,1,0,0,0,0,0,,,170881459,e49a33bb-c4ad-4b33-a3a4-f345ec0aa55f,2022-07-20T22:10:09,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,324,1,8399,10.1177/1352458515576984,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2005,2015,10,8399,1,1,2
2022-07-20T19:09:58.298-03:00,2022-12-24T10:46:52.816-03:00,Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals.,Kok,2011-01-01,3093,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV infected individuals,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,199,199,,,,,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_evaluate_changes_in_seropos,0,1,0,0,0,0,0,0,0,1,0,0,0,0,,,170882392,bbb3b7bb-b803-42be-953b-b4179e087fcc,2022-07-20T22:20:43,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,325,1,3093,10.1097/QAI.0b013e318204a1c3,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2009,2011,2,3093,1,1,1
2022-07-20T19:20:31.689-03:00,2024-04-25T20:10:58.255-04:00,"Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.",Korodi,2005-01-01,2795,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1984 1985 1986 1987 1988 1989 1990,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI NO SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,janus__norway__cancer_registry,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population blood_donors patient_population,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"3 cohorts: Janus Biobank, Helsinski Heart Study and Northern Sweden Health and Disease Study.",blood_donation diagnostic_sample other_non_serological_survey,1,0,0,1,1,0,,yes,Participants with prostate cancer,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,8591,804,200000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,"Year of sample collection is unclear, in Table I we found the calendar year of recruitment that could be use to estimate it.",170958462,a492a01e-138a-4415-9b19-1b7bbfa186a6,2022-07-21T10:11:26,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,326,1,2795,10.1158/1055-9965.EPI-05-0602,0,0,0,1,0,1,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1984,2005,21,2795,1,3,3
2022-07-21T07:10:38.001-03:00,2022-12-06T10:33:55.186-07:00,"Hepatitis E virus in patients with acute hepatitis in Cape Town, South Africa, 2011.",Korsman,2019-01-01,4117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"Being tested for hepatitis, and a negative HAV, HBV, HCV result.",no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,391,391,2970,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se to_evaluate_outcomes_of_seropo,0,1,0,0,0,0,0,1,1,0,0,0,0,0,,,170960143,f10532eb-333b-47cb-a7d2-6243c584b563,2022-07-21T10:19:25,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,327,1,4117,10.7196/SAMJ.2019.v109i8.13867,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2011,2019,8,4117,1,1,1
2022-12-05T15:52:51.928-03:00,2022-12-05T17:51:18.487-03:00,SARS-CoV-2 Sero-Surveillance in Greece: Evolution over Time and Epidemiological Attributes during the Pre-Vaccination Pandemic Era,Koureas,2022-01-01,14415,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,GR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,55947,55947,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,1,0,1,0,0,0,0,,,206389024,e67ee2ec-d7b7-4bdb-a13c-2b9998c242f1,2022-12-05T20:51:11,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,560,1,14415,10.3390/diagnostics12020295,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2020,2022,2,1441,1,1,1
2022-03-02T11:19:26.322-05:00,2022-12-11T21:48:10.109-05:00,Age-specific HPV seroprevalence among young females in The Netherlands,Kramer,2010-01-01,3548,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,pienter__netherlands,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,yes,age-specific 11-26 years old,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,637,637,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,PIENTER2,144408206,e88a2e4e-4816-494b-af03-dd4af6e8a9dc,2022-03-02T16:25:12,,,submitted_via_web,awinter,vpQrgGPTK7VgMoGYycNBPf,,18,1,3548,10.1136/sti.2009.041210,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2006,2010,4,3548,1,1,1
2022-08-14T18:03:20.433-03:00,2023-01-14T16:19:53.512-08:00,Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.,Kreimer,2019-01-01,1939,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,AU DK FR DE GR IT NL NO SE US,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,us_national_cancer_institute__,,yes,janus__norway__cancer_registry,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,oropharyngeal squamous cell carcinoma,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic blood_donation_site diagnostic_center_laboratory,0,0,1,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,6557,743,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_evaluate_outcomes_of_seropo to_compare_population_seroposi,0,1,0,0,0,0,0,0,1,0,0,0,1,0,,,176613506,4cc9342b-79ec-4bb1-997c-f11c22c8374e,2022-08-17T17:38:02,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,450,1,1939,10.1093/annonc/mdz138,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,1974,2019,45,1939,1,10,1
2022-05-15T10:05:28.334-04:00,2022-12-20T09:18:23.860-07:00,Results of the Screening of Tick-Borne Encephalitis Virus Antibodies in Human Sera from Eight Districts Collected Two Decades Apart.,Kriz,2015-01-01,4246,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1985 1986 1987 1988 1989 2001 1978 1979 1980 1981 1982 1983 1984,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CZ,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,a previous cross sectional sero survey,seroprevalence_study,0,0,1,0,0,0,,yes,Aged 10-59,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,704,704,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,tick_borne_encephalitis,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,157106649,3e4e7abf-432c-4d0c-9201-7d9aa6b0a862,2022-05-15T14:14:47,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,85,1,4246,10.1089/vbz.2014.1747,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,1985,2015,30,4246,1,1,1
2022-08-11T15:17:36.179-03:00,2022-12-27T12:03:56.702-07:00,Immune response at 12–23 months following a single dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine,Krow-Lucal,2020-01-01,5018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,u_s__defense_medical_surveilla,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,Previously vaccinated for JE,diagnostic_sample,0,0,0,1,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__samples_de_identified yes__exempt_as_public_health_s,0,0,0,0,1,1,0,0,,250,250,250,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,japanese_encephalitis,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_antibody_kin_vacc,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,year of sample collection is unknown,175379712,b0edcf45-0604-4da7-9898-a17c898d80bc,2022-08-11T18:33:52,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,434,1,5018,10.1016/j.vaccine.2020.08.061,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,2020,,5018,1,1,1
2022-07-13T11:51:46.150-03:00,2022-12-26T16:30:40.175-03:00,Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.,Krumbholz,2013-01-01,3206,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999 2000 2001 2002 2003 2004 2005 2006 2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,2 serosurveys (Influenza A and Herpes Simplex Virus) + blood donors (control group),seroprevalence_study,0,0,1,0,0,0,,unknown,,yes,Participants with an illness impeding an adequate immune response were excluded from the study,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2760,2360,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,169436968,3e028873-e309-4799-9c3f-007128bc7a6a,2022-07-13T21:13:07,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,292,1,3206,10.1007/s00430-013-0303-4,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,1999,2013,14,3206,1,1,1
2022-07-07T14:25:53.590-07:00,2022-12-14T21:01:06.578-07:00,Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.,Kudesia,2002-01-01,4164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,blood samples submitted for routine tests,diagnostic_sample,0,0,0,1,0,0,,no,,yes,Infants aged less than 1 year (due to presence of maternal antibodies),hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1530,1530,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos other,1,0,0,0,0,0,0,0,0,1,0,0,0,1,to determine the target age group for any future vaccination strategy,,168484898,f8a8f6a2-1a5f-4648-af02-e58eb641d5b0,2022-07-07T21:35:10,,,submitted_via_web,abernas,v45acXkSNUkFv8KgQJXh42,,250,1,4164,10.1136/jcp.55.2.154,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1977,2002,25,4164,1,1,1
2022-12-16T15:45:27.564-03:00,2022-12-16T15:51:09.371-03:00,"Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.",Kugeler,2022-01-01,14445,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,2002,1598,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_compare_the_use_of_residual,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,,208814842,f16beb03-316d-4f20-94dd-2b3cb1050a1a,2022-12-16T18:51:00,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,591,1,14445,10.1177/00333549211055137,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2020,2022,2,1444,1,1,1
2022-05-15T10:26:11.904-04:00,2023-01-18T11:39:30.888-08:00,"Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India.",Kurien,2005-01-01,2381,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,an earlier community cluster survey on sexually transmitted diseases,seroprevalence_study,0,0,1,0,0,0,,yes,aged 15-45 yr,unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,1853,1853,1981,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,157109422,1cf95251-13cd-487c-a1a4-4184722c49b4,2022-05-15T14:34:32,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,87,1,2381,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,1998,2005,7,2381,1,1,1
2022-06-28T09:46:15.641-03:00,2022-12-20T22:08:25.533-05:00,Comparative hepatitis A seroepidemiology in 10 European countries.,Kurkela,2012-01-01,3920,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2000 2001 2002 2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BE CZ FI DE IT LT MT RO SK GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory unknown,0,0,0,0,0,1,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,34985,34985,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_compare_population_seroposi,1,0,0,0,0,0,0,0,0,0,0,0,1,0,,,166308157,53375dc1-5907-4307-9a08-141eec18a478,2022-06-28T13:14:19,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,184,1,3920,10.1017/S0950268812000015,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1996,2012,16,3920,1,10,2
2022-08-23T14:43:19.423-03:00,2022-12-26T16:52:57.810-03:00,Rubella outbreak on Tokunoshima Island in 2004: a population-based study of pregnant women.,Kusumoto,2010-01-01,3274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,232,232,,venous,0,1,hemagglutination_inhibition_as elisa_eia__enzyme_immunoassay,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,178020135,a0590050-7bfc-424e-9a82-1e4f32b9340b,2022-08-23T17:54:50,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,466,1,3274,10.1111/j.1447-0756.2010.01277.x,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2004,2010,6,3274,1,1,1
2023-02-24T11:57:11.357-05:00,2023-02-24T13:54:37.457-05:00,Assessing the risk of dengue virus transmission in a non-endemic city surrounded by endemic and hyperendemic areas,Kwan,2017-01-01,3150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,HK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,3827,3827,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,221343304,2b40dd39-bd91-4f12-af6d-af46bcabf50f,2023-02-24T18:54:47,,,submitted_via_web,abernas,vJzTYFwzQYR9pFHSy55TD3,,617,1,3150,10.1016/j.ijid.2017.01.008,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2014,2017,3,3150,1,1,1
2022-07-13T18:12:56.003-03:00,2024-04-25T20:14:37.912-04:00,Poor immunity status against poliomyelitis in medical students: a semi-anonymous study.,Külshammer,2013-01-01,2927,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005 2006 2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,university_students,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,Medical students,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,none,0,0,0,0,1,no,0,0,0,0,0,0,0,1,,851,851,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,poliomyelitis__polio,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,169438139,7bea1d97-dd3a-4533-8146-315901090a4a,2022-07-13T21:23:21,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,293,1,2927,10.1007/s00430-012-0237-2,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2004,2013,9,2927,1,1,1
2022-07-12T13:30:51.012-03:00,2022-12-23T11:05:01.116-03:00,Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.,Ladhani,2012-01-01,2851,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2693,2693,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hemophilus_influenza__hib,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,"fluorescent bead assay is the test they used, I believe ELISA is the best fit as option for selection",169221253,65c1f422-f8d5-4695-bd58-a03996c091d6,2022-07-12T21:56:08,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,286,1,2851,10.2807/ese.17.46.20313-en,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2009,2012,3,2851,1,1,1
2022-05-15T20:53:06.684-04:00,2023-02-09T10:31:28.898-05:00,Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department,Laeyendecker,2021-01-01,5783,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,all available remnant blood from hematology samples from ED patients aged >17 years were collected during the study period.,diagnostic_sample,0,0,0,1,0,0,,yes,aged 17 or older,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,3255,3255,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,157154785,98ff5e58-27b0-46ac-bb92-fe2c6e02e9c3,2022-05-16T01:06:13,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,92,1,5783,10.1016/j.ajem.2021.04.081,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2021,1,5783,1,1,1
2022-08-14T10:36:22.357-03:00,2022-12-20T09:04:25.634-07:00,"Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses.",Lai,2012-01-01,4209,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,national_pediatric_seroprevale,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Aged 1-17 years,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"immunocompromised, immunosupresive therapy, or diagnosis of perthussis, diphteria, polyomielitis, measles, mumbs, rubella, chickenpox, hepatitis b, dengue and hand foot mouth disease.",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1200,1200,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria pertussis poliomyelitis__polio,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,175873852,4e507abd-7e01-4d1e-a059-c8826a08f580,2022-08-14T13:50:46,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,445,1,4209,10.1016/j.vaccine.2012.03.059,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2008,2012,4,4209,3,1,1
2022-07-12T18:55:56.984-03:00,2022-12-16T14:49:19.386-05:00,Dengue outbreaks: a constant risk for Reunion Island. Results from a seroprevalence study among blood donors.,Larrieu,2014-01-01,3679,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,RE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,1825,1825,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,169222153,270e1232-a85e-4f8f-b494-1eb30b69c50f,2022-07-12T22:06:32,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,287,1,3679,10.1093/trstmh/trt110,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,1,2008,2014,6,3679,1,1,1
2022-06-20T18:25:26.706-03:00,2022-12-23T08:48:33.207-03:00,"Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.",Laukkanen,2003-01-01,2686,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1974 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,finnish_maternity_cohort__fmc,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Finnish maternity cohort,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,16000,16000,1200000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,164529483,5df3f8fd-5183-45a1-aada-3d723a3a5afe,2022-06-20T21:50:40,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,146,1,2686,10.1099/vir.0.18995-0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1974,2003,29,2686,1,1,1
2022-07-12T19:06:21.233-03:00,2022-12-11T21:28:22.511-05:00,Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.,Le Vu,2021-01-01,3463,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,unspecified_serial_cross_secti,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,11000,11000,,venous,0,1,neutralization_test epitope_blocking_assay_using_m,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,National serosurveillance system from France.,169223474,a18fee1f-b360-4920-878e-ddab439ff022,2022-07-12T22:29:44,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,288,1,3463,10.1038/s41467-021-23233-6,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2020,2021,1,3463,1,1,1
2022-07-13T18:33:29.917-03:00,2022-12-26T16:33:55.527-03:00,Pertussis seroprevalence in korean adolescents and adults using anti-pertussis toxin immunoglobulin G.,Lee,2014-01-01,3212,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged >11 years,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,1192,1192,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,170142799,15792003-efa1-4081-97b7-ecaa98ff9272,2022-07-17T20:49:35,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,295,1,3212,10.3346/jkms.2014.29.5.652,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2012,2014,2,3212,1,1,1
2022-06-17T09:44:22.666-03:00,2022-12-21T12:11:02.473-05:00,Seroepidemiology of hepatitis A in Korea: changes over the past 30 years.,Lee,2011-01-01,3953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Serum samples were collected from subjects aged 1-79 y,yes,"Sera referred for the diagnosis of infectious diseases such as measles, mumps, rubella, hepatitis A and  HIV were excluded.",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1872,1872,2061,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,163825886,2658c7b1-636f-4c88-bfd0-d8e113390fd5,2022-06-17T13:03:35,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,135,1,3953,10.3346/jkms.2011.26.6.791,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2008,2011,3,3953,1,1,1
2022-07-13T18:23:11.364-03:00,2022-12-21T21:05:27.691-05:00,Seroepidemiology of Varicella-Zoster Virus in Korea,Lee,2013-01-01,4004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,1302,1302,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,169439088,99bf6af5-2162-41c8-a8ee-a0181f7dc493,2022-07-13T21:33:40,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,294,1,4004,10.3346/jkms.2013.28.2.195,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2009,2013,4,4004,1,1,1
2022-07-17T17:49:27.042-03:00,2022-12-21T21:07:20.662-05:00,Retrospective Seroepidemiology study of dengue virus infection in Taiwan.,Lee,2021-01-01,4005,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,TW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Flu Serosurvey,seroprevalence_study,0,0,1,0,0,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,1308,1308,1558,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,170143964,5e9f50b5-651c-416f-a199-f4ad128da906,2022-07-17T20:59:51,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,296,1,4005,10.1186/s12879-021-05809-1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2010,2021,11,4005,1,1,1
2022-08-17T15:06:39.042-03:00,2023-01-04T13:38:52.282-07:00,Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s,Lehtinen,2006-01-01,6665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,finnish_maternity_cohort__fmc,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,yes,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,7805,7805,230998,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,176623107,b3e8c6be-5a12-44e0-ac0f-bb7c0c22f2fa,2022-08-17T18:16:38,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,453,1,6665,10.1002/ijc.22131,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1983,2006,23,6665,1,1,1
2022-07-17T17:59:41.957-03:00,2023-01-04T12:22:53.114-07:00,Hepatitis E virus in Cuba,Lemos,2000-01-01,6146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CU,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Blood donors, patients on plasmapheresis and patients with acute hepatitis.",blood_donation diagnostic_sample other,1,0,0,1,0,1,plasmapheresis,yes,"HBV, HCV and HIV 1-2 negative",unknown,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,none,0,0,0,0,1,no,0,0,0,0,0,0,0,1,,1852,1852,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th did_not_account_for_bias_none_of_the_abo,0,1,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,Year of sample collection is unknown,170145050,8a3046bd-2b36-41f2-ae4a-aa6cff96a086,2022-07-17T21:11:50,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,297,1,6146,10.1016/S1386-6532(99)00062-1,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,1,,2000,,6146,1,1,2
2022-07-17T18:11:41.905-03:00,2024-04-25T20:34:49.947-04:00,Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population.,Lerdsamran,2011-01-01,4206,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2005 2006 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"blood donors, general population, health care workers. The patient population was not considered residual",blood_donation,1,0,0,0,0,0,,no,,no,,household blood_donation_site,1,0,0,1,0,0,0,0,0,0,,hospital_clinic blood_bank,0,1,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,668,580,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_estimate_infection_rates_or,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,170152710,4bc980cf-ca24-4ab3-820b-04c0089a4bf1,2022-07-17T23:23:58,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,298,1,4206,10.1371/journal.pone.0016164,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2005,2011,6,4206,1,1,1
2022-12-05T15:35:51.841-03:00,2022-12-05T15:52:51.769-03:00,Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves,Lerdsamran,2022-01-01,15840,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016 2017 2018 2019 2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1) Anonymized prepandemic COVID-19 serum samples collected from healthy adults between 2015 and 2019. 2) Anonymized archival serum samples from COVID-19 patients,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic unknown,0,0,1,0,0,0,0,0,1,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,4964,442,,venous,0,1,neutralization_test chemiluminescence_immunoassay,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,206371465,9d64921d-e532-4b11-8846-d46c37e18b28,2022-12-05T18:52:44,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,559,1,15840,10.1371/journal.pone.0263316,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2015,2022,7,1584,1,1,2
2022-06-20T08:51:23.034-03:00,2022-12-20T09:14:55.469-07:00,Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy.,Levine,2011-01-01,4236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_defense_force_health_su,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,adults born in 1988 and 1989,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,441,441,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,mumps,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,164377360,384e38fe-f2b3-4133-be6c-c41d0dcefb94,2022-06-20T12:02:30,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,140,1,4236,10.1016/j.vaccine.2011.01.103,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2007,2011,4,4236,1,1,1
2022-07-18T16:59:21.951-03:00,2023-01-09T17:44:22.471-08:00,"SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study.",Lewin,2021-01-01,1322,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Free of COVID-19 symptoms for 14 days,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,7691,7691,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_describe_viral_dynamics,1,0,0,0,0,1,0,0,0,0,0,1,0,0,,,170484007,6a0b3d8e-0da6-41ed-966b-d4fdd17e4050,2022-07-19T11:10:43,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,311,1,1322,10.17269/s41997-021-00531-6,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,1,2020,2021,1,1322,1,1,1
2022-07-19T08:10:42.338-03:00,2023-01-09T11:10:34.350-07:00,Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates,Li,2020-01-01,9367,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006 2007 2008 2009 2010 2011 2012 2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,injection_drug_users inmates_incarcerated_individua,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,,IDU prisoner's participant in a prospective HCV study,seroprevalence_study,0,0,1,0,0,0,,no,,no,,other,0,0,0,0,0,0,0,0,0,1,Prison,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,no,0,0,0,0,0,0,0,1,,590,590,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,170486762,d0b7f463-35d2-4ee7-8e85-dfe95d03c5ad,2022-07-19T11:23:57,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,312,1,9367,10.1016/j.vaccine.2020.02.076,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,2005,2020,15,9367,1,1,2
2022-07-19T08:23:49.433-03:00,2023-01-10T10:47:50.223-07:00,Epidemiological survey and screening strategy for dengue virus in blood donors from Yunnan Province,Li,2021-01-01,9592,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2254,2254,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,170491747,22760e3d-0a00-4c51-bf1b-15bdb7bdd644,2022-07-19T11:48:05,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,313,1,9592,10.1186/s12879-021-05810-8,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2019,2021,2,9592,1,1,1
2022-11-29T17:22:16.661-03:00,2023-01-11T10:48:29.581-07:00,"Social Vulnerability and Rurality Associated With Higher Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Induced Seroprevalence: A Nationwide Blood Donor Study-United States, July 2020-June 2021.",Li,2022-01-01,14429,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,1555745,1555745,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,204718082,62eb1fe3-4088-4766-9470-afc927cc2ded,2022-11-29T20:39:32,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,527,1,14429,10.1093/cid/ciac105,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2022,2,1442,1,1,1
2022-11-29T17:11:13.013-03:00,2023-07-05T15:15:23.680-07:00,"Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.",Lim,2021-01-01,14400,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,78990,78990,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,204715296,befd70c5-9365-4706-a7df-9e0217a6c651,2022-11-29T20:22:10,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,526,1,14400,10.1093/cid/ciab185,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2020,2021,1,1440,1,1,1
2022-05-06T09:29:13.820-04:00,2022-12-21T22:08:41.015-05:00,"Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China.",Lin,2016-01-01,4074,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients of all ages admitted to a hospital in the city of Guangzhou in southern China,diagnostic_sample,0,0,0,1,0,0,,yes,patients from non-respiratory diseases wards,yes,signs of influenza-like illness at presentation or during hospitalization,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,5630,5630,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d conducted_sensitivity_analysis,0,1,1,0,0,1,0,0,1,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,155530979,64b2d9dc-c631-4765-a045-d510e6a83120,2022-05-06T13:48:43,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,64,1,4074,10.1186/s12879-016-1983-3,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,1,0,0,0,2013,2016,3,4074,1,1,1
2022-07-19T08:58:37.859-03:00,2022-12-23T08:41:57.604-03:00,Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.,Liu,2013-01-01,2661,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Aged 16-88,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,Influenza like symptoms in the previous 6 months,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,513,486,,venous,0,1,neutralization_test hemagglutination_inhibition_as elisa_eia__enzyme_immunoassay,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,170586688,73d4b54c-7c47-49f3-997b-842f91045e30,2022-07-19T17:38:18,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,315,1,2661,10.1371/journal.pone.0058810,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,0,2008,2013,5,2661,1,1,1
2022-08-21T19:35:34.107-04:00,2024-04-25T20:28:32.023-04:00,Seroprevalence of dengue in the general population of Hong Kong.,Lo,2013-01-01,4017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,HK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population blood_donors,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"blood donors; healthy volunteers from a university, community centre, and a hospital",blood_donation other_non_serological_survey,1,0,0,0,1,0,,no,,no,,hospital_clinic blood_donation_site unknown,0,0,1,1,0,0,0,0,1,0,,household blood_bank,1,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,685,685,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,178008010,4f163499-030c-4977-9fa2-ba60064b9a5e,2022-08-23T17:09:39,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,462,1,4017,10.1111/tmi.12136,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2007,2013,6,4017,1,1,2
2022-07-19T14:38:07.489-03:00,2022-12-21T21:20:18.746-05:00,Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey.,Loenenbach,2019-01-01,4021,2016 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1997 1998 1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,option_22,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,6517,6517,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,170591412,ae13bda3-f5df-426b-8be6-975dcff4ff1a,2022-07-19T17:59:16,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,316,1,4021,10.1016/j.ijid.2019.03.022,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,1997,2019,22,4021,1,1,1
2022-11-29T17:03:37.310-03:00,2023-01-11T11:07:24.575-07:00,Seroprevalence of mucosal and cutaneous human papillomavirus (HPV) types among children and adolescents in the general population in Germany.,Loenenbach,2022-01-01,14524,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2003 2004 2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,kiggs,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,12257,12257,17641,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,204713353,88774c47-7cb0-4490-91d9-590c13f5e243,2022-11-29T20:11:06,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,525,1,14524,10.1186/s12879-022-07028-8,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2003,2022,19,1452,1,1,1
2022-11-25T14:46:34.033-03:00,2023-01-11T11:26:18.765-07:00,"Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak.",Lombardi,2021-01-01,14702,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,people living with HIV,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1389,1389,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_evaluate_changes_in_seropos,0,1,0,0,0,0,0,0,0,1,0,0,0,0,,,203554440,dc5d636e-9adf-4799-b5c7-e79d2e81706a,2022-11-25T19:57:57,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,509,1,14702,10.3390/diagnostics11071154,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2021,1,1470,1,1,1
2022-07-19T14:59:04.607-03:00,2022-12-20T21:36:26.615-05:00,"Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype?",Lopes,2017-01-01,3851,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,600,600,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_e,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,Year of sample collection is unknown,170594567,9447a5b9-1387-4049-85f9-6c067bd5c0b9,2022-07-19T18:12:22,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,317,1,3851,10.1017/S0950268817000565,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,1,,2017,,3851,2,1,1
2022-06-17T09:05:32.800-03:00,2023-01-14T16:41:50.901-08:00,Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period.,Lopez,2021-01-01,1985,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,individuals 5- 99 years of age from four UNC Health hospitals in central North Carolina,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,9624,9624,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,163815595,03c975ee-fa7c-481b-b36f-8dcdcdb01ab4,2022-06-17T12:26:00,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,133,1,1985,10.1101/2021.03.25.21254320,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2021,1,1985,1,1,1
2022-12-05T15:16:41.107-03:00,2022-12-05T15:35:51.696-03:00,Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020.,Lopez,2022-01-01,14510,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,12471,12471,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,206368826,dfa502de-0e0f-46db-acfa-f2d11d40d287,2022-12-05T18:35:44,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,558,1,14510,10.1128/msphere.00841-21,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2020,2022,2,1451,1,1,1
2022-07-19T15:12:11.491-03:00,2022-12-26T16:54:47.874-03:00,Gaps in Serologic Immunity against Contemporary Swine-Origin Influenza A Viruses among Healthy Individuals in the United States.,Lorbach,2021-01-01,3278,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011 2012 2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Seroepidemiological cohort,other_non_serological_survey,0,0,0,0,1,0,,no,,yes,immunocompromised,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,153,153,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results,0,1,1,0,0,0,0,0,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,170597493,3263143e-85e1-4a12-8177-db3a34f395cb,2022-07-19T18:27:49,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,318,1,3278,10.3390/v13010127,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,2010,2021,11,3278,1,1,1
2022-07-21T07:19:14.862-03:00,2022-12-11T17:35:28.950-05:00,Comparison of hepatitis A seroprevalence in blood donors in South Tunisia between 2000 and 2007.,Louati,2009-01-01,3341,2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2000 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,Aged 18-30 years,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,752,752,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,171491496,06b5e9c1-426a-499f-8616-464fdae1800f,2022-07-23T21:21:55,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,330,1,3341,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,1,2000,2009,9,3341,1,1,1
2022-06-28T10:26:36.361-03:00,2022-12-21T21:36:45.044-05:00,"Dengue seroprevalence of healthy adults in Singapore: serosurvey among blood donors, 2009.",Low,2015-01-01,4029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,Aged 16 to 60,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,3995,3995,12000,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,166316502,78a26118-4b55-4fcb-8265-be4ca707d630,2022-06-28T13:40:09,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,186,1,4029,10.4269/ajtmh.14-0671,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2009,2015,6,4029,1,1,1
2022-12-05T15:02:30.482-03:00,2022-12-05T15:16:40.977-03:00,Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: repeated cross-sectional surveys 2020-21,Lucinde,2022-01-01,15858,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,KE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"Women who did not provide a sample at their first antenatal care visit, or 113 women attending their second or subsequent ANC visit, were excluded.",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2981,2981,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,206364425,34663fc2-0415-4a33-9e39-268e8e833002,2022-12-05T18:16:34,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,557,1,15858,10.1101/2022.03.03.22271860,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2022,2,1585,1,1,1
2022-08-08T11:19:57.056-04:00,2023-01-18T11:50:13.687-08:00,Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.,Lukhwareni,2009-01-01,2418,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005 2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"patients attending Tshepang HIV clinic at Dr. George Mukhari Hospital at University of Limpopo, Medunsa Campus (Pretoria City)",diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,192,192,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_seroprevalence_amo to_describe_antibody_kin_infect to_estimate_infection_rates_or,0,1,0,0,1,1,0,0,0,0,0,0,0,0,,,174639085,e8c66fcd-8a95-4c3c-8535-042f0ca13dec,2022-08-08T15:36:45,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,410,1,2418,10.1002/jmv.21418,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2004,2009,5,2418,1,1,1
2022-08-08T16:14:06.157-03:00,2024-04-25T20:36:32.765-04:00,"Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer",Lumme,2016-01-01,8646,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1990 1991 1992 1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI NO SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,janus__norway__cancer_registry,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population blood_donors patient_population,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample other_non_serological_survey,1,0,0,1,1,0,,yes,cases were patients with prostate cancer,no,,household blood_donation_site diagnostic_center_laboratory,1,0,0,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2438,483,209000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo to_evaluate_outcomes_of_seropo,0,1,0,0,0,0,0,0,1,0,0,0,0,0,,,174697651,e64542ed-8e0e-4695-8b64-c583967ead09,2022-08-08T20:37:08,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,417,1,8646,10.3109/0284186X.2016.1139178,0,0,0,1,0,1,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,1973,2016,43,8646,1,3,3
2022-07-11T11:52:08.117-03:00,2022-12-24T10:39:51.513-03:00,No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.,Luostarinen,1999-01-01,3041,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FI NO SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,finnish_maternity_cohort__fmc,,yes,janus__norway__cancer_registry,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,pregnant_women blood_donors patient_population,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Finish Maternity Cohort, Vasterbotten project, Janus project",blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site diagnostic_center_laboratory,0,0,1,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,530000,530000,1149000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,,169004719,8d856c1c-28a1-4886-8af4-b9c05dea98ab,2022-07-11T19:15:07,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,269,1,3041,10.1002/(sici)1097-0215(19990315)80:6<818::aid-ijc4>3.0.co;2-t,0,0,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,1973,1999,26,3041,1,3,3
2022-12-05T14:32:34.093-03:00,2022-12-05T15:02:30.392-03:00,Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia.,Lynch,2021-01-01,14215,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,100,100,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_antibody_kin_infect,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,206360967,ba23bac5-ea46-4390-8768-ce7de4cbd544,2022-12-05T18:02:23,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,556,1,14215,10.3390/v13081618,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2021,1,1421,1,1,1
2023-03-26T23:59:20.489-04:00,2023-03-27T00:25:38.366-04:00,Results of the next scheduled revaccination against diphtheria in the adult population in 2014-2016 according to serological testing data,MAKSIMOVA,2021-01-01,16570,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,RU,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,other,"Russian - serological monitoring of the state of collective immunity to infections controlled by means of specific prevention (diphtheria, tetanus, whooping cough, measles, rubella, mumps, poliomyelitis, hepatitis B)",no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,109295,109295,,,,,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,227964885,debfd204-bf82-4ae1-a46f-424ae9f0abab,2023-03-27T04:26:28,,,submitted_via_web,awinter,vJzTYFwzQYR9pFHSy55TD3,,618,1,16570,,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2013,2021,8,1657,1,1,1
2022-07-11T16:14:55.812-03:00,2022-12-19T08:44:52.457-05:00,"Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.",Ma,2015-01-01,3787,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"non-fever, non-rash ill patients less than 35 years old",unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,632,632,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,169006722,e7fd8e23-770b-4ebc-a264-c390e86b4674,2022-07-11T19:28:50,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,270,1,3787,10.1186/s12879-015-0752-z,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2013,2015,2,3787,1,1,1
2022-12-04T13:18:11.344-03:00,2022-12-04T13:35:05.143-03:00,"Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020.",Machalek,2022-01-01,14532,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,4799,4799,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results,1,0,1,1,0,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,206067705,8e4f4161-4a9c-4028-b827-9f940b008563,2022-12-04T16:34:58,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,553,1,14532,10.1371/journal.pone.0265858,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,0,0,1,2020,2022,2,1453,1,1,1
2022-07-11T16:28:39.098-03:00,2023-01-10T21:59:44.671-08:00,The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia.,Mahallawi,2021-01-01,1536,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,SA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,Eligible participants for this study were those with no current COVID-19 symptoms and no confirmed previous SARS-CoV-2 infection.,yes,"Blood donors were excluded if they were diagnosed with existing diseases or presented with physically identifiable symptoms of any infection, including cough, sore throat, or fever. All participants were confirmed to be free from all viral infections, including hepatitis B and C, human immunodeficiency virus (HIV) 1 and 2, and human T-cell leukemia-lymphoma virus",blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1212,1212,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,169125391,9475cfe5-3f60-4a40-8456-01dac2189d29,2022-07-12T13:35:57,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,271,1,1536,10.1016/j.sjbs.2020.12.009,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,1,2020,2021,1,1536,1,1,1
2022-12-04T13:00:13.326-03:00,2022-12-04T13:18:10.983-03:00,Unexpected Detection of Anti-SARS-CoV-2 Antibodies Before the Declaration of the COVID-19 Pandemic,Mahallawi,2022-01-01,15661,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,SA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,478,478,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_estimate_infection_rates_or,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,206064401,151fd59d-3184-41b5-a7ff-0e18a0586093,2022-12-04T16:18:03,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,552,1,15661,10.3389/fmed.2022.923715,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2019,2022,3,1566,1,1,1
2022-07-12T10:35:46.840-03:00,2022-12-24T11:02:07.488-03:00,Estimated cumulative incidence of pandemic (H1N1) influenza among pregnant women during the first wave of the 2009 pandemic.,Mahmud,2010-01-01,3156,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Samples from the Manitoba Maternal Serum Screening Program,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,548,548,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,169137616,6ce289ca-2394-479c-a6cb-5278e5a3e5f5,2022-07-12T14:30:19,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,272,1,3156,10.1503/cmaj.100488,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2009,2010,1,3156,1,1,1
2022-06-16T15:05:20.157-07:00,2024-04-25T20:24:24.715-04:00,Seroprevalence of measles-specific antibodies in the group predominantly affected by measles in 2006-2009 in Poland.,Makówka,2014-01-01,3933,2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2006 2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,PL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Serum obtained from patients hospitalized on trauma-orthopedic and surgical wards in Lubelskie, Mazowieckie, witokrzyskie, Warmisko–mazurskie and Wielkopolskie provinces and laryngological ward in Mazowieckie province as part of the research “Prevalence of HCV infections with utility analysis of screening”. Patients were females and males aged 18+ admitted to wards due to emergencies (accidents, injuries) or hospitalized due to appendicitis, hernia and cholecystis; and who present with preserved consciousness at the day of study and who signed informed consent.",diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,no,0,0,0,0,0,0,0,1,,483,483,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f,0,0,1,0,1,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,163710657,7015e9a5-e538-439e-b917-a655b9bbf543,2022-06-16T22:24:26,,,submitted_via_web,mpilews1,vi8ujSt4tdYVZ6Wbycvi9H,,127,1,3933,,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,2006,2014,8,3933,1,1,1
2022-07-12T12:02:08.869-07:00,2024-04-25T20:35:49.445-04:00,Significant cross reactive antibodies to influenza virus in adults and children during a period of marked antigenic drift,Mandelboim,2014-01-01,8041,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_national_serum_bank_by_,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,adults aged 35-50 years old; children aged 1-3 years old,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,480,480,,,,,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling,1,0,0,0,0,0,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,1,1,0,0,0,,,169215507,92b7db5b-3326-4bc5-b1ff-3c18260336a8,2022-07-12T20:56:22,,,submitted_via_web,abernas,vQteqvkE44GFbPjGfNx2An,,282,1,8041,10.1186/1471-2334-14-346,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2002,2014,12,8041,1,1,1
2022-12-04T12:43:53.281-03:00,2022-12-04T13:00:13.019-03:00,SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021.,Mandolo,2021-01-01,14333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,MW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,yes,same as blood donors,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,5085,5085,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_infect to_evaluate_changes_in_seropos,1,0,0,0,1,0,0,0,0,1,0,0,0,0,,,206061394,c1651073-0669-4b92-b61e-8f5aedc6a4e1,2022-12-04T16:00:05,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,551,1,14333,10.1186/s12916-021-02187-y,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2021,1,1433,1,1,1
2022-11-30T14:48:41.727-03:00,2023-01-11T11:52:22.185-07:00,Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study,Maneikis,2021-01-01,16356,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,LT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"patients with malignancies, >18 y, with available samples, with 2 doses",diagnostic_sample,0,0,0,1,0,0,,no,,,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,953,885,1303,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc,0,1,0,1,0,0,0,0,0,0,0,0,0,0,,,205027661,860f1850-ab0c-4b24-81f8-713a39f8f973,2022-11-30T18:08:07,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,538,1,16356,10.1016/S2352-3026(21)00169-1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2021,2021,0,1635,1,1,1
2022-11-30T14:26:34.323-03:00,2023-01-11T11:44:14.522-07:00,"SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia",Manning,2022-01-01,15928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006 2007 2008 2009 2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,KH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients infected with malaria,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,528,528,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_seroprevalence_amo to_describe_cross_reactivity,0,1,0,0,0,0,0,0,0,0,1,0,0,0,,,205021070,1cb7630b-1f6a-4cfe-b4e2-e6a9fb794086,2022-11-30T17:48:35,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,537,1,15928,10.3201/eid2802.211725,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2005,2022,17,1592,1,1,1
2022-07-12T11:30:08.748-03:00,2023-01-10T10:54:33.963-07:00,Immunity to diphtheria and tetanus in England and Wales,Maple,2000-01-01,14116,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,6230,6230,,venous,0,1,elisa_eia__enzyme_immunoassay fluorescent_immunoassay,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,diptheria tetanus,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,169139725,dce178b8-8933-4b8e-b692-6adbfde3cadb,2022-07-12T14:39:44,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,273,1,14116,10.1016/S0264-410X(00)00184-5,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,1996,2000,4,1411,2,1,1
2022-07-23T18:21:45.552-03:00,2023-01-10T21:50:06.455-08:00,"Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.",Marais,2000-01-01,1424,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994 1995 1996 1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"woman in Cape Town with cervical intraepithelial neoplasia (CIN) (n = 95), cervical cancer (n = 40), female blood donors (n = 95) and children (n = 110).",diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,340,242,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_seroprevalence_amo to_describe_antibody_kin_infect to_identify_risk_factors_of_se,0,1,0,0,1,0,0,1,0,0,0,0,0,0,,,171493284,e9a94d94-cab9-47f7-8f43-c0ac6fc330c0,2022-07-23T21:45:19,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,331,1,1424,10.1002/(sici)1096-9071(200004)60:4<403::aid-jmv7>3.0.co;2-6,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1994,2000,6,1424,1,1,1
2022-05-04T15:46:12.043-04:00,2023-01-04T13:31:10.585-07:00,"Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa",Marais,1997-01-01,6433,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Children Aged 1-12.,diagnostic_sample,0,0,0,1,0,0,,yes,"Children aged 1-12, with samples available after check up.",unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,250,155,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,155282006,82cc3f54-66be-4789-aea2-ced5bdb870ca,2022-05-04T19:57:51,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,54,1,6433,10.1002/(SICI)1096-9071(199702)51:2<126::AID-JMV7>3.0.CO;2-9,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1994,1997,3,6433,1,1,1
2022-11-30T14:08:44.163-03:00,2023-01-11T10:59:19.184-07:00,"SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy.",Marchi,2022-01-01,14496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,2480,2480,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,205013861,ca0e1dcf-1216-4029-9277-45a5be96ab8f,2022-11-30T17:26:27,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,536,1,14496,10.3390/v14071441,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,2020,2022,2,1449,1,1,1
2022-11-30T13:31:30.112-03:00,2023-05-17T19:13:09.275-04:00,Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer.,Marquis,2021-01-01,14159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,1001,1001,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles mumps,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d conducted_sensitivity_analysis,0,0,1,1,0,1,0,0,1,to_describe_seroprevalence_amo to_evaluate_outcomes_of_seropo,0,1,0,0,0,0,0,0,1,0,0,0,0,0,,,205007520,8facf295-abbd-4afa-80c2-61242d02ba3f,2022-11-30T17:08:38,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,535,1,14159,10.1001/jamanetworkopen.2021.18508,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,2019,2021,2,1415,2,1,1
2022-07-12T11:39:34.362-03:00,2023-01-09T11:18:43.997-07:00,Immune response to sars-cov-2 in an asymptomatic pediatric allergic cohort,Marsteller,2021-01-01,9581,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,pediatric allergic cohort,diagnostic_sample,0,0,0,1,0,0,,yes,"between the ages of 4 and 18 years, residence in the US, and asymptomatic",unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,172,172,250,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results,0,1,1,0,0,0,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,169141752,5ac6f701-ac30-4b21-9f5e-edc0c1c677b2,2022-07-12T14:49:48,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,274,1,9581,10.3390/antib10020022,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,2020,2021,1,9581,1,1,1
2022-06-20T09:14:17.892-03:00,2022-12-23T08:32:59.243-03:00,The current epidemiology of hepatitis A infection in South Africa: implications for vaccination.,Martin,1994-01-01,2593,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1988 1989 1990 1991,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"The  White female serum samples were obtained from attenders at urban sexually transmitted disease (STD) clinics,  family planning (FP) clinics and antenatal (AN) clinics. The White male serum samples, including those from  homosexual individuals, were obtained from attenders at  urban STD clinics.",diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,473,473,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,164386346,3bf9d708-49b3-42d3-8395-31acbb50d2a8,2022-06-20T12:29:58,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,142,1,2593,10.1016/0035-9203(94)90080-9,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1988,1994,6,2593,1,1,1
2022-11-30T13:12:14.112-03:00,2023-01-11T11:45:44.639-07:00,Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors,Martin,2022-01-01,15933,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,ES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation plasma_donation,1,1,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2421,2421,120082,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_antibody_kin_infect to_identify_risk_factors_of_se,0,0,0,0,1,0,0,1,0,0,0,0,0,0,,"some residual samples came from convalescent plasma donors, but it's unclear how many came from blood donors and how many from CP donors",204993798,77425b4b-956e-4b27-8c2d-cbedb44bfe18,2022-11-30T16:31:24,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,534,1,15933,10.1371/journal.pone.0264124,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1593,1,1,1
2022-11-30T12:58:07.709-03:00,2023-01-10T13:40:47.206-07:00,"Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation.",Martinez-Acuña,2021-01-01,14245,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,MX,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,2068,2068,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,204987471,421ba6d0-b314-4224-932a-b9ba4dde497c,2022-11-30T16:12:08,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,533,1,14245,10.3390/v13071225,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2021,1,1424,1,1,1
2022-06-27T06:40:20.798-03:00,2023-01-04T12:18:09.195-07:00,Hepatitis E virus: Relevance in blood donors and other risk groups,Mateos,1998-01-01,6056,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"blood donors, hemodialysis patients, children with posttransfusion HCV infection.",blood_donation diagnostic_sample,1,0,0,1,0,0,,yes,"blood donors, hemodialysis patients, children with posttransfusion HCV infection.",unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,968,968,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_seroprevalence_amo,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,year of samples collection is unknown,166009353,76d38004-c440-4682-bccc-83613cf5add6,2022-06-27T09:49:59,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,177,1,6056,10.1159/000031002,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,,1998,,6056,1,1,2
2022-07-12T11:49:37.115-03:00,2022-12-20T22:00:34.637-05:00,Diphtheria immunity in Flanders,Matheï,1997-01-01,3896,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,1679,1679,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,169153783,ca612f1c-7c83-4b4c-aca8-44cc9cc76787,2022-07-12T15:49:12,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,275,1,3896,10.1007/BF01708551,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,1993,1997,4,3896,1,1,1
2022-08-17T16:42:38.789-03:00,2024-04-25T20:37:19.608-04:00,The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya,Mburu,2021-01-01,14117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,KE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,2 cohort study,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,4497,4497,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results,0,0,1,1,0,0,0,0,0,to_evaluate_outcomes_of_seropo,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,176642774,e7a3128a-81b0-4443-bf1b-260063391567,2022-08-17T19:55:39,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,457,1,14117,10.1186/s12916-021-01906-9,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,2019,2021,2,1411,1,1,1
2022-11-30T09:50:16.520-03:00,2023-01-11T10:32:52.713-07:00,National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of,McAuley,2021-01-01,14361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified yes__exempt_as_public_health_s,0,0,0,0,1,1,0,0,,13428,13428,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,204939203,fa1e68e8-883d-44ac-9914-11bb74fc000c,2022-11-30T14:21:45,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,532,1,14361,10.1016/j.puhe.2021.08.005,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2021,1,1436,1,1,1
2022-07-12T12:49:00.260-03:00,2022-12-21T12:14:46.741-05:00,"Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019-April 2020.",McCulloch,2021-01-01,3956,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,inpatients and outpatients >18 years who underwent routine screening for hepatitis viruses,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,766,766,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,169157323,8dd9ae75-1cd8-43a2-8801-59d21bbc3922,2022-07-12T16:05:38,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,276,1,3956,10.1371/journal.pone.0252235,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2019,2021,2,3956,1,1,1
2022-07-12T13:19:41.910-03:00,2022-12-16T14:54:51.773-05:00,"Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.",McVernon,2010-01-01,3688,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Samples were used after blood donation for a dengue surveillance study,blood_donation,1,0,0,0,0,0,,yes,Aged >16 years,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,1275,1275,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,169165298,f325ee9f-2c7d-437c-a2f3-cedac9273f19,2022-07-12T16:31:01,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,278,1,3688,10.2807/ese.15.40.19678-en,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,1,0,0,0,1,2009,2010,1,3688,1,1,1
2022-07-12T13:05:27.374-03:00,2022-12-20T22:13:03.192-05:00,"Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.",McVernon,2014-01-01,3934,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3101,3101,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,169160668,501d5d11-fbca-41f8-9974-7eebec220ca2,2022-07-12T16:19:53,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,277,1,3934,10.1111/irv.12225,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,1,2009,2014,5,3934,1,1,1
2022-07-12T19:29:17.635-03:00,2022-12-11T21:30:26.652-05:00,"Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia.",Medi,2018-01-01,3484,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,RS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 29 days - 83 years,yes,Specimens of immunocompromised patients and recipients of blood and blood products during the past 6 months were excluded,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,3570,3570,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,1,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,169353546,ccd0e69b-7ec0-4075-9874-d6632fc8fef4,2022-07-13T14:16:34,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,289,1,3484,10.1017/S0950268818001619,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1,0,1,0,0,0,0,0,2015,2018,3,3484,1,1,1
2022-06-21T15:21:07.363-07:00,2024-04-25T20:31:44.944-04:00,"Declining seroprevalence of hepatitis A in Vojvodina, Serbia.",Medic,2019-01-01,4133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,RS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Either remaining from routine lab testing or population-based random sampling,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"Infants <1 yera of age, immunocompromised individuals and recent recipients of blood and blood products",hospital_clinic unknown,0,0,1,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,3466,3466,,,,,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,164819057,654d3097-29c5-4338-9f01-e212be27a8bc,2022-06-21T22:28:56,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,160,1,4133,10.1371/journal.pone.0217176,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2015,2019,4,4133,1,1,1
2022-07-13T11:16:23.450-03:00,2023-01-18T11:53:41.178-08:00,HPV Serology Testing Confirms High HPV Immunisation Coverage in England.,Mesher,2016-01-01,2438,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 15-19 years,yes,"Sera from immunocompromised individuals and repeat sera from the same individuals are excluded. Specimens collected in January-March following the due date of first vaccine dose were excluded in order to study seroprevalence after, not during, the scheduled full course of immunisation.",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,2146,2146,2469,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_describe_antibody_kin_infect,1,0,0,1,1,0,0,0,0,0,0,0,0,0,,,169358383,cdff673a-bfad-436d-ba3c-7547ba4de28c,2022-07-13T14:35:52,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,290,1,2438,10.1371/journal.pone.0150107,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2010,2016,6,2438,1,1,1
2022-07-13T11:35:42.134-03:00,2023-01-09T11:13:59.726-07:00,Post-vaccination HPV seroprevalence among female sexual health clinic attenders in England,Mesher,2021-01-01,9496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011 2012 2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,gumcad_sti_surveillance_system,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,16 to 20 year-old women attending six specialist sexual health services (SSHS),diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__samples_de_identified yes__exempt_as_public_health_s,0,0,0,0,1,1,0,0,,3870,3870,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_identify_risk_factors_of_se,1,0,0,1,0,0,0,1,0,0,0,0,0,0,,,169362800,c9ca7c48-7c1c-49f4-89aa-29fa66cfea68,2022-07-13T14:51:56,,,submitted_via_web,iesteban,vQteqvkE44GFbPjGfNx2An,,291,1,9496,10.1016/j.vaccine.2021.05.018,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2011,2021,10,9496,1,1,1
2022-07-19T15:27:38.035-03:00,2023-01-18T11:23:55.956-08:00,Influenza virus A(H1N1)2009 antibody-dependent cellular cytotoxicity in young children prior to the H1N1 pandemic.,Mesman,2016-01-01,2290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,A longitudinal pertussis research study,seroprevalence_study,0,0,1,0,0,0,,yes,Aged 9 years at inclusion,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,110,110,,venous,0,1,neutralization_test protein_microarray__pa,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos to_describe_cross_reactivity to_describe_viral_dynamics,1,0,0,0,0,0,0,0,0,1,1,1,0,0,,,170773546,ce5439e0-adf8-4228-9a2c-214c7d288fb7,2022-07-20T13:54:24,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,322,1,2290,10.1099/jgv.0.000552,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,2009,2016,7,2290,1,1,1
2022-07-23T14:42:55.192-07:00,2022-12-11T17:55:44.972-05:00,"Evidence of autochthonous hepatitis E in a Portuguese pediatric cohort, 1992-1995.",Mesquita,2016-01-01,3426,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1992 1993 1994 1995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,PT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,H. pylori pediatric cohort aged 1-13 years old,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,71,71,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171493694,7242e48e-ab2c-45ee-a276-2381aa01d8ef,2022-07-23T21:51:43,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,332,1,3426,10.1002/jmv.24414,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1992,2016,24,3426,1,1,1
2022-07-27T15:52:32.557-03:00,2022-12-16T15:04:53.880-05:00,Seroprevalence of 34 human papillomavirus types in the German general population.,Michael,2008-01-01,3693,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1985 1986 1987 1988 1989 1991 1992,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,german_national_nutrition_surv,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Multiple samples,diagnostic_sample other_non_serological_survey,0,0,0,1,1,0,,yes,Aged 1-82 years,unknown,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1797,1797,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,172317170,520e83fe-241b-4f5d-ad3d-e40710a270ba,2022-07-27T19:23:43,,,submitted_via_web,iesteban,vLT9WLEGcKDiqsV6vaVroi,,361,1,3693,10.1371/journal.ppat.1000091,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,1985,2008,23,3693,1,1,2
2022-07-28T13:07:21.640-03:00,2022-12-20T13:15:54.850-05:00,Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.,Miller,2010-01-01,3813,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,3357,3357,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,1,0,1,0,0,0,0,,,172517622,2ab38457-f93d-4997-a799-da797f626419,2022-07-28T16:23:02,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,363,1,3813,10.1016/S0140-6736(09)62126-7,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2008,2010,2,3813,1,1,1
2022-07-28T13:22:50.994-03:00,2022-12-05T17:15:11.474-05:00,Hepatitis E virus in donor plasma collected in Japan.,Minagi,2016-01-01,3331,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,plasma_donors,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,plasma_donation,0,1,0,0,0,0,,unknown,,unknown,,plasma_donation_site,0,0,0,0,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,36,36,620140,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,172520119,434334e4-c7b5-4cfd-bf57-758aeeb28229,2022-07-28T16:33:31,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,364,1,3331,10.1111/vox.12425,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,2004,2016,12,3331,1,1,1
2022-07-28T13:33:19.771-03:00,2024-04-25T20:17:27.199-04:00,Serological evidence of hepatitis E virus infection in an indigenous North American population.,Minuk,2007-01-01,3230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1980,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,indigenous_people,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,393,393,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,172524848,7d04df13-6021-49cd-80bf-4e31282e52f3,2022-07-28T16:53:18,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,365,1,3230,10.1155/2007/289059,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1980,2007,27,3230,1,1,1
2022-08-23T15:39:01.194-03:00,2023-05-21T10:27:40.070-04:00,Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion.,Mitsui,2004-01-01,3567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Hemodyalisis patients,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,416,416,,venous,0,1,hemagglutination_inhibition_as elisa_eia__enzyme_immunoassay,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b hepatitis_e,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,178040846,6ca184bc-88fb-4a95-bfd4-06bf98685186,2022-08-23T19:06:30,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,470,1,3567,10.1002/jmv.20215,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1977,2004,27,3567,2,1,1
2022-11-30T09:26:34.785-03:00,2023-01-11T11:43:18.706-07:00,Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation,Miyara,2022-01-01,15903,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,175,175,,venous,0,1,neutralization_test multiplex,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,testing_samples_multiple_times_for_the_s,0,0,0,0,0,0,0,1,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,204891789,ed56db6c-d76f-4486-901b-9ce8a651c990,2022-11-30T12:36:29,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,530,1,15903,10.3389/fimmu.2022.790334,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2020,2022,2,1590,1,1,1
2022-11-30T09:16:05.406-03:00,2024-04-25T20:41:41.371-04:00,Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant women,Moat,2022-01-01,16003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,newborns,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,8683,8683,,fingerprick,1,0,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,204887581,9ca8be8d-3193-4f49-a294-3d777ffee914,2022-11-30T12:26:28,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,529,1,16003,10.1080/21645515.2022.2089498,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2022,2,1600,1,1,1
2022-06-10T10:36:57.807-07:00,2022-12-20T12:56:27.919-05:00,Seroepidemiology of hepatitis E in selected Australian populations.,Moaven,1995-01-01,3789,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1992,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"six groups: 1) blood donors, 2) residual from routine syphilis testing for refugees, 3) residual from travellers clinic 4) patients with self-limiting hep 5) patients with fulminant hep requiring liver transplant and did not have identifiable cauese for their hep, 6) control sera from patients with acute hep (HAV, HBV, EBC, CMV)",blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,585,533,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling testing_samples_multiple_times_for_the_s,1,0,0,0,0,0,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,162728020,5906afbb-8a0a-4e0a-8e9c-4cfcb683b81b,2022-06-12T17:52:50,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,119,1,3789,10.1002/jmv.1890450316,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,1992,1995,3,3789,1,1,2
2022-05-08T10:42:15.891-04:00,2022-12-05T21:41:58.191-05:00,"Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006.",Mohammed,2012-01-01,3432,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,PR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,300,300,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results testing_samples_multiple_times_for_the_s,0,0,1,0,0,0,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,155917912,409b60ea-5479-42d0-97a0-3537601736d5,2022-05-08T14:56:57,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,68,1,3432,10.1111/j.1537-2995.2011.03492.x,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,2006,2012,6,3432,1,1,1
2022-08-04T16:56:04.694-04:00,2023-01-18T11:55:28.107-08:00,Risk factors for hepatitis E virus seropositivity in Dutch blood donors.,Mooij,2018-01-01,2439,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors plasma_donors,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Dutch blood bank Sanquin,plasma_donation,0,1,0,0,0,0,,no,,no,,blood_donation_site plasma_donation_site,0,0,0,1,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,2100,2100,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,174173342,318731ca-bb09-42f5-9f9f-91da0df204cf,2022-08-05T17:59:28,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,402,1,2439,10.1186/s12879-018-3078-9,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2016,2018,2,2439,1,1,1
2022-07-23T19:12:18.233-03:00,2022-12-19T08:37:35.990-05:00,The changing epidemiological pattern of hepatitis A in England and Wales.,Morris,2002-01-01,3769,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,4188,4188,,venous,0,1,elisa_eia__enzyme_immunoassay radio_immunoassay,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171616896,f3bb0f2e-83de-42e7-a959-e294c4249113,2022-07-24T18:48:03,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,337,1,3769,10.1017/s095026880200701x,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,1996,2002,6,3769,1,1,1
2022-06-21T16:31:24.560-03:00,2023-01-04T13:19:07.770-07:00,Hepatitis A virus transmission by blood products in the United States,Mosley,1994-01-01,6297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1985 1986 1987 1988 1989 1990 1991 1992,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Persons with clotting factor deficiencies,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,epi_data_not_on_vpd_of_interest__e_g__hi,0,0,0,1,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,339,339,,venous,0,1,radio_immunoassay,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,164797239,1e42750b-cb7d-4792-9b47-6a0f8baae8d8,2022-06-21T19:56:24,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,157,1,6297,10.1159/000462666,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1985,1994,9,6297,1,1,1
2022-06-28T10:53:54.669-03:00,2022-12-11T21:24:52.256-05:00,Detection and characterization of hepatitis E virus genotype 3 in HIV-infected patients and blood donors from southern Brazil.,Moss da Silva,2019-01-01,3460,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012 2013 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,blood donors and HIV infected patients,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,601,601,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,166324724,ff425b7b-83bf-443c-9dc2-4db1738bf983,2022-06-28T14:08:32,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,188,1,3460,10.1016/j.ijid.2019.06.027,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,1,0,1,1,0,0,0,1,2012,2019,7,3460,1,1,2
2022-07-24T15:47:54.632-03:00,2022-12-20T09:23:34.555-07:00,Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study,Motaze,2020-01-01,4252,2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2016 2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,samples from a measles surveillance program,seroprevalence_study,0,0,1,0,0,0,,yes,Negative testing for measles,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,6057,6057,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,171618120,459473d9-52fd-46fe-900d-7f403dd0497c,2022-07-24T18:58:50,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,338,1,4252,10.1080/21645515.2020.1738834,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2016,2020,4,4252,1,1,1
2022-07-24T15:58:41.194-03:00,2022-12-23T11:14:56.043-03:00,"Prevalence of human papillomavirus in Jeddah, Saudi Arabia.",Mousa,2019-01-01,2951,2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2012 2013 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,SA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,966,966,966,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171619680,4f9b9ce3-df67-4399-9bf7-c3666cbe3ee8,2022-07-24T19:08:04,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,339,1,2951,10.5144/0256-4947.2019.403,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2012,2019,7,2951,1,1,1
2022-12-04T10:38:24.715-03:00,2022-12-04T10:45:02.030-03:00,"Increasing rate of anti-SARS-CoV-2 antibodies between the first and second waves of COVID-19 in São Paulo, Brazil: A cross-sectional blood donors-based study.",Moya Rios do Vale,2022-01-01,14577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2806,2806,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,0,0,0,0,0,0,0,1,0,1,0,0,0,0,,,206029138,a434e531-5723-4c2c-aa4d-9388329af109,2022-12-04T13:44:53,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,550,1,14577,10.1016/j.clinsp.2022.100016,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1457,1,1,1
2022-07-24T16:07:55.131-03:00,2023-05-14T20:34:41.116-07:00,Sero-prevalence of mumps antibodies in subpopulations subsequently affected by a large scale mumps epidemic in Israel.,Muhsen,2011-01-01,3844,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_national_serum_bank_by_,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 1-20 years,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2550,2550,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,mumps,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,171620614,492e3094-2226-41ec-ae8d-b5c443caca52,2022-07-24T19:17:06,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,340,1,3844,10.1016/j.vaccine.2011.03.047,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,1997,2011,14,3844,1,1,1
2022-07-06T09:07:17.632-07:00,2024-04-25T20:23:28.453-04:00,Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease.,Muhsen,2008-01-01,3872,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1998 1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_national_serum_bank_by_,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Diagnostics labs and healthy blood donors (excluding samples from those with confirmed or suspected immunological disorders),blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,3330,3330,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,mumps,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,168484082,cee65368-408b-46bb-a110-fe31a1aa8454,2022-07-07T21:26:04,,,submitted_via_web,abernas,v45acXkSNUkFv8KgQJXh42,,249,1,3872,10.1017/S0950268807008989,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,1998,2008,10,3872,1,1,2
2022-12-05T14:22:41.769-03:00,2022-12-05T14:32:34.022-03:00,"Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020.",Mun,2022-01-01,14587,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,9954,9954,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,206354246,66bd69f6-e68a-4138-b349-598f1612e6eb,2022-12-05T17:32:27,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,555,1,14587,10.12659/MSM.934926,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2020,2022,2,1458,1,1,1
2022-07-24T16:16:57.179-03:00,2023-01-18T12:03:46.975-08:00,"Immunity against diphtheria among children aged 5-17 years in India, 2017-18: a cross-sectional, population-based serosurvey.",Murhekar,2021-01-01,701,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"samples from a cross-sectional, population-based serosurvey for dengue infection",seroprevalence_study,0,0,1,0,0,0,,yes,Aged 5-17 years,,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,8309,8309,12300,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,171622539,2641308d-5aa0-47fa-a9e6-c45d617ec519,2022-07-24T19:31:36,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,341,1,701,10.1016/S1473-3099(20)30595-8,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2017,2021,4,701,1,1,1
2022-04-06T09:38:06.630-04:00,2022-12-11T22:18:40.557-05:00,"Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.",Murrill,2002-01-01,3641,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,injection_drug_users,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,IDUs admitted to drug treatment centers,seroprevalence_study,0,0,1,0,0,0,,no,,no,,other,0,0,0,0,0,0,0,0,0,1,Methadone maintenance programs,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,no,0,0,0,0,0,0,0,1,,1717,1717,,venous,0,1,radio_immunoassay,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,150618088,d208a048-d407-436a-b7c5-a10826e6bd63,2022-04-06T14:04:45,,,submitted_via_web,awinter,vxpVczfD72C8Q6wLmKdViQ,,21,1,3641,10.2105/ajph.92.3.385,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1993,2002,9,3641,1,1,1
2022-06-22T07:08:37.949-03:00,2024-04-25T20:44:48.849-04:00,SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020,Muñoz-Medina,2021-01-01,1969,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,MX,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"specimens were collected from 34 clinical laboratories (CLs; i.e., in each state’s main hospital) and 34 blood banks (BBs; i.e., in either the hospitals or unique to the respective states), across all 32 of the United Mexican States.",blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,yes,excluding patients with fever within the previous two weeks and/or patients with an acute respiratory infection,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,24273,24273,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,164921499,0a8d5880-0a44-454d-962f-0d05bedef041,2022-06-22T10:17:06,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,161,1,1969,10.3390/microorganisms9040850,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,1,1,0,0,1,1,0,0,0,1,2020,2021,1,1969,1,1,2
2022-06-17T09:25:49.406-03:00,2022-12-20T13:11:00.581-05:00,Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study.,Nah,2021-01-01,3809,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,examinees who underwent health check-ups at 16 health  promotion centres in 13 Korean cities,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"Subjects who had COVID-19-related symptoms or  who had a history of return from abroad or contact  with confirmed COVID-19 patients within 2 weeks were  excluded. Those who had a history of malignancy, stroke  or myocardial infarction were also excluded",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,4085,4085,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d,1,1,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,163820096,1f26958a-f3c4-469f-9982-20882f366bfd,2022-06-17T12:44:33,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,134,1,3809,10.1136/bmjopen-2021-049837,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,2020,2021,1,3809,1,1,1
2022-05-15T10:14:37.341-04:00,2024-04-25T20:27:30.099-04:00,A comparison of hepatitis B seroepidemiology in ten European countries.,Nardone,2009-01-01,4006,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2000 2001 2002 2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BE CZ FI DE IE IT LU NL RO SK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,34284,34284,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_compare_population_seroposi,1,0,0,0,0,0,0,0,0,0,0,0,1,0,,,157108029,c324d071-03e9-492d-9b34-92719bd3d03a,2022-05-15T14:26:21,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,86,1,4006,10.1017/S0950268808001672,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1996,2009,13,4006,1,10,2
2022-05-15T20:35:23.135-04:00,2022-12-14T20:48:04.599-07:00,Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.,Nardone,2008-01-01,4157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2000 2001 2002 2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU BE BG CY CZ HU IE IL LV LT LU MT RO SK SI SE GB,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"either by residual sera collected during  routine laboratory testing (11 of 17),  by population-based random sampling  (five of 17), or a combination of these  two methods (one of 17)",seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,40365,40365,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos other,1,0,0,0,0,0,0,0,0,0,0,0,0,1,to evaluate the effectiveness of mass vaccination programs,,157154443,d83fe874-0e75-4a50-8a49-31ef05ef1574,2022-05-16T00:53:16,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,91,1,4157,10.2471/blt.07.042010,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1996,2008,12,4157,1,17,2
2022-06-10T09:58:39.539-07:00,2022-12-20T09:20:01.624-07:00,The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.,Nardone,2007-01-01,4248,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2000 2001 2002 2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BE FI DE IE IL IT LU NL SK ES GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Residual from routine lab testing (6 of 11 countries) or population-based random sampling (5 of 11 countries),seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,no,,no,,hospital_clinic unknown,0,0,1,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,19499,19499,,,,,elisa_eia__enzyme_immunoassay fluorescent_antibody_to_membra,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,1,1,0,1,0,to_describe_population_seropos to_compare_population_seroposi,1,0,0,0,0,0,0,0,0,0,0,0,1,0,,,162410728,4b19002e-7cdb-4889-9c5f-b4cfacb93aa2,2022-06-10T17:23:46,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,117,1,4248,10.1016/j.vaccine.2007.07.036,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,1,0,0,0,0,1996,2007,11,4248,1,11,2
2022-02-17T21:03:27.999-05:00,2023-01-09T17:48:39.878-08:00,Seroprevalence of hepatitis E virus among blood donors in Qatar,Nasrallah,2017-01-01,1350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,QA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Blood Donor Unit at HamadMedical Corporation,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,5854,5854,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,to_evaluate_the_need_for_blood,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,Objective was to screen of not for HEV among blood donors.  Therefore maybe not biased sample?,142262770,dc3b7976-4ed9-40b7-8127-5fe259219cde,2022-02-18T02:08:28,,,submitted_via_web,awinter,vpQrgGPTK7VgMoGYycNBPf,,2,,1350,10.1111/trf.14116,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,2013,2017,4,1350,1,1,1
2022-07-24T16:31:27.091-03:00,2022-12-16T15:37:11.277-05:00,Rising hepatitis A immunity in U.S. military recruits.,Nevin,2007-01-01,3745,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,u_s__defense_medical_surveilla,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"Exclusion criteria included age <18 at time of serum collection, age >34 at day of entry to military service, previous military service, or the absence of a serum specimen obtained within 6 months before the date of entry",unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2592,2592,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171628504,0b0db173-8b8e-41b3-ae3f-71363822e2d2,2022-07-24T20:28:20,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,342,1,3745,10.7205/milmed.172.7.787,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2004,2007,3,3745,1,1,1
2022-06-17T08:17:22.686-03:00,2022-12-20T21:42:54.429-05:00,"Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.",Newall,2008-01-01,3864,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,individuals aged 0–69 years,diagnostic_sample,0,0,0,1,0,0,,yes,aged 0–69 years,yes,"subjects who were immunosuppressed, had received multiple or recent transfusions (i.e., within 3 months), or were known to be infected with HIV were excluded on the basis of clinical information available to the pathology provider.",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2770,2770,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,163801930,6a3c1339-a663-49bc-858e-dbda588cc025,2022-06-17T11:29:25,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,131,1,3864,10.1086/587895,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2005,2008,3,3864,1,1,1
2022-07-24T20:00:15.880-03:00,2022-12-26T16:40:31.867-03:00,Seroprevalence of vaccine-preventable diseases among children and adolescents in Singapore: Results from the National Paediatric Seroprevalence Survey 2018.,Ng,2020-01-01,3265,2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,national_pediatric_seroprevale,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Aged 1-17 years, and singapore residents",diagnostic_sample,0,0,0,1,0,0,,no,,yes,"immunocompromised, undergoing immuno-suppressive therapy, or were diagnosed with measles, mumps, rubella, varicella, poliomyelitis, diphtheria, pertussis, tetanus, hepatitis B, hand, foot and mouth disease, dengue or chikungunya.",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__exempt_as_public_health_s,0,0,0,0,0,1,0,0,,1200,1200,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria hepatitis_b measles rubella tetanus varicella_herpes_zoster,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,,171695652,b2eebe2d-0f43-4bb4-a31d-37966a2a0b04,2022-07-25T09:32:20,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,345,1,3265,10.1016/j.ijid.2019.12.015,1,0,0,1,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2017,2020,3,3265,6,1,1
2022-07-12T14:03:59.437-07:00,2022-12-11T21:22:44.577-05:00,SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.,Ng,2020-01-01,3449,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,remnant serum and plasma specimens from the clinical laboratories at UCSF; serum samples from blood donors in the San Francisco Bay Area,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic blood_donation_site plasma_donation_site,0,0,1,1,1,0,0,0,0,0,,household blood_bank,1,0,1,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2505,2505,,venous,0,1,neutralization_test chemiluminescence_immunoassay,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_infect,1,0,0,0,1,0,0,0,0,0,0,0,0,0,,,169217477,cb64db12-00ed-4af4-83ed-bfb5a7f07c18,2022-07-12T21:18:29,,,submitted_via_web,abernas,vQteqvkE44GFbPjGfNx2An,,284,1,3449,10.1038/s41467-020-18468-8,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,2020,2020,0,3449,1,1,2
2022-06-21T15:28:45.850-07:00,2022-12-11T22:06:52.718-05:00,Structure of general-population antibody titer distributions to influenza A virus.,Nhat,2017-01-01,3614,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010 2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,VN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,hospital laboratory samples from four hospital labs in southern Vietnam,diagnostic_sample,0,0,0,1,0,0,,no,,yes,HIV wards were excluded,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,20152,20152,,venous,0,1,protein_microarray__pa,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling weighted_final_results,1,0,0,1,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168166224,76b1092c-73f4-4c83-8b26-25f677d104c0,2022-07-06T15:34:42,,,submitted_via_web,abernas,v45acXkSNUkFv8KgQJXh42,,227,1,3614,10.1038/s41598-017-06177-0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,2009,2017,8,3614,1,1,1
2022-06-21T16:56:14.787-03:00,2022-12-11T21:27:01.094-05:00,Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016.,Niederhauser,2018-01-01,3462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,CH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__received_waiver_on_re_con yes__samples_de_identified,0,0,0,1,1,0,0,0,,4005,3605,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,164800135,e7e4b45f-0025-4254-a0f9-edf7102ea9fa,2022-06-21T20:14:40,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,158,1,3462,10.2807/1560-7917.ES.2018.23.35.1700616,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,1,2014,2018,4,3462,1,1,1
2022-12-04T09:44:48.632-03:00,2023-02-01T10:17:41.743-07:00,Persistence of Naturally Acquired and Functional SARS-CoV-2 Antibodies in Blood Donors One Year after Infection.,Nunhofer,2022-01-01,14499,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,AT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__received_waiver_on_re_con,1,1,0,1,0,0,0,0,,51797,51797,,venous,0,1,neutralization_test chemiluminescence_immunoassay,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s conducted_sensitivity_analysis,0,0,1,0,0,1,0,1,1,to_describe_antibody_kin_infect to_identify_risk_factors_of_se,0,0,0,0,1,0,0,1,0,0,0,0,0,0,,,206014666,5eaf0d6a-ca33-42a8-916f-e010b0219353,2022-12-04T12:50:39,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,545,1,14499,10.3390/v14030637,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,1,0,0,1,2021,2022,1,1449,1,1,1
2022-07-24T17:28:11.241-03:00,2022-12-26T16:36:56.413-03:00,Hepatitis E virus infection in the Irish blood donor population.,O'Riordan,2016-01-01,3233,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,IE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1076,1076,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,171629023,8597bbaf-5165-4e11-b3e9-407961beb661,2022-07-24T20:35:46,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,343,1,3233,10.1111/trf.13757,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2012,2016,4,3233,1,1,1
2022-06-16T15:28:07.259-07:00,2022-12-16T15:10:20.585-05:00,"Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007.",Ochieng,2015-01-01,3698,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,KE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Kenya AIDS Indicator Survey (KAIS 2007) national population-based household survey of persons aged 15-64,seroprevalence_study,0,0,1,0,0,0,,yes,only HIV-negative samples (as HIV-positive samples were unavailable at time of residual survey),no,,household,1,0,0,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1091,1091,15853,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th weighted_final_results compared_to_other_published_estimates__d,1,1,0,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,163711625,1ca7f5f5-fdf3-4193-a549-570d0bc88452,2022-06-16T22:39:02,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,129,1,3698,10.1371/journal.pone.0132645,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,0,0,2007,2015,8,3698,1,1,1
2022-06-24T10:15:53.604-03:00,2022-12-21T21:53:18.314-05:00,Seroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey.,Okabayashi,2019-01-01,4051,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,LA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,unknown,,yes,Participants aged 3-4,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2058,2058,2184,fingerprick,1,0,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,mumps,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,165522657,df093149-37b5-41c5-bed8-f64ea0733c5e,2022-06-24T13:38:25,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,166,1,4051,10.1186/s13104-019-4194-3,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2014,2019,5,4051,1,1,1
2022-08-23T15:08:37.498-03:00,2022-12-05T17:04:59.135-05:00,Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study.,Olsøy,2019-01-01,3320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"population based survey, not national",other_non_serological_survey,0,0,0,0,1,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1800,1800,21083,venous,0,1,elisa_eia__enzyme_immunoassay rapid_test_igg_lateral_flow,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,178029152,8b1ead07-7367-4fbd-93a7-ef59a10e5d3c,2022-08-23T18:26:47,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,468,1,3320,10.1007/s00430-019-00599-5,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,2015,2019,4,3320,1,1,1
2022-05-12T22:02:32.449-04:00,2022-12-26T16:56:57.064-03:00,Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.,Orner,2021-01-01,3290,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"patients hospitalized with a PCR-confirmed Coronavirus Disease 19 (COVID-19) diagnosis at Montefiore Medical Center (Bronx, NY) or Washington University Medical Center (St. Louis, MO).",diagnostic_sample,0,0,0,1,0,0,,yes,patients hospitalized with a PCR-confirmed Coronavirus Disease 19 (COVID-19) diagnosis,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,389,389,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f,0,0,1,0,1,0,0,0,0,to_describe_population_seropos to_describe_seroprevalence_amo to_identify_risk_factors_of_se,1,1,0,0,0,0,0,1,0,0,0,0,0,0,,Three hundred fifty-nine residual samples were obtained from 89 hospitalized patients,156738119,e2c24c6d-2912-4255-b025-44166c2cc336,2022-05-13T02:20:02,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,82,1,3290,10.1016/j.diagmicrobio.2020.115300,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,2020,2021,1,3290,1,1,1
2022-06-16T15:50:55.326-07:00,2022-12-20T09:10:30.222-07:00,"Ten years of serological surveillance in England and Wales: methods, results, implications and action.",Osborne,2000-01-01,4220,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Aliquots of serum from residues remaining following the completion of microbiological and/or biochemical investigations,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,46491,46491,,venous,0,1,hemagglutination_inhibition_as elisa_eia__enzyme_immunoassay,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria hepatitis_a hepatitis_b measles mumps rubella varicella_herpes_zoster,0,0,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,acknowledged_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Residual samples actually greater than number noted, as measles sample were "">10,000"" but were counted as exactly 10,000 mathematically",163927827,f4c48a8c-abbc-4cf2-b89b-3797f4c1994b,2022-06-17T21:29:28,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,137,1,4220,10.1093/ije/29.2.362,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1986,2000,14,4220,7,1,1
2022-12-01T18:17:31.089-03:00,2023-04-24T10:53:13.052-07:00,Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) study.,Osman,2022-01-01,14459,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010 2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,cirn__canada,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,unknown,,unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,11176,11176,,venous,0,1,neutralization_test multiplex,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,205398124,14de0dfb-5a77-49a0-b283-5ba89c71f4eb,2022-12-01T21:38:44,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,543,1,14459,10.1016/j.vaccine.2022.04.011,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2009,2022,13,1445,1,1,1
2022-08-11T15:33:41.667-03:00,2022-12-14T20:51:45.989-07:00,High prevalence of previous dengue virus infection among first-generation Surinamese immigrants in the Netherlands.,Overbosch,2014-01-01,4158,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population migrants,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,first-generation Surinamese immigrants living in the Netherlands,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,400,400,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,175382041,4d83bcb9-c5dd-4992-a439-714103e816e4,2022-08-11T18:44:26,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,435,1,4158,10.1186/1471-2334-14-493,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2008,2014,6,4158,1,1,2
2022-12-01T17:45:34.383-03:00,2023-04-24T10:52:13.406-07:00,National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.,Palmateer,2021-01-01,14263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women patient_population,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,41477,41477,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,205394132,d45bbd19-c16b-41ac-ac08-655acc815e23,2022-12-01T21:17:25,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,542,1,14263,10.1016/j.puhe.2021.07.006,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,2019,2021,2,1426,1,1,2
2022-07-24T17:35:37.374-03:00,2022-12-21T21:41:22.860-05:00,"Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.",Pang,2018-01-01,4036,2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population school_children,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,The individuals with a history of MMR vaccination or a history of mumps within a month before blood sample collection were excluded,school hospital_clinic diagnostic_center_laboratory,0,1,1,0,0,1,0,0,0,1,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2662,2662,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,mumps,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th,0,1,0,0,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,171639748,e41b0dd4-394d-414f-92d6-003573a37f4a,2022-07-24T23:00:25,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,344,1,4036,10.3390/ijerph15102089,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2017,2018,1,4036,1,1,2
2022-06-20T09:29:48.681-03:00,2022-12-11T17:31:49.253-05:00,"Prevalence of hepatitis E virus IgG antibodies in patients from a referral unit of liver diseases in Salvador, Bahia, Brazil.",Parana,1997-01-01,3330,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1992 1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Specimens analyzed were from 200 blood donors, 79 patients with acute viral hepatitis (AVH), 392 hemodialyzed patients, and 30 carriers of schistosomiasis.",blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,epi_data_not_on_vpd_of_interest__e_g__hi,0,0,0,1,0,no,0,0,0,0,0,0,0,1,,701,701,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_seroprevalence_amo to_identify_risk_factors_of_se,1,1,0,0,0,0,0,1,0,0,0,0,0,0,,,164391042,29f82c13-357a-40ed-94af-e1d94134e5fb,2022-06-20T12:41:46,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,143,1,3330,10.4269/ajtmh.1997.57.60,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1992,1997,5,3330,1,1,2
2022-12-01T17:20:28.054-03:00,2023-04-24T10:50:44.814-07:00,"Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.",Park,2022-01-01,14521,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,KR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,1048,1048,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,,205387150,6b15b921-e53c-4f0e-8422-2095bc0f0db5,2022-12-01T20:45:28,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,541,1,14521,10.1371/journal.pone.0262820,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2022,2,1452,1,1,1
2022-07-25T06:32:09.217-03:00,2023-01-09T10:58:49.675-07:00,Detection of hepatitis E virus genotype 1 among blood donors from Southwest of Iran,Parsa,2016-01-01,9122,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,IR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,700,700,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,171697516,1251e5b0-6c13-49e3-bc77-d01fdb047b85,2022-07-25T09:41:27,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,346,1,9122,10.5812/hepatmon.34202,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2014,2016,2,9122,1,1,1
2022-07-25T06:41:16.263-03:00,2022-12-14T21:41:45.861-07:00,"High prevalence of hepatitis E virus antibodies in Sao Paulo, Southeastern Brazil: analysis of a group of blood donors representative of the general population.",Passos-Castilho,2017-01-01,4193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,500,500,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171699841,bca7e988-0f4b-4a1a-b33a-29f021b6f3e2,2022-07-25T09:53:48,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,347,1,4193,10.1016/j.bjid.2017.05.004,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,1,2014,2017,3,4193,1,1,1
2022-07-23T15:00:33.541-07:00,2023-01-10T10:47:05.002-07:00,First molecular epidemiological study of hepatitis B and D in individuals infected with human T-lymphotropic virus 1/2 from Argentina,Pataccini,2021-01-01,9583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,AR,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HTLV-1/2-positive samples,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,202,202,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171609370,eb89d769-7aeb-490f-8340-f036794aa2e9,2022-07-24T17:45:31,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,334,1,9583,10.1002/jmv.26366,0,0,0,1,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2000,2021,21,9583,1,1,2
2022-05-21T13:44:41.110-04:00,2024-04-19T11:51:15.806-04:00,Australian mumps serosurvey 2012-2013: any cause for concern?,Patel,2020-01-01,3663,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,32 diagnostic laboratories in all states and territories around Australia during 2012 and 2013,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,Known  infection with human immunodeficiency virus;  any other immunocompromising condition;  and transfusion of blood products within the  past three months,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2729,2729,12411,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,mumps,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,1,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,results compared with other serosurveys but to evaluate change over time,158356639,b746f6c2-6601-4771-91ca-1ea4dd1f6a24,2022-05-21T18:22:50,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,108,1,3663,10.33321/cdi.2020.44.67,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1,0,1,0,0,0,0,0,2012,2020,8,3663,1,1,1
2022-06-14T13:34:16.226-07:00,2024-04-25T20:57:30.033-04:00,"Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.",Patic,2020-01-01,4003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,RS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,age stratification with equal numbers by gender,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,3404,3404,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d,1,1,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,163219887,67935b31-33c4-4cd3-8e51-ff8ebec5c6b6,2022-06-14T20:52:54,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,125,1,4003,10.1371/journal.pone.0227413,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,2015,2020,5,4003,1,1,1
2022-07-25T06:53:37.031-03:00,2022-12-11T21:40:06.357-05:00,Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.,Pauly,2018-01-01,3538,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012 2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,LA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population healthcare_workers,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic unknown,0,0,1,0,0,0,0,0,1,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,2444,2444,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,poliomyelitis__polio,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results testing_samples_multiple_times_for_the_s,0,0,1,0,0,0,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,171704525,5ed9edaf-3317-472e-bf7e-61659f4891a0,2022-07-25T10:16:24,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,348,1,3538,10.1371/journal.pone.0197370,0,0,1,0,0,0,1,1,0,1,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,2012,2018,6,3538,1,1,3
2022-07-25T07:16:13.696-03:00,2024-04-25T20:33:02.859-04:00,The seroepidemiology of rubella in western Europe.,Pebody,2000-01-01,4156,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994 1995 1996 1997 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DK FI FR DE GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,unknown,,yes,immunocompromised,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,,,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,1,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,"Total sample size is unclear ""The actual total number of sera collected varied between 2766 and 8306""",171831780,4c6e32c9-18f8-4502-ba83-e6f0a16fa37e,2022-07-25T18:40:51,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,349,1,4156,10.1017/s0950268899004574,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,1,1,1,0,1,0,0,0,0,0,1994,2000,6,4156,1,5,2
2022-12-01T16:49:45.178-03:00,2023-04-24T10:48:17.993-07:00,Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic.,Pedersen,2022-01-01,14481,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017 2018 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,BR CA DK GA SN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__received_waiver_on_re_con yes__samples_de_identified,1,1,0,1,1,0,0,0,,586,572,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,205383068,9f5c0023-05cd-482b-89e4-d1884055e408,2022-12-01T20:20:22,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,540,1,14481,10.1038/s41598-022-17241-9,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2017,2022,5,1448,1,5,1
2022-07-25T15:40:39.237-03:00,2023-01-04T12:16:48.748-07:00,Immunity to diphtheria in a sample of the Canadian adult population,Pelletier,1998-01-01,5947,1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,plasma_donors,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,plasma_donation,0,1,0,0,0,0,,unknown,,unknown,,plasma_donation_site,0,0,0,0,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1619,1619,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171840781,3dc9f73a-9c78-4b6a-a601-34659a12b4db,2022-07-25T19:27:33,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,350,1,5947,10.1155/1998/690372,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,1,1996,1998,2,5947,1,1,1
2022-12-04T13:35:05.536-03:00,2022-12-05T14:22:41.715-03:00,Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment.,Persson Berg,2022-01-01,14837,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with multiple sclerosis,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1028,884,1157,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,206351356,4c2949cc-9f95-44f2-a59b-fe230ad50cc5,2022-12-05T17:22:34,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,554,1,14837,10.1136/bmjno-2022-000271,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2010,2022,12,1483,1,1,1
2022-07-25T16:27:21.388-03:00,2022-12-23T10:47:33.883-03:00,Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors.,Petrovi,2014-01-01,2740,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,RS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,200,200,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171842216,a64baf16-9094-4bee-8511-3b24fe1ff640,2022-07-25T19:36:52,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,351,1,2740,10.3855/jidc.4369,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2010,2014,4,2740,1,1,1
2022-06-16T15:39:01.343-07:00,2022-12-27T10:50:09.913-07:00,Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana,Phinius,2020-01-01,4903,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006 2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,BW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV-1c infected treatment naive patients enrolled in a previous Botswana Harvard AIDS Institute Partnership study,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,442,442,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,163712609,a6b93eac-92c7-46ae-94d7-24303540c219,2022-06-16T22:51:05,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,130,1,4903,10.1097/MD.0000000000019341,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,2005,2020,15,4903,1,1,1
2022-05-12T21:30:04.011-04:00,2022-12-22T11:46:29.609-03:00,Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel,Pichyangkul,2014-01-01,2495,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1949 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 2000 2008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,u_s__defense_medical_surveilla,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,other,0,0,0,0,0,0,0,0,0,1,Department of Defense Serum Repository,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,200,200,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_cross_reactivity,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,156736467,dc2021ba-4dc1-4df5-b056-61095bad62b5,2022-05-13T01:48:11,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,80,1,2495,10.4269/ajtmh.13-0151,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,1949,2014,65,2495,1,1,1
2022-05-15T10:53:53.692-04:00,2022-12-05T21:36:37.808-05:00,Population-Level Herd Protection of Males From a Female Human Papillomavirus Vaccination Program: Evidence from Australian Serosurveillance,Pillsbury,2017-01-01,3421,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,males aged 15-39,yes,"individuals known to be immunosuppressed,  infected with human immunodeficiency virus (HIV), or who  had received multiple or recent transfusions",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,735,735,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,157153180,be9bd63f-2847-464a-be00-2d978f3f7cb2,2022-05-16T00:13:13,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,88,1,3421,10.1093/cid/cix436,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2012,2017,5,3421,1,1,1
2022-07-25T16:36:40.402-03:00,2022-12-26T17:02:26.088-03:00,"Diphtheria-neutralizing antibody levels in healthy adults from Rio de Janeiro, Brazil.",Pimenta,2006-01-01,3304,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,140,140,240,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171846057,e183d029-b81a-40be-8510-3ee860383981,2022-07-25T20:00:06,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,352,1,3304,10.1590/s0074-02762006000400019,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2002,2006,4,3304,1,1,1
2022-12-04T10:17:40.191-03:00,2022-12-04T10:38:24.553-03:00,SARS-CoV-2 seroprevalence in blood donors before and after the first wave in Catalonia (Spain).,Piron,2022-01-01,14706,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,ES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,18-70 years old,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,16999,16999,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,206027670,2f7c7785-7fce-4622-8284-1695689decd8,2022-12-04T13:38:17,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,549,1,14706,10.2450/2022.0232-21,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,1,0,0,0,1,2020,2022,2,1470,1,1,1
2022-12-04T10:09:21.105-03:00,2022-12-04T10:17:40.042-03:00,Hepatitis E virus in blood donors from Argentina: A possible source of viral infection?,Pisano,2022-01-01,14396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016 2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,AR,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,547,547,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood to_identify_risk_factors_of_se,0,0,1,0,0,0,0,1,0,0,0,0,0,0,,,206022163,c8899610-e432-4d44-b7e7-a5bfa3113855,2022-12-04T13:17:32,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,548,1,14396,10.1016/j.tmaid.2022.102355,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2016,2022,6,1439,1,1,1
2022-07-25T16:59:54.434-03:00,2023-01-18T11:57:06.622-08:00,Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients.,Pistone,2010-01-01,2446,2005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2002 2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"Patients were included if they were HIV-positive, had been vaccinated with the YF live attenuated vaccine 17D (Stamaril, Sanofi Pasteur MSD, Lyon, France) between 2002 and 2003, and had pre- and post-vaccination samples in the hospital’s blood bank.",no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,43,46,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,yellow_fever,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc,0,1,0,1,0,0,0,0,0,0,0,0,0,0,,,172178246,70339a56-02d0-45d4-9bab-16a3814ba98f,2022-07-27T09:51:28,,,submitted_via_web,iesteban,vRhpsSejRy2CZXdamdVt7q,,353,1,2446,10.2174/157016210793499277,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2002,2010,8,2446,1,1,1
2022-12-04T09:57:42.055-03:00,2022-12-04T10:09:20.986-03:00,The seroepidemiology of dengue in a US military population based in Puerto Rico during the early phase of the Zika pandemic.,Pollett,2022-01-01,14490,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,PR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,u_s__defense_medical_surveilla,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,500,500,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,206020143,96d6343d-2617-40d3-a58a-36187e1666dd,2022-12-04T13:09:13,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,547,1,14490,10.1371/journal.pntd.0009986,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2015,2022,7,1449,1,1,1
2022-07-27T07:09:28.788-03:00,2022-12-05T17:24:49.964-05:00,Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.,Prabdial-Sing,2019-01-01,3343,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Fever rash surveillance,diagnostic_sample,0,0,0,1,0,0,,yes,"Aged <15 years, and negative for measles and rubeola",yes,insufficient sample,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,450,450,7017,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,172185944,ece5753c-08f4-45b4-8327-a4cc0fc04768,2022-07-27T10:22:05,,,submitted_via_web,iesteban,vLT9WLEGcKDiqsV6vaVroi,,354,1,3343,10.1371/journal.pone.0217415,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2013,2019,6,3343,1,1,1
2022-05-06T08:55:50.563-04:00,2022-12-26T16:29:23.494-03:00,Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.,Pramoolsinsap,1999-01-01,3202,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,adults with liver disease (CLD or HBV or HBC infection),diagnostic_sample,0,0,0,1,0,0,,yes,adults with liver disease (CLD or HBV or HBC infection),unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,no,0,0,0,0,0,0,0,1,,1015,820,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,year of sample collection unknown,155527444,47b37f86-779e-45ce-b8e7-c971f8b9c295,2022-05-06T13:29:25,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,63,1,3202,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,1999,,3202,1,1,1
2022-12-04T09:50:46.846-03:00,2022-12-04T09:57:41.980-03:00,"Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil.",Prete,2022-01-01,14422,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,223,223,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_antibody_kin_infect to_estimate_infection_rates_or,0,0,0,0,1,1,0,0,0,0,0,0,0,0,,,206016439,897fb1ba-0ce2-42e1-8681-18950302069b,2022-12-04T12:57:43,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,546,1,14422,10.1186/s12879-022-07094-y,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,1,0,0,0,1,2020,2022,2,1442,1,1,1
2022-08-23T14:54:40.021-03:00,2023-01-06T10:41:33.497-07:00,Hepatitis B serological markers and plasma DNA concentrations,Price,2017-01-01,8416,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,UG ZW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,untreated HBV/HIV-coinfected individuals in two sub-Saharan settings,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"likely to be unable to attend follow-up, likely to have poor compliance, acute infection including intense phase of tuberculosis treatment, malignancy requiring chemotherapy, laboratory test result indicative of contraindication to ART (including alanine transaminase greater than five times the upper limit of normal), pregnancy, and breastfeeding",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,no,0,0,0,0,0,0,0,1,,3316,3316,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_estimate_infection_rates_or,0,1,0,0,0,1,0,0,0,0,0,0,0,0,,year of sample collection is unknown,178024415,14657954-d60f-40c6-9463-318c4e99cc73,2022-08-23T18:08:49,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,467,1,8416,10.1097/QAD.0000000000001454,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,,2017,,8416,1,2,1
2022-07-27T07:21:55.029-03:00,2023-01-18T12:18:25.411-08:00,Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.,Purswani,2016-01-01,1611,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,immunized children with perinatal HIV and perinatally HIV-exposed but uninfected (PHEU) children,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 7-16 years,yes,Their last VZV vaccination had to be >21 days before the date the specimen was obtained,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,653,653,678,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc to_evaluate_outcomes_of_seropo,0,1,0,1,0,0,0,0,1,0,0,0,0,0,,,172189988,a9955ca1-d93a-4e89-95b6-29ef2bdb9415,2022-07-27T10:40:41,,,submitted_via_web,iesteban,vLT9WLEGcKDiqsV6vaVroi,,355,1,1611,10.1093/cid/civ734,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2007,2016,9,1611,1,1,1
2022-06-21T09:45:21.286-03:00,2022-12-20T22:15:44.839-05:00,Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy.,Puttini,2015-01-01,3938,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007 2008 2009 2010 2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,blood donors and renal transplant recipients,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,epi_data_not_on_vpd_of_interest__e_g__hi,0,0,0,1,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,250,250,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_seroprevalence_amo to_identify_risk_factors_of_se,1,1,0,0,0,0,0,1,0,0,0,0,0,0,,,164675832,023f5349-0248-465a-a10e-bb6d93571052,2022-06-21T12:59:21,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,149,1,3938,,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2007,2015,8,3938,1,1,2
2022-07-07T08:37:11.122-07:00,2022-12-14T21:35:21.105-07:00,The seroprevalence for hepatitis E viral antibodies in the northern region of Portugal (among the donor population),Queiros,1997-01-01,4189,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Northern region of Portugal, 18-65 years old",blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1473,1473,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_a hepatitis_b hepatitis_e,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,168427315,9ab8e803-75d0-4cd2-a6dd-c38573c64674,2022-07-07T16:06:14,,,submitted_via_web,mpilews1,v45acXkSNUkFv8KgQJXh42,,246,1,4189,,0,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,,1997,,4189,3,1,1
2022-07-27T07:40:30.077-03:00,2024-04-25T20:32:20.777-04:00,The utility of seroepidemiology for tracking trends in pertussis infection.,Quinn,2010-01-01,4146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,national cross sectional serosurvey,diagnostic_sample,0,0,0,1,0,0,,no,,yes,"Residual sera from subjects who were immunosuppressed, had received multiple or recent (within 3 months) blood transfusions, or were known to be infected with HIV were excluded by staff at the diagnostic laboratory.",diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1999,1999,7700,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_estimate_infection_rates_or to_evaluate_changes_in_seropos,0,0,0,0,0,1,0,0,0,1,0,0,0,0,,,172194220,6d6bdc9e-1cf6-40c7-a123-ecd6c8da4ad0,2022-07-27T10:57:37,,,submitted_via_web,iesteban,vLT9WLEGcKDiqsV6vaVroi,,356,1,4146,10.1017/S0950268809990707,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2002,2010,8,4146,1,1,1
2022-07-27T07:57:26.417-03:00,2023-01-15T13:55:52.901-08:00,Seroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.,Radin,2015-01-01,2212,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,u_s__defense_medical_surveilla,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,3 specific age groups,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified yes__exempt_as_public_health_s,0,0,0,0,1,1,0,0,,198,198,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,1,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_identify_risk_factors_of_se,1,0,0,1,0,0,0,1,0,0,0,0,0,0,,,172197461,5d132ea6-3ba0-41eb-829b-2384ebe25639,2022-07-27T11:13:20,,,submitted_via_web,iesteban,vLT9WLEGcKDiqsV6vaVroi,,357,1,2212,10.1371/journal.pone.0121037,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,1,0,0,0,0,2009,2015,6,2212,1,1,1
2022-06-21T10:14:48.071-07:00,2022-12-27T10:46:34.079-07:00,Antibody specificity following a recent bordetella pertussis infection in adolescence is correlated with the pertussis vaccine received in childhood,Raeven,2019-01-01,4514,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,DK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"sera submitted for diagnosis of pertussis to Statens Serum Institut (Copenhagen, Denmark)",diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,36,36,,,,,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,,164764852,4d6ac2db-bd72-4698-9dc4-478089247c50,2022-06-21T17:23:32,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,155,1,4514,10.3389/fimmu.2019.01364,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2014,2019,5,4514,1,1,1
2022-12-22T17:24:41.687-03:00,2022-12-22T17:40:22.375-03:00,"Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries",Rahman,2021-01-01,16444,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BR MX US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Men from a HPV study,seroprevalence_study,0,0,1,0,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,600,600,3695,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results,1,0,1,0,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,year of sample collection is unknown,209965087,0087a442-1e6a-4667-9007-4dae6f5e9f7a,2022-12-22T20:40:13,,,submitted_via_web,iesteban,vJzTYFwzQYR9pFHSy55TD3,,610,1,16444,10.1371/journal.pone.0253005,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,,2021,,1644,1,3,1
2022-12-21T17:22:39.564-03:00,2022-12-22T17:14:42.333-03:00,Seroprevalence of IgG Anti-SARS-CoV-2 among voluntary blood donors in dubai: Demographic and risk factors,Raouf,2021-01-01,16208,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,AE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,yes,COVID-19 previous diagnosis,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1418,1418,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,209962519,c331674f-8708-4070-abee-bef4ea90d3b2,2022-12-22T20:14:33,,,submitted_via_web,iesteban,vJzTYFwzQYR9pFHSy55TD3,,608,1,16208,10.1159/000517456,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,1,2020,2021,1,1620,1,1,1
2022-12-11T13:28:33.601-03:00,2022-12-12T15:02:44.254-03:00,Pediatric SARS-CoV-2 seroprevalence during mitigation procedures in Southwestern Pennsylvania.,Rapsinski,2021-01-01,14644,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"Patients were excluded if their residential zip code was outside the region of interest, if they were under 6-months-old, or they had recently received antibody-modifying treatments.",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2338,2338,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,1,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,207858015,0e67777e-e990-4944-957d-8c13df788b79,2022-12-12T18:02:36,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,574,1,14644,10.1016/j.jcvp.2021.100026,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,1,0,1,0,0,0,0,0,2020,2021,1,1464,1,1,1
2022-07-27T08:13:08.581-03:00,2023-01-08T10:40:11.594-08:00,Varicella susceptibility in a Canadian population.,Ratnam,2000-01-01,321,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1992 1993 1995 1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women school_children healthcare_workers,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,no,,no,,school hospital_clinic diagnostic_center_laboratory,0,1,1,0,0,1,0,0,0,1,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,10750,10750,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_estimate_infection_rates_or to_identify_risk_factors_of_se,0,1,0,0,0,1,0,1,0,0,0,0,0,0,,,172200531,b48c362d-3f07-4f34-a2db-31156a580e88,2022-07-27T11:24:50,,,submitted_via_web,iesteban,vLT9WLEGcKDiqsV6vaVroi,,358,1,321,10.1155/2000/243163,1,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1992,2000,8,321,1,1,3
2022-12-09T10:53:03.071-03:00,2022-12-09T11:05:45.474-03:00,Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era.,Reedman,2022-01-01,14438,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,149522,149522,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,207294625,61c06cc4-af99-40f9-80bf-75dafe8453b1,2022-12-09T14:05:38,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,573,1,14438,10.1128/spectrum.00339-22,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2021,2022,1,1443,1,1,1
2022-06-28T11:08:23.653-03:00,2022-12-24T11:13:13.004-03:00,Hepatitis E: are psychiatric patients on special risk?,Reinheimer,2012-01-01,3184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"blood donors, patients with elevated liver enzymes, psychiatric patients, and from the department of infectious diseases",blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,835,835,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,166328061,18582842-8d39-48fa-a39a-e4a943e77fbc,2022-06-28T14:20:56,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,189,1,3184,10.1007/s00430-011-0218-x,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,1,0,1,0,0,1,1,0,0,0,1,2008,2012,4,3184,1,1,2
2022-07-07T08:10:57.144-07:00,2024-04-25T20:19:09.783-04:00,Prevalence of varicella-zoster virus antibodies in young adults from different Brazilian climatic regions,Reis,2003-01-01,3348,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"20-29 year olds, five state capitals in different regions by climate",blood_donation,1,0,0,0,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,975,975,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168425758,3af235c7-6fd7-4957-867f-313195abe1bc,2022-07-07T16:02:06,,,submitted_via_web,mpilews1,v45acXkSNUkFv8KgQJXh42,,245,1,3348,10.1590/s0037-86822003000300001,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1997,2003,6,3348,1,1,1
2022-05-01T22:33:58.662-04:00,2023-01-11T12:54:06.521-08:00,Hepatitis E virus seroprevalence and molecular study among blood donors in China.,Ren,2014-01-01,1630,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,10741 blood donors + 797 blood donors with elevated ALT,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,11544,11544,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,154969381,29d3404d-e854-484d-9bdc-a55de1cecec8,2022-05-02T02:44:18,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,46,1,1630,10.1111/trf.12530,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2005,2014,9,1630,1,1,1
2022-06-24T16:12:44.234-03:00,2022-12-11T22:10:08.158-05:00,The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.,Rendi-Wagner,2010-01-01,3621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000 2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,israel_national_serum_bank_by_,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,yes,immunological disorders,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,1982,1982,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,165601814,f261fdc1-21e5-4c3c-bece-fdf0a9143ebe,2022-06-24T19:25:32,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,171,1,3621,10.1016/j.vaccine.2010.02.104,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2000,2010,10,3621,1,1,2
2022-08-08T15:59:48.497-03:00,2022-12-21T22:16:03.178-05:00,Varicella-zoster virus susceptibility and primary healthcare consultations in Norway.,Rimseliene,2016-01-01,4086,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2006 2007 2008 2011 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,Laboratories however exclude samples from known HIV and hepatitis cases,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2103,2103,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,174684752,5b631c89-0592-4ee8-81fc-5638fe567ecf,2022-08-08T19:14:17,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,416,1,4086,10.1186/s12879-016-1581-4,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2006,2016,10,4086,1,1,1
2022-05-10T08:04:21.687-04:00,2024-04-25T20:30:45.645-04:00,"Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.",Risti,2019-01-01,4063,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,RS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,esen__european__studies,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"healthy subjects, aged 12 months and older",yes,signs or symptoms of acute illness on routine blood count,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,3199,3199,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,156220078,3f1dc560-f8d3-45a3-ae12-119b72cb9d83,2022-05-10T12:22:21,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,71,1,4063,10.1371/journal.pone.0216219,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2015,2019,4,4063,1,1,1
2022-07-19T15:29:48.765-07:00,2022-12-11T17:37:34.568-05:00,Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.,Rizzo,2010-01-01,3344,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,seroepidemiological survey from left over specimen taken for diagnostic purposes or routine ascertainment obtained from clinical laboratories in 18 of 20 regions in Italy,seroprevalence_study,0,0,1,0,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,587,587,3660,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,170639123,f65888a3-d996-476c-8fc4-e1d54d650803,2022-07-19T22:43:33,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,321,1,3344,10.1016/j.vaccine.2010.03.006,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,2003,2010,7,3344,1,1,1
2022-12-09T08:21:25.381-03:00,2024-04-25T20:42:24.735-04:00,Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months,Robertson,2021-01-01,16416,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,IE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors healthcare_workers,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,yes,"Exclusion criteria included anyone with a blood disorder or contraindication to giving a blood sample, or anyone currently exhibiting symptoms of COVID-19.",blood_donation_site diagnostic_center_laboratory unknown,0,0,0,1,0,1,0,0,1,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,880,697,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,0,0,1,0,1,0,to_describe_antibody_kin_infect to_evaluate_changes_in_seropos,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,207291943,491f396a-4398-4286-863f-c455e3fadbd1,2022-12-09T13:52:55,,,submitted_via_web,iesteban,v4Vwub42CjuNiA7VfdpJtU,,572,1,16416,10.1136/bmjopen-2020-048142,1,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,1,1,0,0,1,1,0,0,0,1,2020,2021,1,1641,1,1,2
2022-11-25T16:58:02.456-03:00,2023-01-11T10:52:05.186-07:00,Prevalence of hepatitis B immunity and infection in home self-sampling HIV service users.,Roche,2022-01-01,14473,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV study,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2172,2172,9179,fingerprick,1,0,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,203557572,95d63b4d-8012-4f93-bc97-44194044bdfe,2022-11-25T20:13:09,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,510,1,14473,10.1136/sextrans-2021-055071,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2016,2022,6,1447,1,1,1
2022-08-05T14:28:58.468-04:00,2023-01-04T12:09:58.485-07:00,Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects,Rollag,1990-01-01,5819,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Subjects with a coagulation factor defect,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,no,0,0,0,0,0,0,0,1,,32,324,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,174636337,0913797f-e4e2-485d-ab87-99d3f1aad768,2022-08-08T15:20:07,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,409,1,5819,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1972,1990,18,5819,1,1,1
2022-08-15T10:34:30.567-04:00,2022-12-20T21:56:18.680-05:00,"Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.",Rosario-Rosario,2015-01-01,3881,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"serum samples from laboratory in Lehigh Valley, Pennsylvania, USA",diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,460,4600,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles mumps rubella,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,176059105,41e11321-ccff-4a89-846f-c9096f559136,2022-08-15T15:03:10,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,448,1,3881,10.1111/jtm.12235,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2013,2015,2,3881,3,1,1
2022-05-01T22:44:08.130-04:00,2023-01-15T10:58:17.077-08:00,Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).,Rostad,2020-01-01,2141,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"hospitalized children with MIS-C (n = 10), symptomatic COVID-19 (n = 10), and KD (n = 5) and hospitalized controls (n = 4) at Children’s Healthcare of Atlanta",diagnostic_sample,0,0,0,1,0,0,,yes,"Aged 0-21. hospitalized children with MIS-C, symptomatic COVID-19 , and KD and hospitalized controls at Children’s Healthcare of Atlanta",no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,29,,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_seroprevalence_amo to_describe_antibody_kin_infect,0,1,0,0,1,0,0,0,0,0,0,0,0,0,,"Some of the samples in the potential residual groups were prospective and some were leftovers, it is unclear how many were residual samples.",154969737,7eb49086-5325-4461-93a1-da289cbf61d7,2022-05-02T02:57:38,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,47,1,2141,10.1542/peds.2020-018242,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020,2020,0,2141,1,1,1
2022-08-05T13:59:18.702-04:00,2022-12-26T16:28:12.750-03:00,Rubella seroprofile of the Italian population: an 8-year comparison.,Rota,2007-01-01,3199,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,one hospital-based reference laboratory was contacted in each of the 20 Italian regions to send ~200 samples.  18 regions provided samples,diagnostic_sample,0,0,0,1,0,0,,no,,yes,Sera from individuals known to be affected by an immunodepressive condition or by an acute infection or to have recently undergone a blood transfusion,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,3094,3094,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,174176704,21cdaacc-d0b4-4441-8461-5a8090103b5c,2022-08-05T18:15:52,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,403,1,3199,10.1017/S0950268806007400,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2003,2007,4,3199,1,1,1
2022-12-09T08:13:13.272-03:00,2022-12-09T08:21:25.241-03:00,Trends in SARS-CoV-2 seroprevalence amongst urban paediatric patients compared with a nationwide cohort in the Netherlands.,Rotee,2021-01-01,14658,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,pediatric patients,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"Children with known current COVID-19 related conditions (e.g., respiratory tract infection or multisystem inflammatory syndrome in children (MIS-C) with proven positive SARS-CoV-2 PCR and/or antibodies) were excluded from the analysis",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,449,449,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d,0,1,1,0,1,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,207253591,df3a3a37-6357-457d-b7d5-605113745359,2022-12-09T11:21:18,,,submitted_via_web,iesteban,v4Vwub42CjuNiA7VfdpJtU,,571,1,14658,10.1016/j.jcvp.2021.100045,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,0,2020,2021,1,1465,1,1,1
2022-12-09T08:01:50.536-03:00,2022-12-09T08:13:13.141-03:00,Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2.,Routledge,2022-01-01,14439,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,"outpatient and emergency department visits for adults; for under 18 s, we included both inpatient and outpatient visits due to small numbers of available samples.",yes,we excluded samples if a sample from the same patient had been selected within the previous 14 days,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,1014,1014,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,207251716,5a306761-6b54-416c-ab9d-3a03306c1863,2022-12-09T11:13:06,,,submitted_via_web,iesteban,v4Vwub42CjuNiA7VfdpJtU,,570,1,14439,10.1038/s41467-022-30051-x,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,2021,2022,1,1443,1,1,1
2022-08-08T11:36:36.086-04:00,2023-05-14T20:54:28.522-07:00,Vaccination induced immunity to the hepatitis B virus among high-risk groups in Glasgow 1993-2001: evaluating the effectiveness of the United Kingdom's selective immunisation policy.,Roy,2008-01-01,2896,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1993 1997 2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population injection_drug_users msm,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,,IDU specimens from the West of Scotland Specialist Virology Centre; MSM and heterosexual men and women attending  genito-urinary medicine clinics in the Greater Glasgow area,diagnostic_sample,0,0,0,1,0,0,,yes,restricted samples to within Greater Glasgow area (samples from IDUs had to have specific postcodes and genito-urinary medicine clinic samples had to come from clinics within a certain vicinity),no,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,2866,2866,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,,174642759,e44cce3c-3863-45de-9d10-134ce2e65052,2022-08-08T15:54:52,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,411,1,2896,10.1258/RSMSMJ.53.4.13,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1993,2008,15,2896,1,1,3
2022-08-09T10:09:26.898-04:00,2022-12-05T21:29:56.870-05:00,SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.,Saeed,2021-01-01,3410,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors plasma_donors,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Canadian Blood Services collects blood from a combination of fixed and mobile sites in all larger cities and most urban areas from all provinces except Quebec,blood_donation plasma_donation,1,1,0,0,0,0,,no,,no,,blood_donation_site plasma_donation_site,0,0,0,1,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified yes__other,1,0,0,0,1,0,1,0,Exempt as no confirmatory testing was performed,74642,74642,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d conducted_sensitivity_analysis,0,0,1,1,0,1,0,0,1,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,174839252,1784c253-e191-4c48-8e58-13a49517fd86,2022-08-09T14:21:29,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,423,1,3410,10.1111/trf.16296,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,1,0,0,1,2020,2021,1,3410,1,1,1
2022-11-24T15:42:10.675-03:00,2023-01-11T11:50:59.787-07:00,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard,Saeed,2021-01-01,16312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,8999,8999,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,203221631,7b20b4c6-771c-45ad-8708-3c98106166f1,2022-11-24T18:49:36,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,499,1,16312,10.1111/trf.16623,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,2020,2021,1,1631,1,1,1
2022-06-16T14:21:47.655-07:00,2022-12-21T13:17:24.172-05:00,Seroepidemiology of varicella-zoster virus in Bangladesh.,Saha,2002-01-01,3962,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999 2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BD,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"patients referred to Popular Diagnostic Centre (PDC, a private laboratory and clinical diagnostic facility) and Dhaka Shishu (Children’s) Hospital (DSH)",diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,943,943,,venous,0,1,latex_agglutination__la__test,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,163708168,7bbb70a2-170b-4207-968b-bd78707f6f1b,2022-06-16T22:02:52,,,submitted_via_web,mpilews1,vi8ujSt4tdYVZ6Wbycvi9H,,126,1,3962,10.1179/027249302125002001,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1999,2002,3,3962,1,1,1
2022-08-07T08:45:48.508-03:00,2022-12-16T14:47:23.025-05:00,"Seroprevalence of seasonal and pandemic influenza a in Kuala Lumpur, Malaysia in 2008-2010.",Sam,2013-01-01,3675,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,MY,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,">6 months old, sent for serological testing for non-respiratory pathogens",diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,806,806,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,174423065,02d00624-d33a-40b9-9b79-2af3f9b9245f,2022-08-07T11:55:39,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,406,1,3675,10.1002/jmv.23622,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2008,2013,5,3675,1,1,1
2022-12-08T12:20:47.429-03:00,2022-12-08T13:40:06.424-03:00,"Changing predominant SARS-CoV-2 lineages drives successive COVID-19 waves in Malaysia, February 2020 to March 2021.",Sam,2022-01-01,14479,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,MY,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,653,653,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,207090995,9d2b4db0-aebf-4a20-9098-c3eec48ef0d5,2022-12-08T15:28:13,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,565,1,14479,10.1002/jmv.27441,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2020,2022,2,1447,1,1,1
2022-12-05T18:31:45.158-03:00,2022-12-08T12:20:47.334-03:00,"Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021.",Sanada,2022-01-01,14578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,23234,23234,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,207089225,73bc1a02-faba-43d2-b3e4-ccac0950fd5e,2022-12-08T15:20:40,,,submitted_via_web,iesteban,vPSdJyZuEfAAtTZdtfiAv2,,564,1,14578,10.2188/jea.JE20210324,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,2020,2022,2,1457,1,1,1
2022-08-04T11:39:34.986-04:00,2022-12-24T10:48:07.145-03:00,"Prevalence of antibodies against influenza A and B viruses in children in Germany, 2008 to 2010.",Sauerbrei,2014-01-01,3098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009 2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,blood donors; eight pediatric primary care hospitals and one diagnostic institute for seroprevalence studies of pandemic influenza A,blood_donation seroprevalence_study diagnostic_sample,1,0,1,1,0,0,,unknown,,unknown,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2065,2065,,,,,hemagglutination_inhibition_as elisa_eia__enzyme_immunoassay,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,173924274,69156bb2-af8d-4df2-99d5-aa095558488d,2022-08-04T15:48:51,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,393,1,3098,10.2807/1560-7917.es2014.19.5.20687,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,2008,2014,6,3098,1,1,2
2022-08-09T10:43:30.081-04:00,2022-12-24T10:51:20.165-03:00,Seroprevalence of influenza A and B in German infants and adolescents.,Sauerbrei,2009-01-01,3120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999 2000 2001 2002 2003 2004 2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population school_children,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Residual sera from children and adolescents aged 0-18 years living in Erfurt, Germany for routine diagnostics (medical check-up of school children or determination of immune status); blood donors used as controls",blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1920,1920,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,174850786,3c4a4bae-5c32-4477-bbf3-ec54c754f865,2022-08-09T15:09:41,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,427,1,3120,10.1007/s00430-009-0108-7,1,0,0,0,0,0,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,0,1,1999,2009,10,3120,1,1,3
2022-06-20T09:02:05.354-03:00,2022-12-23T08:37:53.337-03:00,Time course of hepatitis E-specific antibodies in adults.,Schemmerer,2017-01-01,2612,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Patients diagnosed with HEV,diagnostic_sample,0,0,0,1,0,0,,yes,HEV IgG positive and more than 1 one sample available.,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,none,0,0,0,0,1,no,0,0,0,0,0,0,0,1,,199,199,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_antibody_kin_infect to_evaluate_changes_in_seropos,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,164380596,a75af229-2be4-4ffb-800f-b18cda17ff29,2022-06-20T12:14:27,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,141,1,2612,10.1111/jvh.12621,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1996,2017,21,2612,1,1,1
2022-06-24T16:39:44.061-03:00,2022-12-11T17:44:35.472-05:00,Seroprevalence of seven high-risk HPV types in The Netherlands.,Scherpenisse,2012-01-01,3382,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,6384,6384,19781,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results,0,0,1,1,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,165606171,7b47eca4-17ed-4637-a7d2-5e5cfeb58590,2022-06-24T19:58:15,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,173,1,3382,10.1016/j.vaccine.2012.08.068,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,2006,2012,6,3382,1,1,1
2022-07-28T13:53:06.740-03:00,2022-12-16T14:36:38.697-05:00,Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.,Scherpenisse,2012-01-01,3661,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1995 1996 2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,2 cross- sectionales serosurvey studies,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,9688,9688,,,,,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,173071671,5a72cc6f-53a5-4c23-ba1d-455c95942428,2022-07-31T18:16:40,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,367,1,3661,10.1371/journal.pone.0048807,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,1995,2012,17,3661,1,1,1
2022-12-21T17:05:50.895-03:00,2022-12-21T17:22:39.401-03:00,"Hepatitis a virus incidence rates and biomarker dynamics for plasma donors, united states",Schoch,2021-01-01,16183,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016 2017 2018 2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,plasma_donors,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,plasma_donation,0,1,0,0,0,0,,yes,">10 serial donations from 1 month before to 2 months after the first HAV-positive donation available; second, >1 nonreactive donation preceding the first positive donation; and third, some coverage of the late phase of infection",unknown,,plasma_donation_site,0,0,0,0,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,,,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results,0,1,1,0,0,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,sample size is unclear,209769099,081bd843-a314-4a73-a08b-eb657c63d00b,2022-12-21T20:22:29,,,submitted_via_web,iesteban,vK5JR7f6tri3BCsuYQDPWy,,607,1,16183,10.3201/eid2711.204642,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,1,2016,2021,5,1618,1,1,1
2022-06-21T08:57:52.378-03:00,2023-01-09T17:22:21.786-08:00,SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.,Schoenhals,2021-01-01,1184,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,MG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,7259,7259,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_infect to_estimate_infection_rates_or,1,0,0,0,1,1,0,0,0,0,0,0,0,0,,,164658154,03f0116d-29cc-4179-95dc-41650e43d686,2022-06-21T12:14:58,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,147,1,1184,10.1016/j.ebiom.2021.103419,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2021,1,1184,1,1,1
2022-05-18T15:11:12.081-04:00,2024-04-25T20:19:31.835-04:00,A population-based seroprevalence study in South Africa as a tool in the polio eradication initiative.,Schoub,1998-01-01,3535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1995,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,sera from a serum bank used for a vitamin A study,other_non_serological_survey,0,0,0,0,1,0,,yes,six and 71 months of age,unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1291,1291,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,poliomyelitis__polio,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,157804710,6aa2ab34-0c82-4690-8119-1cf43574f2fa,2022-05-18T19:26:15,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,99,1,3535,10.4269/ajtmh.1998.58.650,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1995,1998,3,3535,1,1,1
2022-07-31T15:16:29.434-03:00,2023-01-05T10:25:06.961-07:00,Rubella in South Africa: An impending greek tragedy?,Schoub,2009-01-01,7321,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,8940,8940,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,173072810,6bdb4ad5-311c-4782-a159-a21833880701,2022-07-31T18:28:44,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,368,1,7321,,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2005,2009,4,7321,1,1,1
2022-07-06T08:47:48.868-07:00,2023-01-04T12:11:09.715-07:00,"Prevalence of antibodies against hepatitis A virus, hepatitis B virus, and Treponema pallidum in Mauritius",Schwarz,1991-01-01,5870,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1987,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,MU,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population injection_drug_users non_injecting_drug_users healthcare_workers inmates_incarcerated_individua other,0,0,1,0,1,0,1,1,0,0,0,1,0,0,0,1,0,0,1,"hotel staff, flight personnel, sailors, and sex workers; hospital patients were from either the TB ward or psychiatric department",,blood_donation seroprevalence_study diagnostic_sample,1,0,1,1,0,0,,no,,no,,hospital_clinic blood_donation_site prison unknown,0,0,1,1,0,0,0,1,1,1,,household diagnostic_center_laboratory,1,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,583,583,618,,,,elisa_eia__enzyme_immunoassay radio_immunoassay,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_b,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling,1,0,0,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,"There were 618 stored samples from the hepatitis study, however only 601 serum samples had known sex and age and of those only 583 had sufficient serum remaining for testing, thus the notation of 618 as original sample size",168175140,b79a77f1-93eb-4ecc-b51c-9ebf1bee5f0c,2022-07-06T16:07:28,,,submitted_via_web,abernas,v45acXkSNUkFv8KgQJXh42,,229,1,5870,,0,0,1,1,0,0,1,1,0,1,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,1,1987,1991,4,5870,2,1,5
2022-07-31T15:28:32.345-03:00,2023-01-04T13:21:21.703-07:00,Hepatitis C and arboviral antibodies in the island populations of Mauritius and Rodrigues,Schwarz,1994-01-01,6336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1987,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,MU,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population blood_donors,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV serosurvey study + blood donors,blood_donation seroprevalence_study,1,0,1,0,0,0,,unknown,,unknown,,blood_donation_site unknown,0,0,0,1,0,0,0,0,1,0,,hospital_clinic blood_bank,0,1,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,564,564,,venous,0,1,radio_immunoassay,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,diptheria,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,173073858,426394d8-caa9-48a6-b54e-0e458232823e,2022-07-31T18:40:41,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,369,1,6336,10.1002/jmv.1890440411,1,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,1987,1994,7,6336,1,1,2
2022-06-21T11:03:25.674-03:00,2022-12-23T11:03:45.602-03:00,Hepatitis B immunity in United States military recruits.,Scott,2005-01-01,2850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,u_s__defense_medical_surveilla,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,military,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 18-35 years,yes,Individuals with prior military service were excluded,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2400,2400,185262,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,164710176,758637a1-5cae-4d6f-8fc6-a22b5765348a,2022-06-21T14:19:59,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,151,1,2850,10.1086/429965,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2001,2005,4,2850,1,1,1
2022-12-01T16:09:38.166-03:00,2023-04-24T10:45:12.622-07:00,"Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola.",Sebastião,2021-01-01,14197,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,AO,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,343,343,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,205376267,ad8db8ea-d422-448a-bcc6-1a16b94d52e9,2022-12-01T19:49:43,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,539,1,14197,10.1186/s12879-021-06814-0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2019,2021,2,1419,1,1,1
2022-07-31T15:40:22.910-03:00,2022-12-16T14:51:02.500-05:00,Seroprevalence of antibodies to hepatitis E virus in the normal blood donor population and two aboriginal communities in Malaysia.,Seow,1999-01-01,3686,1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1990 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,MY,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors indigenous_people,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,blood donors + samples from a malaria study,blood_donation seroprevalence_study,1,0,1,0,0,0,,unknown,,unknown,,blood_donation_site unknown,0,0,0,1,0,0,0,0,1,0,,hospital_clinic blood_bank,0,1,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,no,0,0,0,0,0,0,0,1,,232,232,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,173075543,b770eea5-c38a-4f96-8bad-213da63291a9,2022-07-31T18:56:37,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,370,1,3686,10.1002/(sici)1096-9071(199910)59:2<164::aid-jmv7>3.0.co;2-j,0,0,1,0,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,1990,1999,9,3686,1,1,2
2022-05-18T15:03:11.606-04:00,2023-01-09T17:38:56.702-08:00,A Population-based Seroepidemiological Study on Hepatitis E Virus in Iran.,Sepanlou,2010-01-01,1287,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,The survey included Iranian nationals between the ages of 18 and 65 who were  permanent inhabitants of their households,seroprevalence_study,0,0,1,0,0,0,,yes,Iranian nationals between the ages of 18 and 65 who were  permanent inhabitants of their households,unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1423,1423,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,157802062,c895a2c0-6f75-4edf-ad4f-350ac453dfbd,2022-05-18T19:11:22,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,98,1,1287,,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2006,2010,4,1287,1,1,1
2022-06-27T10:35:26.692-03:00,2022-12-21T21:49:41.572-05:00,"Measles seroprevalence, outbreaks, and vaccine coverage in Rwanda.",Seruyange,2016-01-01,4042,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,RW SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,731,731,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results,1,0,1,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,166072435,72da79ad-0221-4fa2-9201-9b29beff2ffb,2022-06-27T13:51:39,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,180,1,4042,10.1080/23744235.2016.1201720,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,1,2015,2016,1,4042,1,2,1
2022-07-31T15:56:25.387-03:00,2022-12-23T11:00:45.900-03:00,New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France.,Servant-Delmas,2016-01-01,2843,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,FR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,immunocompetent multitransfused patients requiring regular transfusions of red blood cells,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,98,98,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,173076990,2ef430ce-8442-435f-97b6-31b79a9493f7,2022-07-31T19:14:05,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,371,1,2843,10.1111/jvh.12531,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1988,2016,28,2843,1,1,1
2022-12-22T17:51:47.132-03:00,2022-12-23T08:00:47.284-03:00,A pilot study on presence of sars-cov-2-rna in iranian blood donors,Sharifi,2021-01-01,16450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,400,400,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,210049576,627430bb-fc11-4b0d-bcca-6582571a78fa,2022-12-23T11:00:36,,,submitted_via_web,iesteban,vJzTYFwzQYR9pFHSy55TD3,,612,1,16450,10.5812/jjm.117424,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2020,2021,1,1645,1,1,1
2022-12-13T13:25:32.220-03:00,2022-12-13T13:46:42.727-03:00,"Seroprevalence of Dengue and Chikungunya antibodies among blood donors in Dar es Salaam and Zanzibar, Tanzania: a cross-sectional study.",Shauri,2021-01-01,14274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,TZ,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,281,281,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,208090802,de1ee3bb-468c-44c0-9f45-85dae9313510,2022-12-13T16:46:34,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,584,1,14274,10.1186/s12879-021-06549-y,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2021,1,1427,1,1,1
2022-12-09T07:33:05.717-03:00,2022-12-09T08:01:50.428-03:00,Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study,Sheward,2022-01-01,15737,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors healthcare_workers,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,66,66,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_cross_reactivity,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,207248868,15553632-698b-4ff3-a8f4-fa3cc2e72071,2022-12-09T11:01:42,,,submitted_via_web,iesteban,v4Vwub42CjuNiA7VfdpJtU,,569,1,15737,10.1016/S1473-3099(22)00129-3,1,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2020,2022,2,1573,1,1,2
2022-07-24T11:01:14.427-07:00,2024-04-25T20:31:08.556-04:00,Hepatitis A virus and hepatitis E virus prevalence relates to human immunodeficiency virus infection in Japanese male blood donors.,Shinohara,2020-01-01,4068,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010 2011 2012 2013 2014 2015 2016 2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,0,0,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors msm,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,HIV-positive male blood donors,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,503,503,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_e,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,171613850,7e019288-dc66-4eaa-82a2-14e9b5f1301a,2022-07-24T18:19:08,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,336,1,4068,10.1111/1348-0421.12780,0,0,1,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2009,2020,11,4068,2,1,2
2022-06-27T10:51:30.803-03:00,2022-12-16T14:48:37.277-05:00,Seroprevalence of varicella-zoster virus in Polish population.,Siennicka,2009-01-01,3676,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1995 1996 1998 1999 2000 2001 2002 2003 2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,PL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,Aged 0-19 years,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1300,1300,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,166079213,59e8f6a5-af7e-46f3-b575-ed2c09029d7e,2022-06-27T14:13:58,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,181,1,3676,,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,1995,2009,14,3676,1,1,1
2022-12-09T07:27:59.542-03:00,2022-12-09T07:33:05.629-03:00,"Low seroprevalence of hepatitis E virus in pregnant women in an urban area near Pretoria, South Africa.",Simani,2022-01-01,14802,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,384,384,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,207242440,3d1bc8b5-fbb0-4e7b-bb48-4933bfd505e6,2022-12-09T10:32:57,,,submitted_via_web,iesteban,v4Vwub42CjuNiA7VfdpJtU,,568,1,14802,10.1016/j.ijregi.2021.12.002,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2017,2022,5,1480,1,1,1
2022-07-31T16:13:53.154-03:00,2023-01-10T21:46:03.748-08:00,InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers.,Sitas,2012-01-01,1357,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU BR CN CZ IR PL RO RU ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Esophageal squamous cell carcinoma case–control studies,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,4062,1561,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d conducted_sensitivity_analysis,0,0,1,0,0,1,0,0,1,to_identify_risk_factors_of_se,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,173078777,6117d19f-1412-46bd-b103-afd0b8acab6f,2022-07-31T19:36:19,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,372,1,1357,10.1093/jnci/djr499,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,0,1995,2012,17,1357,1,9,1
2022-07-31T16:36:06.617-03:00,2023-02-02T09:45:32.514-07:00,Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.,Skowronski,2010-01-01,2071,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,community patient service centres,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1127,1127,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_describe_viral_dynamics,1,0,0,0,0,0,0,1,0,0,0,1,0,0,,,173079742,a6365256-75a8-4715-bbb3-0c5b3c089b48,2022-07-31T19:48:41,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,373,1,2071,10.1503/cmaj.100910,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,2010,2010,0,2071,1,1,1
2022-08-08T15:18:14.721-03:00,2022-12-23T10:55:39.276-03:00,Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.,Skowronski,2011-01-01,2791,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1221,993,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_antibody_kin_infect to_describe_cross_reactivity,1,0,0,0,1,0,0,0,0,0,1,0,0,0,,,174677392,aab08e36-014e-41b0-8a57-c81943119cb5,2022-08-08T18:35:11,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,413,1,2791,10.1093/infdis/jiq039,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,2007,2011,4,2791,1,1,1
2022-07-19T15:13:15.876-07:00,2024-04-25T20:35:21.239-04:00,Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza a virus subtype H3N2 (H3N2v),Skowronski,2012-01-01,7675,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"community-based centers from urban Lower Mainland area of British Columbia, Canada between September and October 2010; sera from seasonal trivalent inactivated influenza vaccine immunogenicity trials from children and adults 2010-2011 also used",seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1499,1499,,,,,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,170637874,de37b104-cb22-40c0-b2bf-2a6e64a0dc7a,2022-07-19T22:29:59,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,320,1,7675,10.1093/infdis/jis500,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2010,2012,2,7675,1,1,2
2022-05-21T14:22:39.483-04:00,2023-01-08T17:40:27.621-08:00,"Dengue RNA detection and seroprevalence in blood donors during an outbreak in the São Paulo State, Brazil, 2016",Slavov,2021-01-01,967,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,aged 18-65,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__samples_de_identified,0,0,0,0,1,0,0,0,,8475,372,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,weighted_final_results compared_to_other_published_estimates__d,0,0,0,1,0,1,0,0,0,to_evaluate_the_need_for_blood to_describe_antibody_kin_infect,0,0,1,0,1,0,0,0,0,0,0,0,0,0,,,158362345,2b4b0585-7d7b-413a-80ae-0b13fd117caa,2022-05-21T19:16:52,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,109,1,967,10.1002/jmv.26619,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,1,2016,2021,5,967,1,1,1
2022-07-31T16:48:28.829-03:00,2022-12-26T16:58:36.833-03:00,"Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012",Slot,2013-01-01,3299,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2011 2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,5239,5239,40176,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,173084990,9aa73b2e-1084-4d30-8aa5-64147ee3e16d,2022-07-31T20:45:31,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,374,1,3299,10.2807/1560-7917.es2013.18.31.20550,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2011,2013,2,3299,1,1,1
2022-12-09T07:21:32.118-03:00,2022-12-09T07:27:59.466-03:00,Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination.,Soeorg,2022-01-01,14435,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,EE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,2517,2517,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_describe_antibody_kin_infect,1,0,0,1,1,0,0,0,0,0,0,0,0,0,,,207241098,f45bd68b-1ecf-4e3c-96be-a0be01a34f38,2022-12-09T10:27:51,,,submitted_via_web,iesteban,v4Vwub42CjuNiA7VfdpJtU,,567,1,14435,10.1080/23744235.2021.1974540,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2021,2022,1,1443,1,1,1
2022-05-08T10:32:49.934-04:00,2022-12-11T17:54:37.012-05:00,Serological and molecular retrospective analysis of hepatitis E suspected cases from the Eastern Brazilian Amazon 1993-2014,Souza,2019-01-01,3413,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"patients with a previous positive or  inconclusive serological results for HEV infection (n = 158); (2)  patients with clinical and laboratory findings of acute hepatitis of  undetermined etiology and/or negativity for HAV, HBV, HCV,  and HDV infection (n = 114); and (3) patients with a specific  demand for hepatitis E virus infection tests (n = 46).",diagnostic_sample,0,0,0,1,0,0,,yes,"patients with a previous positive or  inconclusive serological results for HEV infection,  patients with clinical and laboratory findings of acute hepatitis of  undetermined etiology and/or negativity for HAV, HBV, HCV,  and HDV infection ; patients with a specific  demand for hepatitis E virus infection tests.",unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,318,318,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,155916238,11d57e72-16f5-4215-8c01-98b59377bdc4,2022-05-08T14:42:25,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,67,1,3413,10.1590/0037-8682-0465-2018,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1993,2019,26,3413,1,1,1
2022-05-31T10:16:14.159-04:00,2022-12-22T09:55:14.683-03:00,A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors,Spada,2018-01-01,2458,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors plasma_donors,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation plasma_donation,1,1,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified yes__other,0,0,0,0,1,0,1,0,Donors' consent not deemed necessary due to compliance with 2014 Italian personal data protection for scientific research purposes,10011,10011,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_subsampling compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,160259107,e3434f8e-fc31-4643-960a-081547a9a962,2022-05-31T14:20:23,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,111,1,2458,10.2450/2018.0033-18,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,2015,2018,3,2458,1,1,1
2022-06-21T09:59:12.242-03:00,2022-12-26T16:56:01.377-03:00,"SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.",Spinelli,2021-01-01,3289,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"people living with HIV who underwent routine outpatient laboratory testing in a municipal  health-care system (San Francisco General Hospital, CA, USA).",diagnostic_sample,0,0,0,1,0,0,,yes,HIV patients,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,2256,1138,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results weighted_final_results testing_samples_multiple_times_for_the_s,0,0,1,1,0,0,0,1,0,to_describe_seroprevalence_amo to_estimate_infection_rates_or to_identify_risk_factors_of_se,0,1,0,0,0,1,0,1,0,0,0,0,0,0,,,164703105,ec52c245-ddf0-45d2-9ba7-ea98e0b1bc6c,2022-06-21T14:03:34,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,150,1,3289,10.1016/S2352-3018(21)00072-2,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020,2021,1,3289,1,1,1
2022-05-06T09:48:31.000-04:00,2023-01-10T10:48:55.927-07:00,Prevalence and 9-year incidence of hepatitis E virus infection among North Italian blood donors: Estimated transfusion risk,Spreafico,2020-01-01,9695,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,blood_and_organ_transmissible_,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,767,767,9726,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood to_estimate_infection_rates_or,0,0,1,0,0,1,0,0,0,0,0,0,0,0,,,155913984,8dcadae2-8c04-41ca-bf8d-497db5dd6e70,2022-05-08T14:22:28,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,65,1,9695,10.1111/jvh.13296,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2015,2020,5,9695,1,1,1
2022-12-08T12:28:21.696-03:00,2022-12-09T07:21:32.049-03:00,"Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.",Ssuuna,2022-01-01,14550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,UG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1616,636,,venous,0,1,chemiluminescence_immunoassay rapid_test_igg_lateral_flow,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,207239905,f4b30f4a-e03f-454a-896c-e836407f8b5c,2022-12-09T10:21:24,,,submitted_via_web,iesteban,v4Vwub42CjuNiA7VfdpJtU,,566,1,14550,10.1186/s12879-022-07161-4,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2019,2022,3,1455,1,1,1
2022-07-31T17:45:19.428-03:00,2023-01-15T13:57:26.834-08:00,Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.,Stadlbauer,2021-01-01,2246,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified yes__exempt_as_public_health_s,0,0,0,0,1,1,0,0,,10691,10691,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,173086982,132552c4-a187-463a-89a2-266d3df77206,2022-07-31T21:08:08,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,375,1,2246,10.1038/s41586-020-2912-6,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,2020,2021,1,2246,1,1,1
2022-07-31T18:25:45.591-03:00,2023-01-09T17:20:17.763-08:00,Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland: a cross-sectional study.,Staehelin,2019-01-01,1172,2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2016 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,CH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,migrants,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,133,133,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,diptheria hepatitis_b measles rubella varicella_herpes_zoster,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,,173275333,79821fea-918e-4f8d-a449-c6195fba88f1,2022-08-01T17:30:28,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,376,1,1172,10.1093/jtm/taz035,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2016,2019,3,1172,5,1,1
2022-08-01T14:30:17.019-03:00,2023-01-04T13:47:59.579-07:00,Identification of new endemic tick-borne encephalitis foci in Poland - a pilot seroprevalence study in selected regions,Stefanoff,2008-01-01,6902,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 1997 1998 1999 2000 2001 2002 2003 2004 2005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,PL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,school_children,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,1856,1498,,venous,0,1,hemagglutination_inhibition_as elisa_eia__enzyme_immunoassay radio_immunoassay,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,tick_borne_encephalitis,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,173279525,15f492c4-da86-40b3-9557-443a351267d0,2022-08-01T17:50:00,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,377,1,6902,10.1016/j.ijmm.2008.04.002,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1996,2008,12,6902,1,1,1
2022-08-01T15:04:34.628-03:00,2023-07-05T15:23:21.088-07:00,Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.,Stone,2021-01-01,1827,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,yes,donations made specifically to provide COVID-19 convalescent plasma were excluded,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,50156,50156,499476,venous,0,1,neutralization_test chemiluminescence_immunoassay,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,173288863,22854ef0-2184-41db-bec1-8af1220a326a,2022-08-01T18:49:05,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,379,1,1827,10.1093/cid/ciab537,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,1,2020,2021,1,1827,1,1,1
2022-08-01T14:49:48.374-03:00,2022-12-26T16:37:43.912-03:00,Seroprevalence of human papillomavirus type 16 infection in the United States.,Stone,2002-01-01,3262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1991 1992 1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,7218,7218,9629,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,173282046,01b5f447-f588-4688-b024-ecb582ebf59d,2022-08-01T18:04:46,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,378,1,3262,10.1086/344354,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,1991,2002,11,3262,1,1,1
2022-08-01T15:48:53.952-03:00,2022-12-26T16:48:29.194-03:00,Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors.,Stramer,2016-01-01,3267,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,yes,"reactivity to other infectious disease markers (primarily hepatitis B virus, hepatitis C virus, and human immunodeficiency virus) were excluded.",blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,4499,4499,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,173291077,f2d77af8-a72c-45e9-bbb3-335187e7e555,2022-08-01T19:03:32,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,380,1,3267,10.1111/trf.13355,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,1,2013,2016,3,3267,1,1,1
2022-08-14T10:04:24.302-03:00,2023-01-09T17:43:13.099-08:00,HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates.,Strickler,1999-01-01,1320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1987 1988 1996 1997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,JM US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,STD participants were not considered residual,blood_donation,1,0,0,0,0,0,,unknown,,yes,HTLV-I-seropositive subjects were excluded,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,no,0,0,0,0,0,0,0,1,,1366,535,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se to_compare_population_seroposi,1,0,0,0,0,0,0,1,0,0,0,0,1,0,,,175869934,260b67d3-c5c6-4270-af08-975457c1f116,2022-08-14T13:24:19,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,443,1,1320,10.1002/(sici)1097-0215(19990129)80:3<339::aid-ijc1>3.0.co;2-f,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,1,0,0,0,1,1987,1999,12,1320,1,2,1
2022-08-17T15:43:14.907-03:00,2023-04-24T10:43:42.674-07:00,Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study.,Su,2021-01-01,654,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HBC serosurvey,seroprevalence_study,0,0,1,0,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,30321,30321,31024,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,rubella,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,176636409,faa6d2da-32f9-4595-9c17-1d617b9caa32,2022-08-17T19:18:28,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,455,1,654,10.1016/S1473-3099(20)30475-8,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2014,2021,7,654,1,1,1
2022-08-09T10:27:49.752-04:00,2023-01-05T10:21:01.129-07:00,Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19,Suda,2020-01-01,4974,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,consecutive outpatients with liver disease,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,700,700,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_evaluate_changes_in_seropos,0,1,0,0,0,0,0,0,0,1,0,0,0,0,,,174843503,b2ee8603-67b7-4fcb-8ae3-b6ca86736643,2022-08-09T14:35:53,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,425,1,4974,10.1111/hepr.13551,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2019,2020,1,4974,1,1,1
2022-05-05T08:54:20.551-04:00,2023-01-14T16:17:54.506-08:00,Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic.,Sughayer,2021-01-01,1933,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,JO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1374,1374,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,155371763,5d1d6262-f5a4-4f7e-8bcd-1176ccc11216,2022-05-05T13:12:17,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,58,1,1933,10.1016/j.ijid.2021.04.059,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2021,1,1933,1,1,1
2022-08-02T10:51:17.733-04:00,2024-04-25T20:37:00.346-04:00,"Probable primary and secondary dengue viral infections and associated host factors among university undergraduates in Osun State, Nigeria",Sule,2019-01-01,8972,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,NG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,university_students,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,systematic sample of three from each geopolitical zone,no,,school,0,1,0,0,0,0,0,0,0,1,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,89,89,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_outcomes_of_seropo,1,0,0,0,0,1,0,0,1,0,0,0,0,0,,,173465655,0d608108-4983-4d34-8b41-2c234f7c9eae,2022-08-02T15:15:12,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,382,1,8972,10.1080/20905068.2019.1592935,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,2014,2019,5,8972,1,1,1
2022-08-04T14:37:49.397-04:00,2022-12-11T17:49:18.567-05:00,Prevalence of hepatitis A viral RNA and antibodies among Chinese blood donors.,Sun,2015-01-01,3395,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"serum collected from six blood centers: Suzhou, Beijing, Nanjing, Shanxi, Guangzhou, Deyang. 450 samples with elevated ALT levels and 278 samples with no elevated ALT levels",blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__other,0,0,0,0,0,0,1,0,"""All studies on human subjects were performed in accordance with the ethical standards of the committee on Human Experimentation of Red Cross Society of China""",728,728,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,173972135,e4c43fbf-5d72-48d2-8db4-6540023f63d0,2022-08-04T19:09:14,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,397,1,3395,10.4238/2015.December.9.13,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,2013,2015,2,3395,1,1,1
2022-12-12T16:50:48.276-03:00,2024-04-25T20:38:27.932-04:00,Prevalence of antibodies against seasonal influenza A and B viruses among older adults in rural Thailand: A cross-sectional study.,Suntronwong,2021-01-01,14278,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,176,176,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_cross_reactivity,1,0,0,0,0,0,0,0,0,0,1,0,0,0,,,208079517,c1a9e41c-67e0-45d0-aad7-2219ae9a123a,2022-12-13T16:09:06,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,583,1,14278,10.1371/journal.pone.0256475,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2015,2021,6,1427,1,1,1
2022-04-21T19:42:53.603-04:00,2022-12-27T12:06:16.295-07:00,"Seroprevalence estimates of SARS-CoV-2 infection in convenience sample - Oregon, May 11-June 15, 2020",Sutton,2020-01-01,5349,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients all ages ambulatory emergency or inpatient,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,898,898,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,153423709,6ec0e2cf-1bad-499d-861b-bbe5b8a77bd2,2022-04-23T22:08:27,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,32,1,5349,10.15585/MMWR.MM6932A4,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2020,0,5349,1,1,1
2022-08-23T17:20:06.998-03:00,2024-04-25T20:44:09.440-04:00,"Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.",Sykes,2021-01-01,841,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,4858,4858,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,178062083,7105192e-ebb8-4e5a-9b44-dc94f68a8a76,2022-08-23T20:29:35,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,472,1,841,10.21203/rs.3.rs-233375/v1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2021,2021,0,841,1,1,1
2022-08-09T16:00:55.181-04:00,2022-12-24T10:45:28.652-03:00,"Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy).",Tafuri,2008-01-01,3090,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Children and adolescents from 3 months to 15 years collected as a convenience sample from 6 laboratories in five of the six provinces of the region,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__other,0,0,0,0,0,0,1,0,"Because of Data Protection Act was respected, ethical approval was not required for this study",704,704,,,,,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,poliomyelitis__polio,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,176050929,400a2b15-1e12-4ae1-bdde-ba25c20ec4dc,2022-08-15T14:34:13,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,447,1,3090,10.1186/1471-2334-8-150,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2007,2008,1,3090,1,1,1
2022-12-18T07:35:42.118-03:00,2022-12-18T07:42:31.709-03:00,Pre-vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals.,Takayama,2022-01-01,14720,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,healthcare_workers,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,3677,3677,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,209048786,a949b55f-1214-44cc-8afb-e023199af88d,2022-12-18T10:42:22,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,596,1,14720,10.1272/jnms.JNMS.2022_89-511,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2022,2,1472,1,1,1
2022-06-06T21:22:36.371-04:00,2022-12-11T22:20:02.773-05:00,Anationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan,Takeda,2010-01-01,3642,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,ALT level lof 60 IU/l or lower and tested negative for current blood screening tests,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,12600,12600,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo testing_samples_multiple_times_for_the_s,0,0,0,0,0,0,1,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,161523726,ec1d1f8f-7ba0-41a8-aebc-c704d8b07f75,2022-06-07T01:40:06,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,112,1,3642,10.1111/j.1423-0410.2010.01362.x,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,2005,2010,5,3642,1,1,1
2022-08-17T16:18:16.662-03:00,2023-01-10T13:24:26.766-07:00,Force of Infection and True Infection Rate of Dengue in Singapore: Implications for Dengue Control and Management,Tan,2019-01-01,14120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,7815,7815,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,176640645,982a0c68-f476-41f0-b564-e0874284f0e7,2022-08-17T19:42:50,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,456,1,14120,10.1093/aje/kwz110,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,0,0,0,1,2013,2019,6,1412,1,1,1
2022-07-12T11:39:35.230-07:00,2022-12-16T14:59:36.477-05:00,"Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.",Tandale,2010-01-01,3691,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006 2007 2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,IN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,anonymous leftover sera from the archives referred for dengue diagnosis,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,7652,222,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,0,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,169194345,3e5698ce-a21b-4763-be01-cb2525b506dd,2022-07-12T18:54:16,,,submitted_via_web,abernas,vQteqvkE44GFbPjGfNx2An,,280,1,3691,10.1186/1471-2334-10-255,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,2005,2010,5,3691,1,1,1
2022-06-27T10:19:59.656-03:00,2024-04-25T20:29:49.742-04:00,"Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015.",Tang,2017-01-01,4041,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,convenience samples from a hospital and a serosurvey,diagnostic_sample,0,0,0,1,0,0,,yes,"9 months to 49 years, non rash patients, residing for more than 6 months in the study location of interest",yes,refuse to participate,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1070,1070,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos to_compare_the_use_of_residual to_identify_risk_factors_of_se,1,0,0,0,0,0,1,1,0,0,0,0,0,0,,,166067438,acb7a4c8-9760-49c8-821e-9a335b55003c,2022-06-27T13:35:35,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,179,1,4041,10.1016/j.vaccine.2017.04.018,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2015,2017,2,4041,1,1,1
2022-08-14T10:50:36.276-03:00,2022-12-22T09:58:16.617-03:00,Human papillomavirus seropositivity and subsequent risk of HIV acquisition in rural South African women.,Tanser,2013-01-01,2494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,ZA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV survey study,seroprevalence_study,0,0,1,0,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1049,1049,7829,fingerprick,1,0,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_outcomes_of_seropo,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,,175922387,c76a2576-1006-488f-917e-b520c7943b24,2022-08-14T21:03:29,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,446,1,2494,10.1097/OLQ.0b013e3182918578,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2010,2013,3,2494,1,1,1
2022-12-16T11:53:24.725-03:00,2022-12-16T12:27:11.669-03:00,"Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.",Tanunliong,2022-01-01,14436,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,935,935,,venous,0,1,chemiluminescence_immunoassay multiplex,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_cross_reactivity,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,208777187,ccdc67ef-57f4-4616-b21a-b597d30aa507,2022-12-16T15:27:04,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,589,1,14436,10.3389/fimmu.2022.836449,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2013,2022,9,1443,1,1,1
2022-08-04T11:48:40.651-04:00,2023-05-14T20:36:30.980-07:00,"Prevalence of antibodies to heaptitis E virus among male blood donors in Tabriz, Islamic Republic of Iran",Taremi,2007-01-01,6674,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"consecutive, voluntary, apparently healthy, male blood donors from one blood transfusion centre in Tabriz, Iran",blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,399,399,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,173925451,64879f47-8671-4831-9479-961c811fbc53,2022-08-04T15:54:09,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,394,1,6674,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,2004,2007,3,6674,1,1,1
2022-12-21T16:22:25.083-03:00,2022-12-21T16:30:19.721-03:00,"SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants",Tea,2021-01-01,16401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,807,807,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay other,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,Flow cytometry cell-based assay,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results testing_samples_multiple_times_for_the_s,0,0,1,0,0,0,0,1,0,to_describe_population_seropos to_describe_antibody_kin_vacc,1,0,0,1,0,0,0,0,0,0,0,0,0,0,,,209762480,55c3776c-8681-4f1e-9caf-c2bb4b31e511,2022-12-21T19:30:09,,,submitted_via_web,iesteban,vK5JR7f6tri3BCsuYQDPWy,,605,1,16401,10.1371/journal.pmed.1003656,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,2020,2021,1,1640,1,1,2
2022-07-06T08:34:32.085-07:00,2024-04-25T20:22:08.786-04:00,"Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.",Tharmaphornpilas,2009-01-01,3862,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,2004 hepatitis immunity study,diagnostic_sample,0,0,0,1,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,6213,6213,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles mumps rubella,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,168169673,3ac0411c-0b88-40ec-8da4-7f024795ed5a,2022-07-06T15:47:59,,,submitted_via_web,abernas,v45acXkSNUkFv8KgQJXh42,,228,1,3862,10.3329/jhpn.v27i1.3320,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,2004,2009,5,3862,3,1,1
2022-05-06T08:32:26.746-04:00,2022-12-24T11:07:12.631-03:00,Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation.,Theeten,2014-01-01,3181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Residual sera from laboratories,diagnostic_sample,0,0,0,1,0,0,,yes,aged 1-19 years,yes,excluded samples from oncology or intensive care wards as well as from patients for whom there was any other indication of an immunosuppressed condition or multiple transfusions,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2379,2379,2443,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,1,1,0,0,1,0,0,0,to_describe_population_seropos to_describe_antibody_kin_vacc to_estimate_infection_rates_or,1,0,0,1,0,1,0,0,0,0,0,0,0,0,,,155522140,6414778a-ea1f-42ef-b46a-c52de84b7275,2022-05-06T12:56:02,,,submitted_via_web,iesteban,v6R867Vmfwe669deTpEUKi,,62,1,3181,10.1017/S0950268813001064,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,2006,2014,8,3181,1,1,1
2022-04-23T19:00:23.054-04:00,2024-04-25T20:25:06.566-04:00,The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium),Thiry,2002-01-01,3945,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999 2000 2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"1-44 years, outpatients, vaccine trials participants, and medical laboratory samples",diagnostic_sample other_non_serological_survey,0,0,0,1,1,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,1968,1968,2007,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,153545701,1758feef-d054-418c-bfdb-241eee30d24b,2022-04-25T00:51:30,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,36,1,3945,10.1007/s00431-002-1053-2,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1999,2002,3,3945,1,1,2
2022-08-14T08:21:50.937-03:00,2022-12-20T22:04:53.893-05:00,Hepatitis E virus (HEV) in Scotland: evidence of recent increase in viral circulation in humans.,Thom,2018-01-01,3902,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011 2012 2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatic liver transplant recipients,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,2043,2043,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,175867789,071bf53b-fb86-441b-8eb3-40d88d3a2b65,2022-08-14T13:04:33,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,442,1,3902,10.2807/1560-7917.ES.2018.23.12.17-00174,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,2011,2018,7,3902,1,1,2
2022-08-08T18:43:27.599-03:00,2023-01-04T13:28:54.298-07:00,Seroreactivity to hepatitis E virus in areas where the disease is not endemic,Thomas,1997-01-01,6431,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors injection_drug_users msm,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,900,900,4374,venous,0,1,elisa_eia__enzyme_immunoassay epitope_blocking_assay_using_m,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,hepatitis_a hepatitis_b hepatitis_e,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,year of sample collection unknown,174709335,859f5fa3-f055-49c3-95ea-7f1cff8b623e,2022-08-08T22:09:13,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,422,1,6431,10.1128/jcm.35.5.1244-1247.1997,0,0,1,1,0,0,1,0,0,0,1,0,1,0,1,0,0,1,0,0,1,1,0,0,0,1,,1997,,6431,3,1,3
2022-07-23T14:51:38.009-07:00,2023-05-21T10:26:18.097-04:00,Exposure to hepatitis B and C of tattooists in Victoria in 1984.,Thompson,1997-01-01,2655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1984,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tattoo_artists,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,41,41,,,,,radio_immunoassay,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,171494281,cf6734ee-99a3-4a9d-88dc-2b375434f319,2022-07-23T22:00:43,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,333,1,2655,10.1111/j.1365-2893.1997.tb00216.x,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1984,1997,13,2655,1,1,1
2022-08-08T18:15:45.092-03:00,2022-12-24T10:38:49.106-03:00,Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.,Thompson,2020-01-01,3036,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,3600,3500,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,174705333,50b5db38-2923-4a9d-ba06-66d4919f928d,2022-08-08T21:32:06,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,420,1,3036,10.2807/1560-7917.ES.2020.25.42.2000685,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2020,2020,0,3036,1,1,1
2022-08-11T14:45:52.382-03:00,2023-01-04T12:12:27.114-07:00,"The prevalence of hepatitis C in patients admitted with acute hepatitis to Fairfield Infectious Diseases Hospital, 1971-1975",Thomson,1998-01-01,5943,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1971 1972 1973 1974 1975,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,hepatitis diagnosis,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1511,1511,,venous,0,1,radio_immunoassay,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,175376452,2f0c2ab3-1582-4d4a-bb53-cc66e5a3407f,2022-08-11T18:17:48,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,433,1,5943,10.5694/j.1326-5377.1998.tb126803.x,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1971,1998,27,5943,1,1,1
2022-08-04T15:09:04.146-04:00,2022-12-23T08:46:18.825-03:00,Probable transmission of hepatitis E virus (HEV) via transfusion in the United States.,Ticehurst,2019-01-01,2677,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000 2001 2002 2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors plasma_donors,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation plasma_donation,1,1,0,0,0,0,,yes,"paired samples from RADAR repository, collected before or immediately after transfusion AND 6-12 months later",yes,unavailability of post-transfusion sample (pre-transfusion samples were collected first),blood_donation_site plasma_donation_site,0,0,0,1,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,3384,3384,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,weighted_final_results compared_to_other_published_estimates__d,0,0,0,1,0,1,0,0,0,to_evaluate_the_need_for_blood,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,173988979,850ae282-1eef-43c2-89fa-2d2494fb399c,2022-08-04T20:55:18,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,398,1,2677,10.1111/trf.15140,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,1,2000,2019,19,2677,1,1,1
2022-12-22T17:40:22.462-03:00,2022-12-22T17:51:47.030-03:00,Serological Evidence of Zika Virus Circulation in Burkina Faso.,Tinto,2022-01-01,14744,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,BF,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con,1,0,0,1,0,0,0,0,,501,501,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,209966337,8e83c41b-6090-4226-a0ff-b2575d83e004,2022-12-22T20:51:38,,,submitted_via_web,iesteban,vJzTYFwzQYR9pFHSy55TD3,,611,1,14744,10.3390/pathogens11070741,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2021,2022,1,1474,1,1,1
2022-08-08T18:31:55.784-03:00,2022-12-24T11:03:18.511-03:00,Hepatitis B virus infection among pregnant women in Haiti: A cross-sectional serosurvey.,Tohme,2016-01-01,3157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,HT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study diagnostic_sample,0,0,1,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1364,1364,6241,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,174706959,dbb34c98-9317-4ec7-8465-33808fc749ad,2022-08-08T21:43:38,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,421,1,3157,10.1016/j.jcv.2016.01.012,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2012,2016,4,3157,1,1,1
2022-08-25T12:54:49.851-04:00,2022-12-05T17:06:25.256-05:00,Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia.,Toyoda,2008-01-01,3322,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with hemophilia (A and B),diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,80,80,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,178636431,258ef731-70fb-4f50-bdcf-789e0e2ab623,2022-08-25T17:08:14,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,474,1,3322,10.1159/000118792,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2003,2008,5,3322,1,1,1
2022-06-24T17:22:12.517-03:00,2022-12-21T13:34:18.140-05:00,Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.,Traoré,2012-01-01,3971,2010 2011 2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,2010 2011 2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,BF,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,367,367,,venous,0,1,elisa_eia__enzyme_immunoassay rapid_test_igg_lateral_flow,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_e,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,165611955,ffa9ab6a-a82f-4400-aa2a-aab121451311,2022-06-24T20:40:19,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,175,1,3971,10.1371/journal.pone.0048125,0,0,1,0,0,0,1,0,1,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2010,2012,2,3971,2,1,2
2022-08-11T17:33:14.304-03:00,2022-12-05T21:48:32.928-05:00,"Seroepidemiology of hepatitis B, C and delta viruses in Tunisia.",Triki,1997-01-01,3433,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,The individuals over 18 -years old were blood donors; those under 18 years were children who attended hospital for surgical purposes,blood_donation diagnostic_sample,1,0,0,1,0,0,,no,,no,,blood_donation_site diagnostic_center_laboratory,0,0,0,1,0,1,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,33363,785,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,Year of sample collection is unknown,175403449,3b915eac-2875-423f-9b47-b6f7fbd23bc5,2022-08-11T20:45:43,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,437,1,3433,10.1016/s0035-9203(97)90374-6,0,0,0,1,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,,1997,,3433,1,1,2
2022-08-11T17:45:31.921-03:00,2022-12-11T17:39:07.750-05:00,Hepatitis E virus infection in selected Brazilian populations.,Trinta,2001-01-01,3358,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994 1995 1996 1997 1998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors patient_population school_children injection_drug_users,0,1,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,Hemodialysis patient,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,1175,1175,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_e,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,175848370,f7838b99-018f-49d5-b850-c784ce0d4d4c,2022-08-14T10:37:29,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,438,1,3358,10.1590/s0074-02762001000100004,0,0,1,0,0,0,1,1,1,0,0,1,1,0,1,0,0,1,0,0,1,0,0,0,0,0,1994,2001,7,3358,2,1,5
2022-08-05T07:06:08.554-03:00,2022-12-06T13:17:54.674-07:00,Influenza D Virus: Serological Evidence in the Italian Population from 2005 to 2017.,Trombetta,2019-01-01,4118,2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,not_specified,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,,other,0,0,0,0,0,1,uknown,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,1281,1281,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,174106033,c916bbee-b838-45f7-8183-121cf169f679,2022-08-05T12:48:15,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,401,1,4118,10.3390/v12010030,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,2005,2019,14,4118,1,1,1
2022-08-25T13:08:05.360-04:00,2023-05-21T10:29:45.231-04:00,Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004,Trombetta,2022-01-01,15718,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,other,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,veterinarians,,seroprevalence_study,0,0,1,0,0,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,no,0,0,0,0,0,0,0,1,,82,82,82,,,,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,209127847,4c2a3700-5d0c-45c1-8427-19a1e7b74716,2022-12-18T23:44:43,,,submitted_via_web,abernas,vK3ffTk4xKTo25GWqMwoxw,,599,1,15718,10.1002/jmv.27466,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2004,2022,18,1571,1,1,1
2022-05-18T15:53:35.624-04:00,2023-02-09T10:34:14.184-05:00,A seroepidemiology study of varicella among children aged 0-12 years in Taiwan.,Tseng,2005-01-01,3528,2005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,TW,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,yes,0-12 years,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,no,0,0,0,0,0,0,0,1,,1401,1401,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,157810883,433f3a33-be04-49a6-b046-9139a6de0d81,2022-05-18T20:06:13,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,101,1,3528,,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2003,2005,2,3528,1,1,1
2022-08-07T09:17:39.688-03:00,2023-01-15T12:08:09.868-08:00,High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa.,Tso,2021-01-01,2186,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017 2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,TZ ZM,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,289,204,,venous,0,1,radio_immunoassay,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,did_not_account_for_bias_none_of_the_abo,0,0,0,0,0,0,1,0,0,to_describe_population_seropos to_describe_cross_reactivity to_compare_population_seroposi,1,0,0,0,0,0,0,0,0,0,1,0,1,0,,,174427641,38e16ece-ef68-4fa8-9ee7-565c2ff002b5,2022-08-07T12:28:44,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,408,1,2186,10.1016/j.ijid.2020.10.104,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,2017,2021,4,2186,1,2,1
2022-05-19T21:00:28.561-04:00,2022-12-23T11:01:37.778-03:00,Hepatitis E virus infection in Hong Kong blood donors.,Tsoi,2020-01-01,2848,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,HK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2000,2000,10000,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,158058620,99e21d10-187f-4ee2-8bb7-9b4bff9fe299,2022-05-20T01:11:13,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,106,1,2848,10.1111/vox.12846,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2015,2020,5,2848,1,1,1
2022-12-18T07:51:50.207-03:00,2022-12-18T07:58:40.159-03:00,"Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays.",Tuite,2022-01-01,14477,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,17999,17999,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,209051028,c4a36297-2098-4e83-8762-26ffa949027c,2022-12-18T10:58:31,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,598,1,14477,10.1128/spectrum.02563-21,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,1,2020,2022,2,1447,1,1,1
2022-12-16T11:14:38.919-03:00,2023-07-05T15:28:54.645-07:00,Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.,Tunheim,2021-01-01,14517,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza surveillance,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,4840,4840,,venous,0,1,other,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,flow cytometry assay,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,0,0,1,0,0,0,0,,,208764177,0fca19fe-8094-4972-a001-4ec495044cb5,2022-12-16T14:26:48,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,586,1,14517,10.1111/irv.12932,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,2019,2021,2,1451,1,1,1
2022-12-13T13:46:42.849-03:00,2022-12-16T11:14:38.807-03:00,"Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.",Tunheim,2022-01-01,14635,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,NO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,Three samples were excluded due to antibody profiles indicating previous treatment with immunoglobulins,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,1926,1926,,venous,0,1,elisa_eia__enzyme_immunoassay other,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,flow cytometry assay,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,208761454,3c0f4b75-fbe9-4bb7-ae17-5d6d4a2a76ec,2022-12-16T14:14:21,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,585,1,14635,10.1111/irv.13024,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,1,0,1,1,0,0,0,0,2021,2022,1,1463,1,1,1
2022-08-17T14:37:50.127-03:00,2022-12-21T13:16:04.654-05:00,Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation.,Unzueta,2016-01-01,3961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,candidates for kidney and heart transplantation,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,333,333,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,176617113,06fd01df-95bc-4410-96f5-2448dc83aa85,2022-08-17T17:52:52,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,451,1,3961,10.5604/16652681.1184202,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2011,2016,5,3961,1,1,1
2022-08-08T18:01:12.811-03:00,2022-12-11T22:07:53.270-05:00,Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.,Uyoga,2021-01-01,3618,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,KE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,Aged 15-66 years,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3098,3098,3174,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,174702931,f1c7e067-a388-4b8e-bfdb-a1aff9e51a90,2022-08-08T21:15:56,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,419,1,3618,10.1126/science.abe1916,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2020,2021,1,3618,1,1,1
2022-06-17T10:03:24.811-03:00,2022-12-26T17:01:29.385-03:00,SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.,Valenti,2021-01-01,3302,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,IT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,yes,"healthy subjects, aged 18-70 years",yes,"active infection or other  active medical conditions, recent surgical procedures,  trips to areas with endemic infective diseases, reported  risk factors for parenterally acquired infections, chronic  degenerative conditions (except for those with stable  arterial hypertension), type 2 diabetes or dyslipidaemia  under control with changes in lifestyle or pharmacological  therapy, diagnosis of cancer or high risk of cardiovascular  events",blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,973,789,3580,venous,0,1,rapid_test_igg_lateral_flow,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th weighted_final_results compared_to_other_published_estimates__d,1,1,0,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,163830802,f3c248a3-d194-4756-9e0c-196ebb002f3a,2022-06-17T13:21:06,,,submitted_via_web,iesteban,vi8ujSt4tdYVZ6Wbycvi9H,,136,1,3302,10.2450/2021.0324-20,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,1,0,1,0,0,0,0,1,2020,2021,1,3302,1,1,1
2022-07-07T14:35:00.040-07:00,2022-12-22T11:56:08.757-03:00,Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites.,Van Doornum,2003-01-01,2544,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Samples from the Antoni van Leeuwenhoek Hospital and Netherlands Cancer Institute serum bank (cancer specimens) and Slotervaart hospital serum bank (controls),diagnostic_sample,0,0,0,1,0,0,,yes,"site of the cancer: penis, cervix, vagina, the upper aerodigestive tract (larynx, oropharynx, tongue, oesophagus and stomach",no,,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,706,706,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,1,1,0,1,0,to_describe_seroprevalence_amo to_evaluate_outcomes_of_seropo,0,1,0,0,0,0,0,0,1,0,0,0,0,0,,,168486242,d95bcbf8-ea8d-4d98-ba0d-202030bde14a,2022-07-07T21:47:21,,,submitted_via_web,abernas,v45acXkSNUkFv8KgQJXh42,,251,1,2544,10.1038/sj.bjc.6600870,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,1,0,0,0,0,1989,2003,14,2544,1,1,1
2022-12-16T15:51:09.516-03:00,2024-04-25T20:39:26.630-04:00,"COVID-19 Antibody Detecting Rapid Diagnostic Tests Show High Cross-Reactivity When Challenged with Pre-Pandemic Malaria, Schistosomiasis and Dengue Samples.",Vanroye,2021-01-01,14697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011 2012 2013 2014 2015 2016 2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,0,0,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,travelers,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,220,220,,venous,0,1,rapid_test_igg_lateral_flow,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_cross_reactivity,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,208816075,94810834-8d95-4006-ab97-800472a6915f,2022-12-16T19:00:00,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,592,1,14697,10.3390/diagnostics11071163,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,2010,2021,11,1469,1,1,1
2022-08-23T16:06:18.853-03:00,2022-12-24T10:42:39.365-03:00,Hepatitis B and C prevalences among blood donors in the south region of Brazil.,Vasconcelos,1994-01-01,3060,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1991,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,no,0,0,0,0,0,0,0,1,,5000,5000,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,178060494,9b38dc17-f373-482c-8e9d-1b25ba0c4e16,2022-08-23T20:20:18,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,471,1,3060,10.1590/s0074-02761994000400002,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,1991,1994,3,3060,1,1,1
2022-12-21T16:08:18.110-03:00,2022-12-21T16:16:08.982-03:00,Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity In US Blood Donors.,Vassallo,2021-01-01,14181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,523068,523068,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,0,1,0,0,0,0,,,209759963,24e44857-e1a1-4416-ae17-da073c7f3b66,2022-12-21T19:15:59,,,submitted_via_web,iesteban,vK5JR7f6tri3BCsuYQDPWy,,603,1,14181,10.1016/j.tmrv.2021.07.003,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,2020,2021,1,1418,1,1,1
2022-05-03T10:38:49.809-04:00,2022-12-20T09:16:07.149-07:00,A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.,Veguilla,2016-01-01,4239,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,MX,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors patient_population,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation diagnostic_sample,1,0,0,1,0,0,,unknown,,unknown,,hospital_clinic blood_donation_site,0,0,1,1,0,0,0,0,0,0,,blood_bank diagnostic_center_laboratory,0,0,1,1,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,2096,1484,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,155158850,173b942a-0c18-467a-b456-926492606306,2022-05-03T23:40:02,,,submitted_via_web,iesteban,vXP8MZVdLZrBVtRGEEHtVx,,52,1,4239,10.1371/journal.pone.0150428,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2010,2016,6,4239,1,1,2
2022-08-09T15:20:36.241-04:00,2022-12-20T09:34:19.552-07:00,Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)-Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination Schedule,Veit,2018-01-01,4388,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,other,SHCS,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,HIV-infected patients,diagnostic_sample,0,0,0,1,0,0,,yes,SHCS participants >18 years of age who had received the YFV,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,247,247,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,yellow_fever,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc,0,1,0,1,0,0,0,0,0,0,0,0,0,0,,,174908748,6ff59f0c-d230-4739-8258-b1e69e8bf778,2022-08-09T19:39:00,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,430,1,4388,10.1093/cid/cix960,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1989,2018,29,4388,1,1,1
2022-08-09T10:21:19.501-04:00,2023-07-18T13:53:32.676-04:00,Hepatitis E virus prevalence in Flemish blood donors,Vercouter,2019-01-01,9267,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,BE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Flanders Red Cross,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,38137,38137,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_the_need_for_blood,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,,174841097,836d9f74-8d82-40ed-911b-e9fc17d1f92e,2022-08-09T14:27:59,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,424,1,9267,10.1111/jvh.13161,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,2015,2019,4,9267,1,1,1
2022-12-16T16:05:02.679-03:00,2022-12-18T07:29:00.089-03:00,Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey.,Vette,2022-01-01,14616,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women blood_donors patient_population,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,yes,Self-reported COVID-19 o sample submitted for its testing,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__received_waiver_on_re_con yes__samples_de_identified,1,0,0,1,1,0,0,0,,11317,11317,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,1,1,1,1,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,209047035,fabd29d2-86e8-4d73-9575-bad26f3f671b,2022-12-18T10:28:53,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,594,1,14616,10.1093/ofid/ofac002,1,0,0,0,0,0,1,1,1,0,0,0,0,0,0,1,1,1,1,0,1,0,0,0,0,0,2020,2022,2,1461,1,1,3
2022-12-19T10:51:59.795-05:00,2024-04-25T19:58:40.616-04:00,Seroepidemiology of hepatitis a in the croatian population,Vilibic-Cavlek,2011-01-01,1071,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008 2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,HR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pregnant_women patient_population,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Hospitalized patients: preoperative check-up (cardiac surgery, renal transplant program) and non-hospitalized patients comin in for routine testing (physical exam, needle stick injury, patient contacts, lymphatic disorders) with no symptoms of acute hepatitis",diagnostic_sample,0,0,0,1,0,0,,no,,yes,chronic liver diseases,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,791,791,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,215384499,23a6562a-e2e2-4bcb-bfc8-be8c6791c3e9,2023-01-26T15:00:05,,,submitted_via_web,abernas,vJzTYFwzQYR9pFHSy55TD3,,615,1,1071,10.5812/kowsar.1735143X.756,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2008,2011,3,1071,1,1,2
2022-12-18T07:29:00.154-03:00,2022-12-18T07:35:42.039-03:00,Age-seroprevalence curves for the multi-strain structure of influenza A virus.,Vinh,2021-01-01,14167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010 2011 2012 2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,0,0,0,0,0,0,0,VN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,yes,samples taken <6 months,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,24402,24402,35688,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results,0,0,1,0,0,0,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,209047844,90e3919c-5d44-440f-9a83-4d8953cd4244,2022-12-18T10:35:33,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,595,1,14167,10.1038/s41467-021-26948-8,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2009,2021,12,1416,1,1,1
2022-08-09T10:35:44.216-04:00,2022-12-20T08:48:07.144-07:00,Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults.,Vyse,2004-01-01,4201,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,anonymized residues of specimens submitted for microbiological or biochemical testing from persons aged 1-20,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified,0,0,0,0,1,0,0,0,,2091,2091,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,acknowledged_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,174845374,da224bee-530a-4091-a0f0-82044deac6fb,2022-08-09T14:43:39,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,426,1,4201,10.1017/s0950268804003140,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1996,2004,8,4201,1,1,1
2022-12-18T18:55:30.159-05:00,2024-04-25T20:45:37.907-04:00,Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry,Wachter,2022-01-01,14485,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020 2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,pediatric patients aged 0-17,diagnostic_sample,0,0,0,1,0,0,,no,,yes,samples without enough residual blood; patients with numerous blood samples only had one sample used for analysis,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2626,2626,,,,,neutralization_test elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_seroprevalence_amo to_estimate_infection_rates_or,1,1,0,0,0,1,0,0,0,0,0,0,0,0,,,209128650,1dffbb32-26df-461c-81d3-4794518419c6,2022-12-19T00:13:59,,,submitted_via_web,abernas,vK5JR7f6tri3BCsuYQDPWy,,600,1,14485,10.1515/cclm-2022-0037,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2020,2022,2,1448,1,1,1
2022-07-12T13:56:12.341-07:00,2022-12-21T21:33:53.845-05:00,Immunity to tetanus and diphtheria in the UK in 2009.,Wagner,2012-01-01,4027,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,hpa_serosurveillance_seroepide,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,routine diagnostic testing representing the entire ranges of age and most geographical regions of the population of England,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,2697,2697,,venous,0,1,elisa_eia__enzyme_immunoassay fluorescent_immunoassay,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,,diptheria tetanus,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_subsampling compared_to_other_published_estimates__d,1,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,169216384,d72caef6-d3c7-43ae-8009-043ee931eeb7,2022-07-12T21:04:19,,,submitted_via_web,abernas,vQteqvkE44GFbPjGfNx2An,,283,1,4027,10.1016/j.vaccine.2012.09.029,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2009,2012,3,4027,2,1,1
2022-07-07T14:56:30.729-07:00,2023-01-08T10:14:27.951-08:00,Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya.,Wahome,2017-01-01,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005 2006 2007 2008 2009 2010 2011 2012 2013 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,KE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,msm,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,HIV-1 vaccine feasibility cohort study,seroprevalence_study,0,0,1,0,0,0,,yes,all HIV-1 negative MSM aged 18-49 years male cohort participants who reported anal sex with another man in the 3 months before enrollment and had stored blood samples available from enrollment and at least 1 follow-up visit from December 2014,yes,Visits after documented HBV vaccination were excluded,unknown,0,0,0,0,0,0,0,0,1,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,312,312,908,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,1,1,1,0,1,0,1,0,to_describe_seroprevalence_amo to_estimate_infection_rates_or to_identify_risk_factors_of_se,0,1,0,0,0,1,0,1,0,0,0,0,0,0,,,168489094,4436b313-7e8b-4cb5-961e-98c3509c50b1,2022-07-07T22:13:38,,,submitted_via_web,abernas,v45acXkSNUkFv8KgQJXh42,,252,1,250,10.1093/ofid/ofw253,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,1,1,0,1,1,0,0,0,0,2005,2017,12,250,1,1,1
2022-08-05T14:15:42.651-04:00,2023-01-14T16:10:48.652-08:00,SARS-CoV-2 Antibody Seroprevalence Among Maintenance Dialysis Patients in the United States.,Walker,2021-01-01,1721,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,routine laboratory screenings of maintenance dialysis patients,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified yes__exempt_as_public_health_s,1,0,0,0,1,1,0,0,,12932,12932,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,174179330,c20fb859-ab56-44bb-9d9f-f5b036e34af4,2022-08-05T18:29:08,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,404,1,1721,10.1016/j.xkme.2021.01.002,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2020,2021,1,1721,1,1,1
2022-08-08T15:47:16.633-03:00,2022-12-11T21:54:12.528-05:00,The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China,Wang,2017-01-01,3561,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,study included 4046 samples that were negative for all routinely screened markers and 5023 samples from donations that were deferred only because of isolated elevated ALT,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,9069,9069,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_evaluate_the_need_for_blood to_identify_risk_factors_of_se,0,0,1,0,0,0,0,1,0,0,0,0,0,0,,year of sample collection is unknown,174682178,3f7ba5e9-2d15-4ead-bd4e-a78a5189adf0,2022-08-08T18:59:59,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,415,1,3561,10.1111/trf.13991,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,,2017,,3561,1,1,1
2022-06-24T16:58:03.653-03:00,2022-12-16T15:29:05.926-05:00,"Serologic assay for avian-origin influenza A (H7N9) virus in adults of Shanghai, Guangzhou and Yunnan, China.",Wang,2014-01-01,3711,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,outpatients from 3 hospitals,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,"respiratory infectious disease, history of influenza vaccination",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,900,900,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,165609310,737f8b73-7eca-4c28-9c7a-27ea88442d55,2022-06-24T20:22:23,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,174,1,3711,10.1016/j.jcv.2014.04.006,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,0,2011,2014,3,3711,1,1,1
2022-08-03T16:24:23.068-03:00,2024-04-25T20:25:49.806-04:00,Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.,Wang,2015-01-01,3964,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IN US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population patient_population,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample other_non_serological_survey,0,0,0,1,1,0,,unknown,,unknown,,household diagnostic_center_laboratory,1,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1078,1078,,venous,0,1,neutralization_test elisa_eia__enzyme_immunoassay immunoblot__western_blot,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_seroprevalence_amo,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,year of sample collection is uknown,173756452,324caa0e-10c0-47c9-8f8e-3a449c929eec,2022-08-03T20:42:27,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,389,1,3964,10.1128/CVI.00799-14,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,,2015,,3964,1,2,2
2022-04-21T19:25:58.859-04:00,2022-12-21T22:14:05.582-05:00,Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey.,Wanlapakorn,2019-01-01,4085,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,TH,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,6 mo - 71 years. Participants were healthy children attending scheduled pediatric health check-ups or people visiting outpatient clinics at provincial hospitals.,diagnostic_sample,0,0,0,1,0,0,,yes,age between 6 months and 60 years (original study inclusion criteria),yes,"no immunological disorders such as AIDS (acquired immunodeficiency syndrome), malignancy, or severe hematologic disorder; and no history of other chronic diseases",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1781,1781,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles rubella,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,Thailand cross sectional serosurvey.,153138555,de8e751e-4471-4ad6-a0ad-7ef8ce0b36d7,2022-04-21T23:43:04,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,31,1,4085,10.1371/journal.pone.0225606,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2014,2019,5,4085,2,1,1
2022-08-07T08:55:28.510-03:00,2023-01-08T17:41:18.082-08:00,Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries.,Wehlin,2021-01-01,1044,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,BE DK FI GR HU IT LT MT NO PL PT RO ES SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,yes,samples should not have been collected for reasons related to the diagnosis of respiratory illnesses,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__samples_de_identified yes__exempt_as_public_health_s,0,0,0,0,1,1,0,0,,7903,7903,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,1,1,1,0,1,0,1,0,to_describe_population_seropos to_compare_population_seroposi,1,0,0,0,0,0,0,0,0,0,0,0,1,0,,,174425947,08d24169-2a35-4c39-aa5c-7156735e232e,2022-08-07T12:17:51,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,407,1,1044,10.1111/apm.13165,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1,0,1,1,0,0,0,0,2010,2021,11,1044,1,14,1
2022-08-17T14:52:41.311-03:00,2023-01-14T16:21:33.025-08:00,Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors.,Weidner,2021-01-01,1952,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,AT,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex epi_data_not_on_vpd_of_interest__e_g__hi,1,0,0,1,0,yes__broad_consent_given_at_ti yes__samples_de_identified,0,1,0,0,1,0,0,0,,20228,20228,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_the_need_for_blood to_identify_risk_factors_of_se,1,0,1,0,0,0,0,1,0,0,0,0,0,0,,,176620452,eb5d6b9e-7be2-4859-9d81-657a4976b29a,2022-08-17T18:06:51,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,452,1,1952,10.1007/s15010-021-01639-0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2020,2021,1,1952,1,1,1
2022-06-28T10:14:10.217-03:00,2023-01-05T10:49:15.367-07:00,"Decline in hepatitis E virus antibody prevalence in southeastern Germany, 1996-2011",Wenzel,2014-01-01,7847,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1996 2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,repeated samples,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,no,0,0,0,0,0,0,0,1,,2184,2184,,venous,0,1,elisa_eia__enzyme_immunoassay immunoblot__western_blot,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,0,1,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,166312271,996882a7-44a3-40de-b772-333b15d27709,2022-06-28T13:26:45,,,submitted_via_web,iesteban,vfKd95G3F2xaB5obwFzk3r,,185,1,7847,10.1002/hep.27244,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,1,0,0,0,0,1996,2014,18,7847,1,1,1
2022-12-18T19:13:50.138-05:00,2024-04-25T20:39:59.002-04:00,Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups,Whitaker,2022-01-01,15777,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,other,Oxford- Royal College of General Practitioners Research and Surveillance Centre (UK),no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,registered patients from 718 English general practices; oversampling from older age groups and clinical risk groups to match rollout of the vaciination program,diagnostic_sample,0,0,0,1,0,0,,no,,yes,Full exclusion criteria in supplemental materials: not registered with GP before study start; practices for which <50% 65+ yr olds have record of COVID-19 vaccination; aged <16; certain date restrictions regarding timing of vaccinations; age caps; vaccine brand unknown/not routinely used in England,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,0,1,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,5591142,5591142,,venous,0,1,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,1,1,0,0,0,1,0,1,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc,0,1,0,1,0,0,0,0,0,0,0,0,0,0,,,209274500,47d3e860-51ef-4d75-921d-0248df469099,2022-12-19T15:52:08,,,submitted_via_web,abernas,vK5JR7f6tri3BCsuYQDPWy,,601,1,15777,10.1016/j.jinf.2021.12.044,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,1,1,0,0,0,0,2021,2022,1,1577,1,1,1
2022-12-16T12:27:11.820-03:00,2024-04-25T20:37:45.582-04:00,Severe chickenpox disease and seroprevalence in Sweden - implications for general vaccination.,Widgren,2021-01-01,14211,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,SE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,957,957,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,208814290,190a4bdf-bec4-4b76-b9d2-fc1a4ec27b75,2022-12-16T18:45:17,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,590,1,14211,10.1016/j.ijid.2021.08.012,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2011,2021,10,1421,1,1,1
2022-08-03T17:55:50.849-03:00,2022-12-21T21:59:14.156-05:00,"Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.",Wiese-Posselt,2017-01-01,4061,2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,2003 2004 2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,DE,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,kiggs,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Aged 1-17 years,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,13433,13433,,venous,0,1,elisa_eia__enzyme_immunoassay fluorescent_antibody_to_membra,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,,varicella_herpes_zoster,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,173764253,09ab8231-fbb0-48ba-bc74-ddabbafd094d,2022-08-03T21:37:53,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,391,1,4061,10.1186/s12879-017-2461-2,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,2003,2017,14,4061,1,1,1
2022-06-07T14:05:47.395-04:00,2023-01-08T17:34:05.343-08:00,The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations,Wong,2021-01-01,940,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,MY,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1003,1003,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d,0,0,1,0,1,1,0,0,0,to_evaluate_the_need_for_blood to_identify_risk_factors_of_se,0,0,1,0,0,0,0,1,0,0,0,0,0,0,,,162405204,1c5202a0-7b2d-4cee-a964-03fcf49398db,2022-06-10T16:59:30,,,submitted_via_web,abernas,vi2DwcDjaJ6wcVBLuKqpCk,,116,1,940,10.1007/s12288-021-01428-7,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,2017,2021,4,940,1,1,1
2022-08-07T09:28:32.924-03:00,2023-01-04T12:19:17.815-07:00,Incidence of pertussis infection in healthcare workers.,Wright,1999-01-01,6071,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1992 1993 1994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,healthcare_workers,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,residents and ED personnel,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,hospital_clinic diagnostic_center_laboratory,0,1,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,145,145,350,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,pertussis,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,174673742,3ae36b3c-27db-4be2-9c72-c9b037f17b03,2022-08-08T18:18:24,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,412,1,6071,,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1992,1999,7,6071,1,1,1
2022-07-22T17:05:40.461-07:00,2022-12-14T21:25:34.301-07:00,Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data.,Wu,2011-01-01,4179,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009 2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,HK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population blood_donors patient_population,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"blood donors (aged 16-59y o), hospital outpatients (aged 5-90 y o), and participants of a community pediatric cohort study (aged 5-14 y o)",blood_donation diagnostic_sample other_non_serological_survey,1,0,0,1,1,0,,no,,unknown,,hospital_clinic blood_donation_site diagnostic_center_laboratory,0,0,1,1,0,1,0,0,0,0,,hospital_clinic blood_bank diagnostic_center_laboratory,0,1,1,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,14766,14766,,venous,0,1,neutralization_test,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,compared_it_to_alternative_data_source_f compared_to_other_published_estimates__d,0,0,0,0,1,1,0,0,0,to_estimate_infection_rates_or,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,171338254,8614d1b7-bd75-49f7-b616-ed6fc075e897,2022-07-23T00:30:27,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,329,1,4179,10.1371/journal.pmed.1001103,1,0,0,0,0,1,1,1,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,1,2009,2011,2,4179,1,1,3
2022-12-16T11:26:55.984-03:00,2022-12-16T11:39:58.311-03:00,"Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020.",Xiao,2021-01-01,14717,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,excluded those that were submitted for autoimmune or cancer screening,hospital_clinic diagnostic_center_laboratory,0,0,1,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,14629,14629,,venous,0,1,neutralization_test chemiluminescence_immunoassay,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results,1,1,1,0,0,0,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,208767135,0cd27675-a098-42fd-9db7-ffdd4e80de41,2022-12-16T14:39:50,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,587,1,14717,10.3390/pathogens10111505,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,2020,2021,1,1471,1,1,1
2022-03-02T08:00:30.111-05:00,2022-12-20T09:09:26.500-07:00,An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients.,Xu,2013-01-01,4216,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006 2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,none,0,0,0,0,1,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,2301,2301,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,0,0,0,1,0,1,0,to_evaluate_the_need_for_blood,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,144372932,de772698-9254-4daa-ade3-5bd92a10c58b,2022-03-02T13:16:35,,,submitted_via_web,iesteban,vpQrgGPTK7VgMoGYycNBPf,,17,1,4216,10.1111/trf.12326,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,2006,2013,7,4216,1,1,1
2022-08-02T15:56:23.957-03:00,2022-12-21T21:43:25.421-05:00,HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits.,Yaar,2019-01-01,4040,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2014 2015 2016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,TR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,unknown,,unknown,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,2011,2011,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,173532490,06f2b31d-6a49-4b0d-8653-49d180b35714,2022-08-02T20:47:34,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,385,1,4040,10.1002/jmv.25567,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2014,2019,5,4040,1,1,1
2022-08-09T11:09:32.357-04:00,2022-12-21T21:52:15.170-05:00,Very low prevalence of anti-HAV in Japan: high potential for future outbreak,Yamamoto,2019-01-01,4047,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014 2015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,JP,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,Stocked serum samples from residents' and employees' annual health check-ups in Hiroshima,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,1200,1200,7682,,,,chemiluminescence_immunoassay,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,174852116,e8fb5fc4-b386-4a87-b670-e5416c186447,2022-08-09T15:17:16,,,submitted_via_web,abernas,v3TqcHtG6WvcGn92mwZbUP,,428,1,4047,10.1038/s41598-018-37349-1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2013,2019,6,4047,1,1,1
2022-08-02T17:47:23.775-03:00,2022-12-16T15:33:34.260-05:00,"Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014.",Yan,2019-01-01,3718,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006 2014,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,samples from 2 hepatis b serosurveys,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,household,1,0,0,0,0,0,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,11777,11777,13129,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,1,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,173534785,9781b19d-c905-4f20-8c22-b30f6f86fd20,2022-08-02T21:04:54,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,386,1,3718,10.1016/j.ijid.2019.03.005,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,2006,2019,13,3718,1,1,1
2022-07-12T14:18:04.109-07:00,2024-04-25T20:23:58.403-04:00,Seroepidemiology of dengue virus infection among adults in Singapore.,Yew,2009-01-01,3883,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,SG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,yes,singapore,,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,national cross-sectional survey,other_non_serological_survey,0,0,0,0,1,0,,no,,no,,unknown,0,0,0,0,0,0,0,0,1,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,4152,4152,,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,dengue,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se,1,0,0,0,0,1,0,1,0,0,0,0,0,0,,,169219594,5c0dd220-564a-41c5-8717-42265e9d02ad,2022-07-12T21:36:51,,,submitted_via_web,abernas,vQteqvkE44GFbPjGfNx2An,,285,1,3883,,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2004,2009,5,3883,1,1,1
2022-04-23T18:44:48.379-04:00,2022-12-16T15:36:02.293-05:00,"Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan.",Younas,2020-01-01,3719,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2019 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,PK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,healthy blood donors,blood_donation,1,0,0,0,0,0,,no,,yes,"fever and any respiratory  symptoms for at least 28 days,  history of COVID-19  infection, donors having close contact with other COVID-19 patientsdonors having positive screening for hepatitis B, hepatitis C, HIV,  syphilis or malaria.",blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,380,380,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,0,0,0,1,0,1,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,153425981,eae85259-4a96-4ac3-8030-ecb3d34542d7,2022-04-23T23:00:33,,,submitted_via_web,iesteban,vKUtNt9DSXAhiWp2SpRobN,,35,1,3719,10.1016/j.transci.2020.102923,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,0,1,1,0,0,0,1,2019,2020,1,3719,1,1,1
2022-08-23T15:26:29.382-03:00,2024-04-25T20:45:16.711-04:00,Hepatitis A virus antibodies in Australian blood donors: implications for immunoglobulin sufficiency.,Young,2015-01-01,2167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,AU,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,2109,2109,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results weighted_final_results compared_to_other_published_estimates__d,0,0,1,1,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,178033014,f6b6b4f7-88ac-4610-9a54-8c77d71be024,2022-08-23T18:39:12,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,469,1,2167,10.1016/j.vaccine.2015.08.003,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,1,2011,2015,4,2167,1,1,1
2022-07-12T14:36:40.459-07:00,2023-01-04T13:43:49.649-07:00,Concurrence of hepatitis B surface antibodies and surface antigen: Implications for postvaccination control of health care workers,Zaaijer,2002-01-01,6767,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1991 1992 1993 1994 1995 1996 1997 1998 1999 2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"samples submitted to CLB-Sanquin, the former Central Laboratory of the Netherlands Red Cross Blood Transfusion Service",diagnostic_sample,0,0,0,1,0,0,,yes,positive test results for HBsAg and anti-HBs,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,no,0,0,0,0,0,0,0,1,,14,14,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,170636270,85af2509-444e-4551-a200-63396ba373fd,2022-07-19T22:13:27,,,submitted_via_web,abernas,vRhpsSejRy2CZXdamdVt7q,,319,1,6767,10.1046/j.1365-2893.2002.00342.x,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1991,2002,11,6767,1,1,1
2022-08-23T14:27:55.207-03:00,2022-12-21T22:22:13.182-05:00,Reevaluating immunization delays after red blood cell transfusion.,Zabeida,2019-01-01,4087,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"Inclusion criteria (n = 50) were being 1 to 18 years old; having a hematologic disease such as sickle cell disease, Blackfan-Diamond anemia, -thalassemia major, or pyruvate kinase deficiency; requiring chronic RBC transfusions at the time at which they received the MMR vaccines; and receiving two doses of the MMR vaccine before the precautionary time frame indicated by the American and Canadian guidelines.",diagnostic_sample,0,0,0,1,0,0,,no,,yes,"Exclusion criteria were being younger than 1 year of age, receiving only one or neither of the MMR vaccine doses, not being transfused within 6 months preceding MMR vaccination, receiving plasma or PLTs within 7 months preceding vaccination or serology sampling, receiving nonspecific IVIGs within 11 months preceding vaccination or serology sampling, receiving a stem cell transplant, receiving a transfusion with washed RBCs, having a known immune deficiency, or allergy to a vaccine component",hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,25,25,50,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles mumps rubella,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th compared_to_other_published_estimates__d,0,1,0,0,0,1,0,0,0,to_describe_seroprevalence_amo to_describe_antibody_kin_vacc,0,1,0,1,0,0,0,0,0,0,0,0,0,0,,year of sample collection is unknown,178017152,52b4e50d-d7c0-4042-b983-0371f699436d,2022-08-23T17:43:31,,,submitted_via_web,iesteban,vBbWUjQ8sd7PfWWWempMEf,,465,1,4087,10.1111/trf.15433,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,,2019,,4087,3,1,1
2022-08-02T15:29:45.676-03:00,2022-12-11T17:51:00.654-05:00,Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.,Zhang,2011-01-01,3402,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood_donors,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,blood_donation,1,0,0,0,0,0,,no,,no,,blood_donation_site,0,0,0,1,0,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,200,200,,venous,0,1,neutralization_test hemagglutination_inhibition_as elisa_eia__enzyme_immunoassay,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,0,1,0,0,1,0,1,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,173511897,a3547029-9a3f-4fcc-baf2-078ea57dc7b5,2022-08-02T18:39:32,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,384,1,3402,10.3109/00365548.2010.539258,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,1,2009,2011,2,3402,1,1,1
2022-07-31T10:55:18.458-04:00,2022-12-27T10:44:44.605-07:00,"Prevalence of hepatitis B virus infection in Kaifeng, China: A 5-year observation",Zhang,2018-01-01,4459,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013 2014 2015 2016 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,samples from patients to Kaifeng Central Hospital,diagnostic_sample,0,0,0,1,0,0,,yes,only samples for general health routine check-ups,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,52848,52848,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_population_seropos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,173045929,b5984fde-1b4a-4cf0-8ab5-f9c75c7ed377,2022-07-31T15:04:19,,,submitted_via_web,abernas,vJxpaqGQRfYLcJenmKU7ER,,366,1,4459,10.4014/mbl.1806.06010,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2013,2018,5,4459,1,1,1
2022-08-01T16:03:15.854-03:00,2022-12-05T21:52:21.260-05:00,"Measles immunity in the China-Myanmar border region, Lincang city, Yunnan province, 2017.",Zhou,2020-01-01,3441,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,CN,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,migrants,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,"immigrants, Myanmar immigrants, 60 years of age or younger, who have been in China for at least 3 months, and whose visit included a blood draw for reasons other than measles",diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,subjects were excluded if they had an immunosuppressive condition or had an acute infection,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti yes__samples_de_identified,1,1,0,0,1,0,0,0,,655,300,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,measles,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,1,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,173510265,f8701a35-439b-4d3d-9f68-b798f9236b81,2022-08-02T18:29:55,,,submitted_via_web,iesteban,vJxpaqGQRfYLcJenmKU7ER,,383,1,3441,10.1080/21645515.2019.1673641,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,2017,2020,3,3441,1,1,1
2022-05-15T20:13:02.887-04:00,2022-12-27T10:43:13.262-07:00,Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017,Zhu,2018-01-01,4437,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2016 2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,HK,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,hospital in- and out-patients + vaccinees,diagnostic_sample,0,0,0,1,0,0,,unknown,,yes,symptomatic for influenza or any acute respiratory illness,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,635,635,,venous,0,1,neutralization_test hemagglutination_inhibition_as,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,used_inclusion_exclusion_criteria_for_th conducted_stratified_analysis__results compared_to_other_published_estimates__d testing_samples_multiple_times_for_the_s,0,1,1,0,0,1,0,1,0,to_describe_population_seropos to_describe_viral_dynamics,1,0,0,0,0,0,0,0,0,0,0,1,0,0,,,157153519,3e4072bc-4ba2-4f0c-a9c4-318acb1766d7,2022-05-16T00:24:00,,,submitted_via_web,iesteban,vKU2RcYrkTMFcboLseYh88,,89,1,4437,10.1038/s41426-018-0041-1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,0,2016,2018,2,4437,1,1,1
2022-03-02T07:34:21.552-05:00,2022-12-05T21:17:28.155-05:00,"Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.",Zimmer,2010-01-01,3394,2010,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__samples_de_identified,1,0,0,0,1,0,0,0,,946,846,,venous,0,1,hemagglutination_inhibition_as,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,influenza,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or,1,0,0,0,0,1,0,0,0,0,0,0,0,0,,,144367429,afa674a2-99a5-4830-b5a7-75a8e2d08521,2022-03-02T12:48:52,,,submitted_via_web,iesteban,vpQrgGPTK7VgMoGYycNBPf,,15,1,3394,10.1371/journal.pone.0011601,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2009,2010,1,3394,1,1,1
2022-12-18T07:46:56.031-03:00,2022-12-18T07:51:50.081-03:00,Unusual high prevalence of antibodies to hepatitis E virus in South Brazil.,Zorzetto,2021-01-01,14208,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,3000,3000,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,209049815,edb09e66-33f3-4656-8da9-13f33e60e459,2022-12-18T10:51:31,,,submitted_via_web,iesteban,vMiC3rKsWQrk7Rn6tEQ2nP,,597,1,14208,10.1093/femsle/fnab076,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,2019,2021,2,1420,1,1,1
2022-08-14T10:24:18.908-03:00,2022-12-11T21:46:47.920-05:00,"Seroprevalence of hepatitis B virus in children with cancer under chemotherapy in 6 hospitals of Santiago, Chile",Zubieta,2009-01-01,3545,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004 2005 2006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,CL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,children with cancer who have undergone chemotherapy or have had an hematopoietic stem cell transplant,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,170,170,281,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,compared_to_other_published_estimates__d,0,0,0,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,175871875,452e213b-1cb9-456e-b332-a93d70447fa5,2022-08-14T13:36:32,,,submitted_via_web,iesteban,v3TqcHtG6WvcGn92mwZbUP,,444,1,3545,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2004,2009,5,3545,1,1,1
2022-07-12T11:06:48.085-07:00,2022-12-20T13:12:28.128-05:00,"HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil.",da Silva,2016-01-01,3812,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010 2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1000 adult chronic HCV infected patients of both genders followed at the outpatient Liver Clinic at the University of Sao Paulo School of Medicine Hospital,diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,1000,1000,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a hepatitis_b,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,169189446,9ce890f9-1860-4b20-b271-50316656ef08,2022-07-12T18:26:00,,,submitted_via_web,abernas,vQteqvkE44GFbPjGfNx2An,,279,1,3812,10.5604/16652681.1212320,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2010,2016,6,3812,2,1,1
2022-07-05T10:33:07.669-03:00,2023-01-18T11:41:45.190-08:00,Is there a change in cytomegalovirus seroepidemiology in Spain?,de Ory,2004-01-01,2406,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1993 1994 1999 2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"(ARM II Seroepidemiological Survey [ARMIISS] run in 1993, and AMR III Seroepidemiological Survey [ARMIIISS] run in 1999)",diagnostic_sample,0,0,0,1,0,0,,yes,Aged 2- 60,unknown,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,no,0,0,0,0,0,0,0,1,,1873,1873,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_a varicella_herpes_zoster,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_estimate_infection_rates_or to_identify_risk_factors_of_se to_evaluate_changes_in_seropos,1,0,0,0,0,1,0,1,0,1,0,0,0,0,,,167880973,94ca0443-3905-4a69-a9c2-161efdba26be,2022-07-05T13:56:37,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,217,1,2406,10.1023/b:ejep.0000013253.56343.6f,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1993,2004,11,2406,2,1,1
2022-07-05T10:56:26.410-03:00,2024-04-25T20:21:01.084-04:00,Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine.,de Voer,2010-01-01,3814,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1995 1996 2006 2007,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,general_population,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,seroprevalence_study,0,0,1,0,0,0,,unknown,,unknown,,unknown,0,0,0,0,0,0,0,0,1,0,,hospital_clinic,0,1,0,0,basic_demographic_data__age__sex epi_data_on_vpd_of_interest__e_g__vaccin,1,0,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,14925,14925,,venous,0,1,multiplex,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,neisseria_meningitis tetanus,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,acknowledged_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_to_other_published_estimates__d,1,0,1,0,0,1,0,0,0,to_describe_population_seropos to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,167886617,62d7b42f-45fd-475a-8061-a3caf13e462d,2022-07-05T14:12:01,,,submitted_via_web,iesteban,v45acXkSNUkFv8KgQJXh42,,218,1,3814,10.1371/journal.pone.0012144,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1995,2010,15,3814,2,1,1
2022-02-17T21:08:18.471-05:00,2022-12-06T10:02:09.957-07:00,Declining prevalence of hepatitis A and silent circulation of hepatitis,deAlmeidaEAraújo,2020-01-01,4105,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011 2012 2013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,BR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,"visits to health centers, age specific: 18+yo",diagnostic_sample,0,0,0,1,0,0,,no,,no,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,household,1,0,0,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin epi_data_not_on_vpd_of_interest__e_g__hi,1,1,1,1,0,yes__broad_consent_given_at_ti,0,1,0,0,0,0,0,0,,990,990,,venous,0,1,elisa_eia__enzyme_immunoassay chemiluminescence_immunoassay immunoblot__western_blot,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,,hepatitis_a hepatitis_e,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,HepE (N=248) a subset of HepA (N=990),142262983,cc3aac25-946a-4632-8313-ed0af08548e5,2022-02-18T02:16:18,,,submitted_via_web,awinter,vpQrgGPTK7VgMoGYycNBPf,,3,,4105,10.1016/j.ijid.2020.09.024,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2011,2020,9,4105,2,1,1
2022-06-17T14:29:18.881-07:00,2023-01-05T10:59:30.034-07:00,Unexpectedly high proportion of drug users and men having sex with men who develop chronic hepatitis B infection,van Houdt,2012-01-01,7890,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,injection_drug_users non_injecting_drug_users msm,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,,Drug users (IDUs and non-IDUs) and MSM,diagnostic_sample,0,0,0,1,0,0,,no,,yes,had less than two follow-up visits,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_not_on_vpd_of_interest__e_g__hi,1,1,0,1,0,no,0,0,0,0,0,0,0,1,,1862,1862,2084,,,,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_b,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,no_mention_of_bias,conducted_stratified_subsampling conducted_stratified_analysis__results compared_it_to_alternative_data_source_f,1,0,1,0,1,0,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se to_evaluate_outcomes_of_seropo to_evaluate_changes_in_seropos,1,0,0,0,0,0,0,1,1,1,0,0,0,0,,,163929333,64fae2ce-14de-4c92-ad36-c41ab3ab11eb,2022-06-17T21:41:53,,,submitted_via_web,abernas,vi8ujSt4tdYVZ6Wbycvi9H,,138,1,7890,10.1016/j.jhep.2012.04.030,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,1984,2012,28,7890,1,1,2
2022-12-21T16:16:09.046-03:00,2022-12-21T16:22:24.997-03:00,Low awareness of past SARS-CoV-2 infection in healthy plasma donors,van den Hurk,2021-01-01,16512,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,US,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,plasma_donors,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,plasma_donation,0,1,0,0,0,0,,unknown,,unknown,,plasma_donation_site,0,0,0,0,1,0,0,0,0,0,,blood_bank,0,0,1,0,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc epi_data_on_vpd_of_interest__e_g__vaccin,1,1,1,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,7150,7150,8275,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,sars_cov_2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,acknowledged_bias,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_population_seropos to_identify_risk_factors_of_se,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,,209761049,92c3d0d6-0872-4d21-979e-dfc6f187a5c7,2022-12-21T19:22:15,,,submitted_via_web,iesteban,vK5JR7f6tri3BCsuYQDPWy,,604,1,16512,10.1016/j.xcrm.2021.100222,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,2020,2021,1,1651,1,1,1
2022-04-20T09:55:24.811-04:00,2022-12-27T12:11:17.521-07:00,Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC,von Witzleben,2021-01-01,5464,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011 2012 2013 2014 2015 2016 2017 2018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1,1,1,0,0,0,0,GB,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,patients with cancer,diagnostic_sample,0,0,0,1,0,0,,no,,no,,diagnostic_center_laboratory,0,0,0,0,0,1,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex,1,0,0,0,0,yes__approved_by_an_ethics_com yes__broad_consent_given_at_ti,1,1,0,0,0,0,0,0,,77,77,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,human_papillomavirus,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,testing_samples_multiple_times_for_the_s,0,0,0,0,0,0,0,1,0,to_evaluate_outcomes_of_seropo,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,152873414,8ccf3d1e-0f2b-42ae-bec3-0276405b8174,2022-04-20T14:12:15,,,submitted_via_web,iesteban,veAwrTM59Sap9PspfNKuZC,,28,1,5464,10.3389/fonc.2020.591063,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2011,2021,10,5464,1,1,1
2022-12-01T18:38:50.183-03:00,2023-04-24T10:54:21.830-07:00,Hepatitis E Infection in Solid Organ Transplant Recipients in Turkey,Öüt,2022-01-01,14508,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TR,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,yes,no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,patient_population,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,solid organ transplant patients,diagnostic_sample,0,0,0,1,0,0,,unknown,,unknown,,hospital_clinic,0,0,1,0,0,0,0,0,0,0,,diagnostic_center_laboratory,0,0,0,1,basic_demographic_data__age__sex extended_demographic_data__e_g__residenc,1,1,0,0,0,yes__approved_by_an_ethics_com,1,0,0,0,0,0,0,0,,485,485,,venous,0,1,elisa_eia__enzyme_immunoassay,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,hepatitis_e,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,residual_sample_not_biased__b_c_the_targ,conducted_stratified_analysis__results compared_to_other_published_estimates__d,0,0,1,0,0,1,0,0,0,to_describe_seroprevalence_amo to_identify_risk_factors_of_se,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,year of sample collection unknown,205400043,d72a35d3-444b-431c-a8ad-0f8b29c835bb,2022-12-01T21:53:48,,,submitted_via_web,iesteban,vK3ffTk4xKTo25GWqMwoxw,,544,1,14508,10.5152/tjg.2021.21071,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,2022,,1450,1,1,1
